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Introduction and aim of the thesis
Life across all kingdoms requires the ability to adapt to environmental 
changes and internally- or externally-inflicted stress. Therefore, all living 
creatures have evolutionarily acquired elaborate mechanisms in order to be 
able to adjust to the countless challenges encountered during their lifespan. 
Arguably, the most essential aspect of life that requires protection is genetic 
information, given that it is the part not only orchestrating all cellular functions 
but also ensuring species continuity. Genetic information, with the exception 
of RNA viruses, is encoded in DNA, whose integrity is thus paramount.
However, genome stability constantly encounters numerous threats, stemming 
from either endogenous sources, such as secondary metabolites and Reactive 
Oxygen Species (ROS) produced during energy production, or exogenous 
sources, such as UV or cosmic radiation, chemicals and other genotoxic 
agents. Furthermore, though endowed with highly accurate mechanisms 
that most often ensure precise DNA metabolism functions, cells are also 
challenged by erroneous DNA replication, transcription blocks, programmed 
induction of DNA Double Strand Breaks (DSBs) for cell differentiation, 
apparent during white blood cell maturation or meiosis, and volatile elements 
acquired during evolution, such as transposable elements. DNA damage 
arising due to all the aforementioned perils needs to be repaired, in order 
for genetic information to be maintained and cellular functions to continue 
normally. Alternatively, if DNA damage persists or DNA repair is inaccurate, 
mutations gradually emerge and the threat of chromosomal aberrations, such 
as amplifications, deletions and translocations, looms gravely. Though cells 
attempt to additionally limit genomic instability by activating other protective 
programs in parallel to DNA repair, such apoptosis and senescence, the 
eventual accumulation of certain mutations will allow few cells to escape 
such failsafe measures and form abnormal precursors, potentially leading 





The DNA Damage Response (DDR)
In order to combat all those foes and ensure genomic integrity, life has 
evolved several protective mechanisms in response to DNA damage, 
collectively known as the DNA Damage Response (DDR) (Fig. 1). Like other 
multifaceted stress responses, DDR is spatiotemporally tightly organised, 
in order to ensure optimal protection in a timely fashion. Initially, cells utilise 
existing resources to signal and deal with DNA damage; more specifically 
existing proteins are modified with a vast array of Post-Translational 
Modifications (PTMs) [1]. PTMs constitute versatile, reversible switches that 
allow signal propagation and scaffolding of downstream protein factories, 
comprised of several repair factors [2, 3]. The most instrumental enzymes in 
DDR, modifying a multitude of downstream targets, are the kinases ATM and 
ATR [4], and the E3 ubiquitin ligases RNF8 and RNF168 [5]. Concomitantly 
to protein PTMs, local or global chromatin remodelling ensues to lift spatial 
limitations imposed by the nucleosome structure and to facilitate access of 
the DNA repair machinery [6]. Subsequently to the change in the PTM status 
of several key proteins and in the chromatin environment, miRNA-induced 
post-transcriptional silencing modulates the differential gene expression of 
existing mRNAs [7], potentially funneling it towards pro-DNA repair profiles [8, 
9]. Furthermore, ribosome occupancy changes upon DNA damage, resulting 
in a partial translational arrest and a partial shift towards the expression of 
repair proteins [10, 11](Chapter 5). Finally, before DDR-related PTMs have 
subsided, the transcriptional response kicks in, culminating in alterations of 
the mRNA profile and eventually the proteome, in a manner often dependent 
on the originally inflicted DNA lesion [12, 13]. 
In the following sections I focus primarily on two key processes enabling 
cells to deal with all different kinds of DNA damage. Firstly, I introduce the 
various DNA repair mechanisms that directly reverse damage and reinstate 
the original genetic information, albeit not always precisely. I then elaborate 
on the nature of DNA Double Strand Breaks (DSBs) and DSB repair 
mechanisms, since most of the work presented in this thesis addresses DSB 
repair. Secondly, I present a brief overview of the intricate interplay between 
DNA damage and translational reprogramming, as a considerable part of 
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my work focuses on this relationship. Finally, I shortly mention how recent 
breakthrough in science-related technology is offering unprecedented ease 
in meticulously exploring the DDR.
DNA Repair Mechanisms
Equipped with cutting-edge scientific tools, several groups have attempted 
to elucidate the DNA repair pathways that have evolved to counteract the 
diverse forms of DNA damage (Fig. 2). More precisely, it is now common 
knowledge that bulky lesions distorting the DNA helix structure are repaired 
by Nucleotide Excision Repair (NER; detailed description in Chapter 2) [14]. 
When such lesions arise in non-transcribed regions they are dealt with Global 
Genome NER (GG-NER) [15], whilst when occurring in the transcribed strand 
they are recognised by the elongating RNA polymerase and taken care of 
by Transcription Coupled NER (TC-NER) [16]. Small adducts inflicted by 
alterations, such as deamination, alkylation and oxidation, of single bases or 
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Figure 1. DNA Damage and temporal regulation of the DNA Damage Response (DDR). 
Most often encountered DNA damage represented graphically on double-stranded DNA. On 
the top part, from left to right illustrated: 6-4 PhotoProduct (6-4PP), CycloPyrimidine Dimer 
(CPD), Interstrand CrossLink (ICL), Double-Strand Break (DSB), base damage, Single-Strand 
Break (SSB). On the bottom part, major processes employed by the DDR, arranged temporally 
from left to right. Picture for translational reprogramming taken from Nature Reviews Cancer. 




Repair (BER) [17]. BER is also responsible for restoring DNA Single Strand 
Breaks (SSBs) that may appear away from the replication fork [18].  On the 
other hand, DSBs are primarily repaired by Non-Homologous End-Joining 
(NHEJ) [19] and Homologous Recombination (HR) [20]. DSBs arise in 
mammalian genomes as a result of programmed endogenous processes, 
like meiosis or V(D)J recombination, and collapsed replication forks at nicked 
or crosslinked DNA. Additionally, exogenous assaults by Ionising Radiation 
(IR), topoisomerase inhibitors or radiomimetic drugs induce DSBs [21]. 
Mismatch Repair (MMR) corrects the infrequent errors of replicative DNA 
polymerases δ and ε, bestowing even higher fidelity in the process of DNA 
replication [22]. Finally, DNA damage that blocks DNA duplication can also 
be bypassed by low-fidelity DNA polymerases, in a process termed Trans-
Lesion Synthesis (TLS) [23]. Though beneficial in terms of dealing with 
the immediate danger of replication blockage, inaccurate TLS introduces 
genomic mutations that may accumulate over time. 
Figure 2. DNA Damage and major DNA repair pathways. Most often encountered 
forms of DNA damage and the repair systems responsible for their removal. Abbreviations 
used: Non-Homologous End-Joining (NHEJ), Homologous Recombination (HR), 
Base Excision Repair (BER), Transcription Coupled Repair (TCR), Transcription 
Coupled-Nucleotide Excision Repair (TC-NER), Global Genome-Nucleotide Excision 
Repair (GG-NER), TransLesion Synthesis (TLS), MisMatch Repair (MMR).  Figure 
adapted from the New England Journal of Medicine. 2009 Nov 5;361(19):1914.
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DNA Double Strand Breaks (DSBs)
Although they do not present the most often encountered form of DNA 
damage, DSBs pose the most challenging threat for repair systems, due 
to the simultaneous loss of information on both DNA strands. Though 
usually grouped altogether, DSBs vary significantly in their nature (Fig. 3). 
Depending on their structure, DSBs can be categorised into one-ended, 
such as those occurring during replication fork stalling or collapse, or two-
ended (pretty much everything else). Alternatively, the covalent attachment 
of a protein adjacent to the DSB, such as SPO11 during meiosis or TOPO-I 
upon treatment with camptothecin, or the synchronous emergence of several 
different lesions within a small DNA region, such as the IR-induced “clustered” 
damage, would render it a “dirty” break. On the contrary, a break not limited 
by nearby damage or masked by an attached protein would be assigned as 
“clean” [21]. The nature of a DSB, in combination with the cell-cycle stage, 
determines the DSB repair pathway that will be put into effect [24] and the 
potential requirement of additional repair pathways such as BER [18].
The importance of repairing DSBs is evident by the plethora of pathways that 
have evolutionarily arisen to contend them. Based on the amount of homology 
that these pathways utilise to restore the original information, they can be 
divided into those using no, little or full homology (Fig. 3). More specifically, 
NHEJ tethers clean or minimally processed DSBs together, employing no 
homology, thus often deviating from the initial sequence after repair [25]. 
On the other end of the spectrum, Homologous Recombination exploits 
the presence of the sister chromatid, or less frequently the homologue, in 
order to precisely reinstate the original DNA sequence [26]. Finally, Theta-
Mediated End-Joining (TMEJ) [27], Microhomology-Mediated End-Joining 
(MMEJ) [28] and Single-Strand Annealing (SSA) [29] utilise increasing 
amounts of homology respectively, so as to inaccurately correct the DNA 
damage. Though the significance of the three latter pathways is undisputed, 
their role in DSB repair is secondary to NHEJ and HR, hence I shall focus on 
those in more detail. NHEJ constitutes the principal repair pathway of DSBs 
in mammals, primarily because of its availability during the entirety of the 




fast and ubiquitous, the absence of homology-use creates a caveat; NHEJ 
is error-prone [25]. On the contrary, HR is error-free, being restricted to the 
cell-cycle stages in which sister chromatids are present, hence late-S or G2 
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Figure 3. Different origins and nature of DSBs. DSBs come in many different forms, one-
ended (depicted in light-green background) or two-ended (depicted in light-orange background), 
“dirty” or “clean”. The nature of the DSB, in combination with the cell-cycle stage it occurs, 
determines the repair pathway used to reverse it. Different DSB repair pathways utilise different 
amounts of homology. Here homology-use is illustrated on a coloured scale, ranging from 
no homology (yellow) to total homology (dark orange). Abbreviations used: Theta-Mediated 
End-Joining (TMEJ), Microhomology Mediated End-Joining (MMEJ), Single Strand Annealing 
(SSA), nucleotide (nt). Figure adapted from Molecular Cell. 2012 Aug 24;47(4):497-510.
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Non-Homologous End-Joining
The core reaction of NHEJ commences with the recognition of the break 
by the KU70-KU80 heterodimer, which creates a scaffolding dock for the 
accrual of downstream factors (Fig. 4a) [19]. The assembly of the KU-
complex ensures that the two ends of the DSB stay tethered, therefore 
being protected from excessive processing by nucleases. The concomitant 
recruitment of the kinase DNA-PKcs results in the phosphorylation of several 
chromatin targets, including XRCC4, Ligase 4, DNA-PKcs itself and histone 
variant H2AX. Although the functional significance of some of these targets 
has remained elusive, the formation of γH2AX culminates in the accumulation 
of 53BP1, which in tandem with the KU-complex, protects the DSB ends 
from nucleolytic editing by MRE11, DNA2 and EXO1. Subsequently to DNA-
PKcs activation, limited processing of the broken ends by ARTEMIS and 
other enzymes creates ligatable ends, which possess a 5’ phosphate and 
a 3’ hydroxyl. Finally, the heterotrimeric complex of DNA Ligase IV-XRCC4-
XLF joins the two ends together, successfully sealing the gap and restoring 
the double-stranded helix structure [25].
Homologous recombination   
HR is a multistep process entailing in a sequential manner, extensive 
processing of the DSB, search for homology and resolution/dissolution of 
formed Holliday junctions (Fig. 4b) [20]. More explicitly, DSBs initially attract 
both the KU-complex and the Mre11-Rad50-Nbs1 (MRN) complex. DNA 
nicking by the Mre11 nuclease and limited DNA resection towards the break 
(3’-5’ resection), by the combined action of Mre11 and CTIP, removes the 
KU-complex and commits the DSB to repair by HR [31]. Subsequent longer 
resection away from the DSB ensues (5’-3’ resection), creating extensive 
regions of 3’-single strand DNA (ssDNA). Long-range resection is executed by 
either of two nucleases EXO1 or DNA2 associating with the DNA-unwinding 
complex of BLM-TOPO3-RMI1 [24]. Resected DNA is immediately coated by 
the ssDNA-binding protein RPA, which forms a stable complex and protects 




RPA must be exchanged for the RAD51 recombinase. This exchange step 
occurs in multiple non-redundant ways, involving either complexes formed 
by RAD51 with RAD52 and RAD54 [32] or more predominantly the BRCA1-
PALB2-BRCA2-RAD51 complex (more details in the following sections) [33]. 
Upon being loaded on DNA, RAD51 forms nucleofilaments, initially probing 
neighbouring and subsequently more distant chromatin for homology [34]. 
When homology is detected, the DNA-RAD51 nucleofilament invades the 
homologous DNA and the correct information is copied. The result of this 
strand invasion is the creation of a D-loop which occasionally is resolved 
by strand-displacement, in a mechanism termed Synthesis-Dependent 
Strand Annealing (SDSA). However, the second DNA end of the D-loop is 
more frequently captured, culminating in the formation of a double Holliday 
Junction (dHJ). dHJs are subjected to processing by different complexes 
of endonucleases and helicases, leading to either their resolution or their 
dissolution [20] (Fig. 4) The net result of this laborious process is the error-
free restoration of the original DNA sequence. In the work presented in 
this thesis (Chapter 4), we have uncovered a novel regulatory level in the 
formation of the BRCA1-PALB2-BRCA2 complex, which is responsible for 
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Figure 4. Main DNA DSB repair pathways. (A) Non-Homologous End-Joining (NHEJ) 
involves (i) KU binding, (ii) DNA PK-cs activation, (iii) End-processing enzymes modifying 
the DNA-ends, (iv) XRCC4-XLF-LIG4 recruitment and (v) DNA religation. (B) Homologous 
Recombination entails (i) DNA end-resection initially by CTIP and the MRN complex, 
subsequently by EXO1 or DNA2 in concert with the BLM, RMI1, TOPO3 complex, (ii) RPA 
coating of 3’single stranded DNA (3’ssDNA), (iii) RPA-RAD51 exchange and RAD51-filament 
formation, (iv) RAD51-mediated search of homology, (v) D-loop formation and DNA synthesis, 
(vi-a) strand displacement and annealing or (vi-b) Holliday Junction formation and resolution/











































































































BRCA1 (BReast CAncer gene 1) is a paramount genome-caretaker, 
responsible for a wide array of protective mechanisms that guard genome 
integrity [35, 36]. Its importance becomes evident by the embryonic lethality 
observed upon homozygous BRCA1 deletion and the highly increased 
risk of tumour formation upon numerous pathogenic germline mutations or 
haploinsufficiency in the BRCA1 gene [35, 37-39].
BRCA1 forms a core complex with BARD1. This union shelters both partners 
from proteasomal degradation. Furthermore, this heterodimeric complex 
constitutes an E3-ubiquitin ligase [40-42] with several identified targets [43-
45], whose catalytic activity however is not essential for tumour suppression 
[46, 47]. Though BRCA1-induced ubiquitylation may be of secondary 
importance, the ability of BRCA1 to recognise and bind phosphorylated 
proteins via its tandem BRCT domains makes it an excellent docking platform 
for several HR proteins. Importantly, phosphorylation-dependent interactions 
between BRCA1 and factors such as ABRAXAS, FANCJ, CTIP are mutually 
exclusive. Abrogation of all these interactions by mutating a key residue in 
the BRCT domain of BRCA1 results in proliferation defects, chromosomal 
instability and reduced formation of functional HR complexes [46, 48]. 
Complex Function Composition HR effect Interaction
Core BRCA1 stabilisation and ubiquitin ligase activiy BRCA1-BARD1 promotes protein-protein
BRCA1A
G2-M checkpoint regulation and 






BRCA1B S phase progression and repair of replication associated DSBs BRCA1-FANCJ-TOPBP1 promotes
phosphorylation 
dependent





BRCC RPA-RAD51 exchange and RAD51 loading onto ssDNA BRCA1-PALB2-BRCA2-RAD51 promotes protein-protein
Table 1. Different BRCA1 complexes. BRCA1 forms several complexes with different 
partners in either a phosphorylation-depedent manner or a direct protein-protein 
interaction fashion. Those complexes have opposing effects on error-free repair by HR. 
Table adapted from Nature Reviews Molecular Cell Biology. 2010 Feb;11(2):138-48.
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To further elaborate, BRCA1 forms two phosphorylation-independent and 3 
phosphorylation-dependent complexes (Table 1):
1. BRCA1 interacts with phosphorylated ABRAXAS to form a complex 
comprising additionally RAP80, BRCC36 and MERIT40 [49, 50]. 
This so-called BRCA1A complex is targeted to DSB-neighbouring 
chromatin thanks to the RAP80-dependent binding of RNF8/RNF168-
ubiquitylated substrates [51, 52]. Though recruited at sites adjacent 
to the DSB, the BRCA1A complex is inhibitory to repair by HR, as it 
appears to limit DNA end-resection and to sequester BRCA1 from 
the single-stranded DNA compartment [53, 54], therefore limiting the 
association of BRCA1 with PALB2 and BRCA2 (Chapter 4), which 
facilitate RAD51 loading and HR. The BRCA1A complex also appears 
to be necessary for efficient regulation of the G2/M checkpoint [51, 
55, 56].
2. BRCA1 binds phosphorylated FANCJ (also known as BACH1 or 
BRIP1) [57, 58] to form the BRCA1B complex along with TOPBP1. 
When bound to BRCA1 in a functional BRCA1B complex, the 
FANCJ helicase promotes repair of replication-associated DSBs by 
HR, therefore assisting timely progression through S phase [59]. 
However, excessive amounts of FANCJ or loss of its ability to interact 
with BRCA1, by mutation of its phoshorylation-acceptor site, hinder 
HR and instead promote error-prone DNA damage bypass [60].
3. BRCA1 interacts with phosphorylated CTIP and the MRN-complex 
[61-63] to build the BRCA1C complex. Though the CDK-dependent 
phosphorylation of CTIP promotes the assembly of this complex and 
has a functional relevance in DT40 chicken cells [63], recent studies 
have indicated that the BRCA1-CTIP interaction is less important 
for DNA end-resection in human cells [48], as CTIP deficient cells 
complemented with the non-phosphorylatable mutant that cannot 
interact with BRCA1 display an unperturbed phenotype.
4. BRCA1 interacts with PALB2 by means of a direct protein-protein 




namesake domain in the N-terminus of PALB2 [33, 64, 65]. As it will 
be described in more detail later, PALB2 bridges the functions of 
BRCA1 and BRCA2, eventually promoting the formation of the BRCC 
complex which is responsible for the loading of RAD51 on ssDNA.
PALB2
Partner And Localiser of BRCA2 (PALB2) was originally identified as a 
protein interacting with BRCA2 and facilitating the latter’s nuclear functions, 
namely its recruitment and retention at sites of DNA damage [66, 67]. Further 
studies established that PALB2 is a tumour suppressor gene, evident by the 
phenotypes observed upon pathogenic PALB2 mutations or heterozygosity, 
namely increased cancer predisposition [68, 69], premature G2 checkpoint 
abrogation [70], aberrant DNA replication and defective DDR [71]. PALB2 is 
a scaffold protein, mediating interactions between various HR factors that 
culminate in the loading of the RAD51 recombinase on ssDNA. Most notably, 
PALB2 promotes the indirect association of BRCA1 and BRCA2 into a 
functional complex, therefore bridging ssDNA with 3’ overhangs, the product 
of early HR, to the latter HR step of homology search which is mediated by 
RAD51.
PALB2 accumulates at DSBs in a predominantly BRCA1-dependent manner, 
even though there is minimal accrual in the latter’s absence [65, 72]. BRCA1 
depleted cells reconstituted with a BRCA1 form that is unable to bind PALB2 
cannot restore HR efficiency to normal levels [33], indicating that BRCA1 
promotes HR primarily via PALB2. Though PALB2 recruitment at DSB 
occurs downstream of BRCA1, its chromatin retention is also mediated by its 
Chromatin Association Motif (ChAM) [73]. Interestingly, complementation of 
PALB2 cells with PALB2 lacking the ChAM domain fails to reinstate mitomycin 
C and olaparib survival rates to the wild-type situation [73], indicating that 
this motif is indeed necessary for the physiological function of PALB2.
As mentioned earlier, PALB2 additionally interacts with BRCA2 via its 
C-terminal-WD40 domain [67, 74]. This interaction is crucial for BRCA2 
recruitment at sites of damage, evident by the disappearance of BRCA2 
foci upon disruption of its association with PALB2 or loss of PALB2 [74]. 
25
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PALB2 depletion also impairs RAD51 assembly at DSBs, although residual, 
RAD52-dependent RAD51 foci formation is still obvious [32]. Furthermore, 
PALB2 itself promotes HR by binding ssDNA and stimulating nucleofilament 
formation via direct interaction with RAD51 [75, 76]. It is worth mentioning 
that PALB2 can also multimerise, an event mediated by the same domain 
that interacts with BRCA1. Over-expression of a small polypeptide containing 
solely this NT-coiled-coil domain acts in a dominant negative manner, 
effectively sequestering endogenous PALB2 from its physiological partners 
and therefore reducing HR efficiency [77]. A plausible scenario arising from 
this observation is that excessive levels of PALB2, unless accompanied 
by elevated amounts of BRCA1, might lead to increased self-association 
and inhibition of its role in HR. Finally, PALB2 in tandem with BRCA2, but 
independently of RAD51, has been shown to promote replication fork restart 
after the induction of replication stress, by specifically recognising and 
interacting with phosphorylated RPA [78]. 
BRCA2
The final key player of the BRCC complex is BRCA2 (BReast CAncer 
gene 2), the actual culprit of RPA-RAD51 exchange. Rather similarly to 
BRCA1, BRCA2 is a prominent guardian of genome integrity, thus earning 
the nickname “chromosome custodian” [35]. Loss or pathogenic mutations 
of BRCA2 notably increase cellular genomic instability, promote malignant 
transformation and predispose to several different forms of cancer [39, 79].
BRCA2 binds ssDNA-dsDNA junctions [80] and facilitates RPA displacement 
[81], while at the same time it associates with RAD51 [82, 83] and promotes 
RAD51 filament formation specifically on ssDNA [84, 85]. BRCA2 accrual at 
double-ended DSBs is entirely dependent on its upstream partners BRCA1 
and PALB2. However, besides its established role in RAD51 loading, BRCA2 
was recently shown to hold a crucial role in the initial stabilisation of stalled 
replication forks and the subsequent error-free restart by HR. BRCA2 fulfils 
this exceptional role in two different ways, either by interacting with Polη 





DNA damage and translational reprogramming
One important response that cells launch upon the induction of DNA 
damage is translational reprogramming, entailing a temporary halt in protein 
synthesis and a shift towards the expression of specific transcripts [10, 88, 
89](Chapter 5). The translational arrest ensures energy preservation, given 
that normal protein synthesis consumes up to 40% of cellular ATP [90], while 
the translational switch promotes the synthesis of pro-survival proteins [11]. 
The importance of this translational response becomes further apparent by 
several unbiased genetic screens, showing that proteins involved in translation 
either constitute primary targets of DNA damage induced phosphorylation 
[91] or play a significant role in protecting against spontaneously induced 
DNA damage, evident by γH2AX formation [92]. Last but not least, several 
studies have now established that excessive protein synthesis fosters 
oncogenic transformation and tumourigenesis [11, 93], channeling new lines 
of research into the development of specific translation inhibitors that halt 
tumour progression [11, 94] or reverse chemoresistance [95]. 
The process of translation can be roughly divided into three stages: initiation, 
elongation and termination, with most of protein-synthesis regulation taking 
place at the rate-limiting step of initiation [11]. Cap-dependent translation-
initiation begins with the formation of a heterotrimeric complex called eIF4F. 
This complex interacts with the mRNA-stabilising protein PABP and in concert 
with the 43S Pre-Initiation Complex (PIC) scans the 5’UTR of mRNAs for the 
first AUG codon [96]. eIF4F is comprised of a scaffolding protein (eIF4G), a 
helicase responsible for RNA unwinding (eIF4A) and a protein recognising 
the m7GTP-modified 5’-end of the mRNA (eiF4E), the so-called mRNA cap 
[93] (Fig. 5a). The latter protein, eIF4E, is the least abundant and most 
diversely controlled, constituting the bottleneck in eIF4F formation and thus 
translation initiation [94]. 
Given its rate-limiting status, several proteins have evolved to antagonise 
the interaction of eIF4E with either the rest of the eIF4F complex or the 
mRNA cap, therefore hindering translation initiation. A prime example of the 
prior form of inhibition is the appropriately termed eIF4E-Binding Proteins 
27
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(4E-BPs). 4E-BPs share extensive homology with eIF4G and thus vie for the 
same binding places on eIF4E [95]. 4E-BP association with eIF4E sequesters 
it from the eIF4F, abrogating eIF4E binding to eIF4G [93] (Fig. 5B). Adding 
an extra regulatory layer, the eIF4E interaction with 4E-BP depends on the 
latter’s phosphorylation status. Hypophosphorylated 4E-BPs readily bind 
and sequester eIF4E while mTOR-induced 4E-BP hyperphosporylation 
abrogates this interaction [96]. Besides eIF4E sequestration, cells inhibit 
translation initiation by expressing a structural analog of eIF4E, a protein 
called 4EHP. While 4EHP retains the ability to bind the mRNA cap, it cannot 
form a productive complex with eIF4G [96], effectively rendering 4EHP-
bound transcripts secluded from the translation machinery (Fig. 5C). As with 
4E-BPs, 4EHP is modulated by PTMs, namely ubiquitination [97] (Chapter 
5) and ISGylation [98]. Both of these modifications appear to facilitate 4EHP 
binding to the cap structure and therefore translation inhibition.
Figure 5. Inhibition of the cap-dependent 
translation initiation complex. (A) The eIF4F 
complex regulates cap-dependent translation 
initiation, binding upstream of the first AUG 
codon and scanning the 5’UTR of the translated 
mRNA. eIF4F consists of scaffolding protein 
eIF4G, RNA helicase eiF4A and m7cap-
mRNA-binding protein eIF4E. PABP binds the 
poly-adenylated tail of the mRNA, creating 
a circular fold. (B) Inhibition of the eIF4E-
eIF4G interaction by 4E-Binding Proteins 
(4E-BPs). 4E-BP hyperphosphorylation lifts 
the inhibitory effect. (C) Competitive inhibition 
of eIF4E binding to the cap of the mRNA by 
4EHP. 4EHP is a structural analog of eIF4E 
binding the cap but not interacting with the 
rest of the eIF4F complex. 4EHP ubiquitylation 
or ISGylation promotes its binding to the 
cap. Abbreviations used: eukaryotic Initiation 
Factor (eIF), Poly-(A) Binding Protein 
(PABP), Ubiquitin (U), Interferon Stimulated 
Gene 15 (ISG). Figure adapted from Nature 


































A breakthrough in scientific tools allows investigating gene 
interactions in genome-wide scale
The last decade has brought huge strides in science-related technology, 
enabling the detailed study of cellular processes such as the DDR. Firstly, 
ever-improving Mass Spectrometry facilities have allowed the meticulous 
study of changes upon DNA damage in the proteome and in the various 
protein PTMs, especially phosphorylation [99, 100] and ubiquitylation [101]. 
Furthermore, the field of transcriptomics has been revolutionised by the 
advances in sequencing techniques [102], dictating a de facto change from 
micro-arrays to Next Generation Sequencing (NGS). The latter not only 
provides an unprecedented, in-depth analysis of the transcriptome upon 
genotoxic stress, but also a comprehensive grasp of the mutational signatures 
in human cancers [103, 104] and repair-pathway-balance after DNA damage 
induction [27, 105]. Finally, it has never been easier to manipulate genomes, 
whether in the conventional way of creating mutants in model organisms 
[106], in the form of siRNA- or shRNA-mediated protein depletion [12, 107] or 
Crisper/Cas9-modification of endogenous loci [108, 109]. These tools have 
granted us the ability to perform functional genomics screens in protein-by-
protein-reduced genomes and to investigate gene interactions in a genome-
wide manner upon various forms of genotoxic stress [12, 110].
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AIMS AND OUTLINE OF THIS THESIS
The meticulous study of the molecular mechanisms that cumulatively 
constitute the DDR is of the outmost importance for numerous reasons. 
Primarily, further elaboration on the interconnection of the processes 
comprising the DDR would enhance our chance of discovering drugable 
targets. The latter might prove useful for the never-ending battle against 
tumourigenesis and neurodegeneration. Furthermore, a better grasp on how 
the DDR works in the tissue or organism level would be undoubtedly beneficial 
for our strive to minimise the effects of ageing. Given their emerging role as 
central regulators of multiple facets of the DDR, the elucidation of protein 
PTMs and specifically ubiquitylation was chosen to be the focal point of my 
study.  
In my thesis I put forward our most notable findings, which further elaborate 
the intricate role of PTMs in the regulation of the DDR at multiple levels. 
Initially, I provide a summary of the recent developments and our views on 
the modulation of NER (Chapter 2). Subsequently, I present the results from 
a genetic screen we performed, showing that the De-Ubiquitylating (DUBs) 
enzymes USP26 and USP37 control both the DSB signalling cascade and 
DSB repair (Chapter 3). In Chapter 4 I introduce our unexpected finding 
that the RNF168 E3-ubiquitin ligase facilitates the error-free repair-pathway 
of HR by mediating PALB2 recruitment at the sites of damage. Illustrating 
the value of extensive, functional genomic screens in the elucidation of the 
DDR, in Chapter 5 I present our results showing that the ARIH1 E3-ubiquitin 
ligase, one of the hits of our screen, orchestrates a DNA-damage induced 
translational arrest that promotes cell survival of both untransformed and 
cancer cells. In Chapter 6, I report our preliminary findings on the role of 
ARIH1 in directly mediating DSB repair. Finally, in Chapter 7, I discuss our 
discoveries under the spectrum of recent advancements in science-related 
technology and novel work in the DDR field. I also submit my thoughts on the 
perspective of the research-projects presented, hoping that further study on 
those will not only advance our understanding of the molecular mechanisms 
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Nucleotide excision repair (NER) is a key component of the DNA damage 
response (DDR) and it is essential to safeguard genome integrity against 
genotoxic insults. The regulation of NER is primarily mediated by protein 
Post-Translational Modification (PTMs). The NER machinery removes a 
wide spectrum of DNA helix distorting lesions, including those induced by 
solar radiation, through two sub-pathways: Global Genome-NER (GG-NER) 
and Transcription Coupled-NER (TC-NER). Severe clinical consequences 
associated with inherited NER defects, including premature ageing, 
neurodegeneration and extreme cancer susceptibility, underscore the 
biological relevance of NER. In the last two decades most of the core NER 
machinery has been elaborately described, shifting attention to molecular 
mechanisms that either facilitate NER in the context of chromatin or promote 
the timely and accurate interplay between NER factors and various PTMs. 
In this review, we summarise and discuss the latest findings in NER. In 
particular, we focus on emerging factors and novel molecular mechanisms 
by which NER is regulated.
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INTRODUCTION
A wide variety of genome-caretaking mechanisms, collectively referred to 
as the DNA damage response (DDR), neutralise the deleterious effects of 
DNA damage and prevent toxicity, mutagenesis and genomic instability. 
The DDR entails both initial sensing of DNA damage and subsequent 
signalling cascades, which activate cell cycle checkpoints and distinct 
repair pathways, depending on the type of damage. Among the various 
human repair pathways, Nucleotide Excision Repair (NER) is the only repair 
system capable of counteracting ultraviolet (UV)-light-induced genotoxic 
insults. NER eliminates DNA photolesions i.e. 6–4 pyrimidine-pyrimidone 
photoproducts (6–4PPs) and Cyclo-butane Pyrimidine Dimers (CPDs). The 
importance of NER in protecting organisms against the carcinogenic effects 
of solar-UV-induced DNA damage is underscored by the hereditary disease 
Xeroderma Pigmentosum (XP). XP patients are clinically characterised by 
hypersensitivity to sunlight, predisposition to skin cancer and, in a minority 
of cases (25%), premature ageing accompanied by severe neurological and 
developmental problems [1]. XP has been linked to defects in seven NER 
genes (XP-A through XP-G) and in a gene encoding DNA polymerase eta 
(XP variant). 
NER removes bulky DNA lesions through two distinct sub-pathways: Global 
Genome-NER (GG-NER) and Transcription Coupled-NER (TC-NER). 
GG-NER corrects DNA damage occurring in the entire genome, whereas 
TC-NER specifically acts on DNA damage in the transcribed strand of 
transcriptionally active genes. The two sub-pathways primarily differ in the 
recognition of DNA lesions in chromatin. GG-NER commences with the 
concerted action of two heterodimeric complexes, namely UV-DDB and XPC–
RAD23, that encompass two XP factors (XPE and XPC), whereas TC-NER 
is initiated by stalling of RNA polymerase II at UV-induced DNA lesions that 
triggers the recruitment of TC-NER specific, non-XP factors. After damage 
recognition, both pathways converge into a common pathway that involves 
DNA unwinding, lesion verification, dual incision, DNA re-synthesis and 
finally ligation. In the last two decades, the core NER machinery has been 




mechanisms that either regulate NER in the chromatin-context or promote 
the spatiotemporally accurate interplay between NER factors and various 
PTMs (Fig.1 and 2). In this review, we summarise the newest findings in the 
field and discuss emerging regulatory mechanisms ensuring NER efficiency.
Transcription Coupled-NER (TC-NER)
Stalling of elongating RNA polymerase by DNA lesions in the transcribed 
strand of active genes initiates fast repair of the blocking DNA damage. This 
process is referred to as Transcription Coupled-NER. Defects in TC-NER are 
associated with the severe developmental and neurological disorder Cockayne 
Syndrome (CS) and the much milder disorder UV sensitive syndrome 
(UVsS), which is primarily characterised by skin photosensitivity. Classic 
CS results from mutations in the Cockayne Syndrome complementation 
group A or B genes (CSA and CSB). A distinct, though much smaller, set of 
mutations in these genes underlies UVsS. Intriguingly, it was recently shown 
that UVsS most often relates to mutations in the KIAA1530 gene, which 
was subsequently renamed to UVSSA (encoding UV-stimulated scaffold 
protein A) [2-4]. As both disorders are characterised by impaired TC-NER, 
but with substantially different clinical outcomes, it is possible that the TC-
NER defect only explains the common hypersensitivity to sunlight, while 
the neurodevelopmental abnormalities observed for CS patients may arise 
largely due to a defect in the CSA/CSB function in other cellular processes 
[5-7]. In line with this scenario, CS proteins have been implicated in other 
processes such as transcription [8, 9], oxidative damage repair [10, 11] and 
maintenance of mitochondrial DNA stability [12-14]. Whether UVSSA exerts 
a role in the aforementioned processes has yet to be determined.
UVSSA: a novel regulator of TC-NER
Current models describe the recruitment of the SNF2/SWI2 
ATPase CSB upon stalling of elongating RNA polymerase II (RNAPIIo) to 
the site of damage, their transient interaction being stabilised in an ATP-
dependent manner [15-17]. This step is followed by the CSB-dependent 
recruitment of CSA, which functions as a DCAF adaptor in the E3 ubiquitin 
ligase complex consisting of Cullin4A, DDB1 and Rbx1/ROC1 (CRL4CSA). 
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This complex has common architectural features with the CRL4DDB2 complex 
responsible for damage recognition in GG-NER [18]. 
Upon identification of UVSSA as the causative gene for UVsS by whole-
exome sequencing [2], microcell-mediated transfer [4] and SILAC- based 
proteomic approaches [3, 19], the role for the UVSSA protein in TC-NER was 
manifested by four research groups. Schwertman et al. and Nakazawa et al. 
showed that, upon UVSSA depletion, the recovery of RNA synthesis after 
damage induction was diminished, while unscheduled DNA synthesis was 
unaffected [2, 3]. In line with these results, immunostaining of UV-induced 
CPDs and 6–4PPs further indicated that UVSSA is dispensable for GG-NER, 
as UVSSA knockdown did not change the overall repair efficiency in either 
wild-type or CSA-deficient cells, confirming its specific role in TC-NER [4, 19]. 
In addition, by either mass spectrometry, or immunoprecipitations combined 
with western blot analyses [2-4, 19], several groups not only recognised 
DDB1, CSA and several TFIIH subunits as UVSSA-interacting proteins in the 
absence of damage, but also showed a UV- and CSA-dependent interaction 
with CSB and RNA polymerase II. 
Three-dimensional structure prediction identified a domain of unknown 
function (DUF20430) near the C-terminus of UVSSA and a domain with 
substantial homology to the Vps-27, Hrs and STAM (VHS) domain close to 
the N-terminus of UVSSA. The presence of both domains is required for TC-
NER activity, as shown by the lack of RNA synthesis recovery by reconstitution 
of several deletion mutants in UV-irradiated UVSSA-deficient cells [2]. The 
VHS domain has been shown to contain the CSA binding site and is likely 
also important for strengthening the UVSSA interaction with CSB or (other) 
ubiquitylated proteins. The CSA binding domain was mapped to a different 
region than the domain required for interaction with TFIIH, but deletion of 
the latter rendered HEK293T cells equally sensitive to UV-irradiation as 
those lacking the CSA interacting domain [19]. In contrast, ChIP experiments 
employing chromatin from cross-linked cells [3] indicate that UVSSA might 
as well be recruited to the repair complex via a RNA polymerase-dependent, 
but UV- and CSA/CSB-independent interaction. The latter scenario is also 




local UV-C DNA damage in CSA- and CSB-deficient cells [3], suggesting that 
it is not the recruitment per se, but merely the stabilisation of UVSSA within 
the repair complex that depends on the CS proteins [3, 4, 7]. In addition, 
UVSSA was implicated in the dephosphorylation of elongating RNAPIIo 
upon stalling at a UV-induced lesion. In KPS3 cells that lack UVSSA, the 
hypo-phosphorylated, initiating form of RNAPII after an initial decrease upon 
UV-irradiation does not reappear. Such an effect is also observed in CSA- or 
CSB deficient cells and certain XP mutants, indicating impaired restoration 
of RNAPII levels, which in repair proficient cells ensures transcription re-
initiation [2, 4, 20]. 
Interestingly, the deubiquitylating enzyme Ubiquitin-Specific Protease 7 
(USP7) was also picked up as a UVSSA interaction partner, irrespectively 
of its cellular localisation or the presence of DNA damage [3, 19]. USP7 
has been reported to target several proteins involved in the DNA damage 
response, as well as tumour suppressors, DNA replication proteins, viral 
proteins and epigenetic modulators [21-23]. USP7 depletion led to diminished 
RNA synthesis recovery and cell survival after UV-damage induction, at levels 
comparable to those observed upon UVSSA-depletion [2, 4]. UVSSA and 
USP7 were found to interact with the same set of TC-NER proteins. Moreover, 
a proteasome- and UV-dependent decrease in CSB levels was shown to 
depend on both UVSSA and USP7 [2]. Taken together, this data indicates 
the formation of a stable UVSSA-USP7 complex, which likely explains the 
common role for both proteins in CSB stabilisation upon DNA damage 
induction. A plausible model for the function of the UVSSA-USP7 complex 
in CSB stabilisation would require UVSSA to bring USP7 in close proximity 
to CSB in the TC-NER complex, thus enabling it to exert its deubiquitylating 
activity on CSB, eventually preventing proteasomal degradation of CSB.
Elongating RNA Polymerase degradation
Several studies have demonstrated that the UV-induced degradation of RNA 
polymerase is dependent on CSA and CSB, although different E3 ubiquitin 
ligases have been suggested to be responsible for the actual K48-linked 
ubiquitylation. A UV-dependent decrease in elongating RNA polymerase in 
is apparent in both repair-proficient and UVSSA-deficient cells [2]. Current 
2
43
Insight in the multilevel regulation of  NER
evidence, regarding RNAPIIo processing by UVSSA and the CS proteins, 
would fit into a model that supports various events upon stalling of RNA 
polymerase at a lesion. UV-irradiated cells lacking one of the CS proteins 
would initiate a signalling cascade, likely prompted by the prolonged stalling 
of RNAPIIo, that eventually would lead to apoptosis. This signalling response 
would most likely be mediated by defective TC-NER in concert with the 
inability to degrade RNA polymerase. However, in UVSSA-deficient cells, 
although TC-NER is defective, CSB- and CSA-dependent removal of RNA 
polymerase is still possible. The net result is not only avoiding persistently 
stalled RNA polymerase at the site of damage but also enabling repair 
via alternative pathways [2, 3]. Although it is postulated that the lesion-
shielding RNA polymerase needs to be displaced from the site of damage, 
in order to increase the accessibility by repair factors and to allow repair, 
UV-mediated degradation of RNA polymerase might only be a last resort, in 
case the impaired transcription elongation becomes detrimental to the cell. 
A mechanism of backtracking of transcribing RNA polymerase would enable 
resumption of transcription after repair, by sliding backward along the DNA 
and RNA. This appears to be a more efficient process than transcription 
termination as a prerequisite for NER. 
Backtracking of elongating RNA Polymerase and transcriptional restart
RNA polymerase backtracking has been implicated in many processes, 
including maintenance of genome stability, control of transcription elongation/
termination; additionally, backtracking has been suggested to possess 
a proofreading function [24, 25]. As opposed to backtracking, the forward 
translocation of RNA polymerase promoted by the DNA translocase Mfd 
has been shown to drive TC-NER in prokaryotes [26-28]. Subsequently to 
displacing stalled bacterial RNA polymerase, Mfd also recruits UvrA, which 
along UvrB initiates repair by attracting the incision factor UvrC. However, 
evidence for an essential role of backtracking in TC-NER in Escherichia coli 
was recently presented [29]. In an in vitro single-round runoff elongation 
assay, ATP-dependent pausing of RNA polymerase was shown to result 
from backtracking mediated by the UvrD helicase, as the extruding RNA was 




Deficiency in the transcript cleavage factors GreA and GreB, that would 
normally counteract backtracking by UvrD, appeared to increase the lesion 
repair rate and also rendered UvrD-deficient cells less sensitive to several 
DNA damage inducing agents. Moreover, in vitro CPD excision by UvrC 
appeared to be severely inhibited in the absence of UvrD, when the elongation 
complex was positioned in a lesion-shielding manner, compared to either the 
presence of UvrD or the assembly of RNA polymerase at a position upstream 
to the CPD. Based on this data, UvrD-induced backtracking was suggested 
to be the main mechanism to displace RNA polymerase from the damage 
during TC-NER in prokaryotes, while stimulation of its forward movement by 
Mfd was proposed to be mainly important for transcription reactivation after 
repair [29]. Whether TC-NER is also driven in eukaryotes by backtracking 
remains to be elucidated. Given the evolutionary conservation of TC-NER 
and the frequent occurrence of backtracking as a regulatory mechanism at 
transcription pausing sites, this scenario is not unlikely [25, 29].
Figure 1. Upon damage-
induced stalling of elongating 
RNA Polymerase II (RNAPIIo), 
the formation of the pre-incision 
complex is initiated by stabilisation 
of the RNAPIIo-CSB interaction 
and subsequent recruitment of 
CSA. UVSSA becomes part of the 
TC-NER complex in either a CSB/
CSA-dependent interaction or by its 
interaction with RNAPIIo. UVSSA 
recruits the de-ubiquitinating 
protein USP7 in the vicinity of 
CSB, thereby removing ubiquitin 
chains from CSB and protecting it 
from degradation. Displacement 
of RNAPIIo from the site of 
damage by either its proteasomal 
degradation or backtracking 
increases accessibility to other 
NER factors. RNAPIIo degradation, 
which depends on CSA and 
CSB, implicates transcription 
termination as a requirement for 
repair, while backtracking enables 
a resumption of transcription after 
repair from a site relatively close 
to the damage. In both cases, specific chromatin remodeling is required for continuation of 
transcription and restoration of gene expression to original levels.
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Transcription restart upon repair completion
At the cellular level, impaired TC-NER in CS or UVSSA-deficient cells results 
in inability to resume RNA synthesis after DNA damage. Recently, several 
groups demonstrated that completion of damage repair itself is not sufficient 
to restart the transcription machinery. Instead, recovery of transcription seems 
to require chromatin reorganisation so as to establish pre-damaged levels of 
gene expression. For example, in addition to the contribution of the histone 
chaperones CAF1 and ASF1 [30], the restart of stalled RNA polymerase 
was shown to be promoted by the SPT16 subunit of FACT (FAcilitates 
Chromatin Transcription), which accelerates the damage-induced exchange 
of histones H2A and H2B [31]. Moreover, a role in transcriptional restart upon 
DNA repair was recently described for the histone chaperone HIRA and the 
methyltransferase Dot1L, which act by stimulating H3.3 incorporation and 
H3K79 dimethylation, respectively [32-34]. In parallel to the chromatin 
relaxation required for early NER events, specific chromatin remodelling 
and PTMs appear to be essential for NER-completion and transcription 
continuation.
Global Genome NER (GG-NER)
Elaborating on the handoff between the two GG-NER sensor complexes
Given the fact that UV-damage recognition appears to be one of the rate-
limiting steps in NER [35], the intricate interplay between the two sensor 
complexes, UV-DDB and XPC-Rad23-Centrin, is paramount. Although 
DDB2 is dispensable for the in vitro reconstitution of the NER reaction [36], 
its in vivo presence has been demonstrated to significantly stimulate XPC 
binding to UV-damaged chromatin [37, 38], especially at lesions otherwise 
intractable by XPC, such as CPDs [39]. 
Several hypotheses have been raised to exemplify the DDB2-to-XPC 
handover. It was initially postulated that a direct interaction between these 
two proteins might exist. Though there have been reports supporting this 
scenario [40, 41], mapping specific interaction-domains and validation of 




indicating that if DDB2 and XPC indeed interact, they do so very transiently. 
On the other hand, it is by now well understood that DDB2 regulates the 
retention time of both UV damage-recognition complexes, as part of the 
CUL4A-DDB1-RBX1 ubiquitin ligase (CRLDDB2) [42]. CRLDDB2 promotes the 
ubiquitylation of XPC and itself upon UV irradiation [41] with the kinetics of 
this modification, not coincidentally, being very similar to the association with 
photo-lesions [43]. Whilst DDB2 poly-ubiquitylation leads to its dissociation 
from the sites of UV damage and its proteasomal degradation [41, 44], the 
atypical poly-ubiquitylation of XPC increases its stability at photo-lesions 
[41, 43]. Although the swift, UV-mediated proteasomal degradation of DDB2 
is counterintuitive, recent reports have sought to elucidate its significance. 
On first instance, it was demonstrated that the residence time of DDB2 at 
photo-lesions is regulated by competing PTMs. DDB2 poly-ADP ribosylation 
(PARylation) and ubiquitylation occur at the same region, with the former 
inhibiting the latter, therefore increasing the half-life of DDB2 [45]. Moreover, 
it has become clear that the timely removal of DDB2, and later XPC, is 
controlled by its ubiquitylation status and its segregation by VCP [46], forming 
an additional regulatory level exerted by ubiquitylation of UV-damage sensor 
complexes. 
Intriguingly, XPC too appears to be tightly modulated by multiple PTMs 
upon UV irradiation, as it was shown not only to be ubiquitylated at several 
sites [47] but also SUMOylated [48]. These two modifications, in contrast 
to the competitive nature of PARylation and ubiquitylation of DDB2, appear 
to behave cooperatively. More explicitly, XPC SUMOylation promotes the 
accumulation of the SUMO-targeted E3 ubiquitin ligase RNF111, which in 
turn further decorates XPC with non-proteolytic K63-ubiquitin chains [43]. 
Given the fact that XPC is intrinsically unstable as a monomer, necessitating 
its association with stabilising partners hRad23A/B [49, 50], it is striking that 
upon UV irradiation and XPC binding to damaged chromatin, hRad23A/B 
dissociates [49]. Concomitantly, XPC ubiquitylation reaches its peak [43], 
raising the possibility that non-canonical XPC ubiquitylation might be initially 
read by downstream effectors in a protective manner that will stabilise XPC 
at the sites of damage. Following UV-damage recognition and verification, 
ubiquitylated XPC is removed by VCP in order to promote the build-up of the 
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downstream repair complex [46].
Restructuring chromatin around UV damage
Like other DNA metabolism processes, NER is to a great extent regulated by 
chromatin status. Highly compacted heterochromatin poses a challenge for 
efficient NER, manifested by the relatively slow repair of bulky DNA lesions 
[51], most likely necessitating carefully modulated and spatiotemporally 
precise chromatin remodeling events. Such events usually promote transient 
Figure 2. (A) UV-DDB is the first NER factor to accumulate at UV damage, as part of the Cullin-
RING-E3 ubiquitin ligase complex CUL4A- DDB1-RBX1. This complex binds to UV damage 
and, in concert with PARP1, tightly regulates the steady-state levels and retention time of 
DDB2 by opposing modifications (PARylation and ubiquitylation). PARP1 creates accessibility 
for recruitment of NER factors by its ability to disrupt chromatin structure and by promoting 
the recruitment of Swi2/Snf2 chromatin remodeler ALC1, thereby stimulating the recruitment 
of XPC to assemble a functional repair complex. (B) XPC ubiquitylation is mediated by the 
UV-DDB complex and by its SUMOylation that promotes the assembly of the SUMO-targeted 
E3 ubiquitin ligase RNF111, which in turn further decorates XPC with non-proteolytic K63-
ubiquitin chains. Following UV-damage recognition and verification, ubiquitylated XPC is 




chromatin decompaction, therefore granting access to the repair machinery 
at sites of damage. Although such open chromatin conformation is beneficial 
at early stages, upon completion of DNA repair, chromatin environment needs 
to be restored to its original state so that epigenetic marks and transcriptional 
status can be maintained [52]. 
While it has been demonstrated that UV damage per se results in histone 
eviction [53], local chromatin de-condensation is more commonly achieved 
by PTMs on core histones and the incorporation of histone variants. 
Alternatively, nucleosome sliding or nucleosome disassembly can take 
place, usually modulated by ATP-dependent chromatin remodelers. As the 
first factor to identify UV photo- lesions, DDB2 facilitates local chromatin 
unfolding in all the aforementioned ways. Independently of its association in 
the CRL ubiquitin ligase complex, DDB2 was shown to promote chromatin 
decompaction, histone eviction and, therefore, the assembly of the NER 
machinery [49]. Recent reports have reinforced this notion by showing that 
DDB2 can promote PARP1-dependent chromatin poly-ADP ribosylation [45, 
54]. PARylation of histones and other chromatin proteins usually leads to a 
less rigid, looser chromatin environment. In addition, DDB2-induced chromatin 
PARylation facilitates the recruitment of the chromatin remodeler ALC1 [45], 
which can further restructure UV-damage containing nucleosomes. As part 
of the CRL E3 ligase complex, DDB2 induces the ubiquitylation of all core 
histones [55-57], resulting in nucleosome destabilisation, H2A-H2B dimer 
loss and decreased histone-DNA interaction, all hallmarks of accessible 
chromatin.
Regulation of incision events
Although NER recognition complexes dictate to a great extent the rate of 
the NER reaction, the spatiotemporal coordination of the pre-and post-
incision stages of NER also appears to be of paramount importance. Tight 
regulation of new repair events (incision), when gap-filling/sealing has not 
been completed, is essential to prevent generation of DNA strand-breaks 
that could lead to illegitimate recombinogenic events. Indeed, generation 
of repair gaps by inhibition of DNA repair synthesis leads to saturation of 
incision events at very low UV doses [34]. Surprisingly, RPA appears to exert 
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a key role in surveilling incision events, being the sole NER protein thus far 
reported to be present both pre- and post-incision [58, 59]. More specifically, 
RPA is recruited prior to incision and remains associated at the repair-site 
after recruitment of post-incision factors, until the gap-filling and ligation 
steps take place. In UV-irradiated, non-cycling cells this RPA-coordination 
is independent of phosphorylation by the related ATR kinase [58, 60]. In 
contrast, in UV-irradiated, cycling cells RPA is released from PML bodies in an 
ATR dependent manner, most likely to compensate for RPA accumulation at 
stalled replication forks. Supporting the notion that RPA availability constitutes 
a NER-bottleneck is the fact that persistently stalled replication forks inhibit 
NER in trans by sequestering RPA from sites of damage [59]. Furthermore, 
in line with a limited RPA pool is the recent finding that excessive amounts of 
ssDNA in replicating cells lead to RPA depletion, particularly in the absence 
of ATR [61].
CONCLUSIONS
Although an extraordinarily broad range of proteins has been implicated in 
NER, strides in our current understanding of the chromatin micro-environment 
make it safe to assume that more factors remain yet unidentified. The recent 
discovery of UVSSA and USP7 in TC-NER certainly point towards that 
direction. Despite the fact that the core NER reaction is well studied, we are 
just beginning to comprehend how NER-related factors are spatiotemporally 
modulated in the restrictive chromatin environment. Recent studies 
have begun to shed more light on the importance of post-translational 
modifications in orchestrating NER, ensuring its efficient “wiring’ with 
other concomitant events, such as signalling cascades and transcriptional 
responses. Furthermore, the potential of competitive or cooperative action 
between PTMs during DNA damage, as shown for DDB2 and XPC, raises 
the possibility of elaborate crosstalk between NER factors. This additionally 
hints towards the assumption that several regulatory levels, having thus far 
received little attention, safeguard the efficacy of NER. Data obtained by 
live imaging, screening assays and mass-spectrometry, along with the ever-
more effective bio-informatical integration of this data, will help us elucidate 
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The faithful repair of DNA double-strand breaks (DSBs) is essential to 
safeguard genome stability. DSBs elicit a signalling cascade involving the E3 
ubiquitin ligases RNF8/RNF168 and the ubiquitin-dependent assembly of the 
BRCA1-Abraxas-RAP80-MERIT40 complex. The association of BRCA1 with 
ubiquitin conjugates, which occurs in a RAP80-dependent manner, is known 
to be inhibitory to DSB repair by homologous recombination (HR). However, 
the precise regulation of this mechanism remains poorly understood. By 
performing genetic screens, we identified USP26 and USP37 as key de-
ubiquitylating enzymes (DUBs) that limit the repressive impact of RNF8/
RNF168 on HR. Both DUBs are recruited to bona fide DSBs where they 
actively remove RNF168-induced ubiquitin conjugates. Depletion of USP26 
or USP37 disrupts the execution of HR and this effect is alleviated by the 
simultaneous depletion of RAP80. In addition, we demonstrate that these 
DUBs prevent the ubiquitin-dependent sequestration of BRCA1 via the 
BRCA1-Abraxas-RAP80-MERIT40 complex, allowing BRCA1 to form a 
complex and cooperate with PALB2-BRCA2-RAD51 in HR. These findings 
reveal a novel ubiquitin-dependent mechanism that orchestrates the spatial 
assembly of distinct BRCA1-containing complexes for efficient repair of 
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INTRODUCTION
DNA double-strand breaks (DSBs) pose a considerable threat to the stability 
of the human genome and their timely repair is essential to safeguard 
genome stability and counteract tumour development [1]. Cells activate 
robust signalling pathways in response to DSBs that coordinate cell cycle 
progression, changes in chromatin structure and DNA repair [2, 3]. Eukaryotic 
cells primarily utilise homologous recombination (HR) or non-homologous 
end-joining (NHEJ) to remove DSBs from their genomes. 
A key feature of the DNA damage response (DDR) is the rapid assembly of 
signalling and repair factors in the vicinity of DSBs, by progressively modifying 
histones and DNA repair enzymes [4, 5]. An initial phosphorylation-dependent 
cascade of post-translational modifications in DSB-containing chromatin 
requires the ATM kinase and culminates into the association of MDC1 with 
phosphorylated histone H2A variant H2AX (γH2AX) [6]. The binding of the 
RNF8 E3 ubiquitin ligase to MDC1 subsequently initiates a ubiquitylation-
dependent cascade, involving the recruitment of the E3 ubiquitin ligase 
RNF168 in cooperation with the E2 ubiquitin-conjugating enzyme UBC13 [7, 
8]. The activity of these enzymes contributes to the ubiquitylation of K13/15 
on histone H2A/H2AX [9, 10], as well as the ubiquitin-dependent assembly 
of 53BP1 [11], RAD18 [12] and the BRCA1-Abraxas-RAP80-MERIT40 (or 
BRCA1-A) complex [13-16] onto DSB-neighbouring chromatin. 
This ubiquitylation cascade is tightly controlled by sophisticated mechanisms 
that entail chromatin remodelling enzymes [17-19] and additional ubiquitin 
ligases [20]. Furthermore, it has recently become clear that the removal of 
ubiquitin by specific de-ubiquitylating enzymes (DUBs) represents an equally 
important regulatory mechanism in the DDR [21-24]. The human genome 
contains ~90 potential DUBs that belong to five distinct subfamilies: ubiquitin-
specific proteases (USPs), ubiquitin carboxy-terminal hydrolases (UCHs), 
ovarian tumour proteases (OTUs), Machado-Joseph disease enzymes 
(MJDs) and JAB1/MPN/MOV34 metalloenzymes (JAMMs). A number of 
DUBs have been linked to reversing RNF8/RNF168-mediated chromatin 




screening approach identified many DUBs with potential roles in the DDR 
[26]. 
Although the principles underlying the RNF8 signalling pathway are by now 
well understood, we are only beginning to comprehend how this pathway is 
linked to the actual repair of DSBs through the major repair pathways NHEJ 
[27]  and HR [28-30]. During HR, the ends of a DSB are resected to expose 
3’ single-stranded DNA (ssDNA) overhangs, which are rapidly coated with 
the ssDNA-binding protein RPA. Following resection, the PALB2 protein is 
recruited by BRCA1 and subsequently facilitates the assembly of BRCA2 
[31, 32]. This, in turn, promotes the exchange of RPA with RAD51, which 
drives the search for and pairing with a homologous sequence, as well as the 
exchange of homologous DNA during the final steps of HR [31-33]. BRCA1 is 
incorporated into distinct multi-protein complexes, including BRCA1-PALB2-
BRCA2-RAD51 and BRCA1-Abraxas-RAP80-MERIT40 [34]. Strikingly, 
while the BRCA1-PALB2-BRCA2-RAD51 complex promotes HR, the 
BRCA1-Abraxas-RAP80-MERIT40 complex functionally antagonises this 
repair process by sequestering BRCA1 from HR sites by binding to RNF8/
RNF168-ubiquitylated chromatin [16, 35-40]. These findings suggest that 
distinct BRCA1-containing complexes can differentially affect HR in a manner 
dependent on DNA damage-induced ubiquitylation. Remarkably, little is 
known about the involvement of DUBs in regulating BRCA1-dependent HR. 
Through genetic screens we identified the de-ubiquitylating enzymes USP26 
and USP37 as key factors critical for DSB repair by HR. Mechanistically, 
we show that by removing RNF168-induced ubiquitin conjugates distal from 
DSBs, these enzymes prevent the ubiquitin-dependent sequestration of 
BRCA1 through the BRCA1-Abraxas-RAP80-MERIT40 complex, ultimately 
allowing BRCA1 to form a complex with PALB2-BRCA2-RAD51 and execute 
HR. Thus, these enzymes promote HR by limiting the repressive impact of 
RAP80 on HR. These findings reveal a novel ubiquitin-dependent mechanism 
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RESULTS
A screen for DUBs reveals novel regulators of 53BP1 and RAD51 
The BRCA1 protein is incorporated into distinct multi-protein complexes that 
are not all competent in promoting HR. While the BRCA1-PALB2-BRCA2-
RAD51 complex promotes HR, the BRCA1-Abraxas-RAP80-MERIT40 
complex functionally antagonises this repair process by sequestering BRCA1 
from HR sites by binding to RNF8/RNF168-ubiquitylated chromatin [16, 35-
40]. These findings suggest that distinct BRCA1-containing complexes can 
differentially affect HR in a manner dependent on RNF8/RNF168 damage-
induced ubiquitylation. Although the responsible E3 ubiquitin ligases RNF8 
and RNF168 have been characterised [7, 8, 13-15], potential DUBs that 
play a role in this ubiquitin-dependent regulation of HR remain elusive. In 
order to identify such proteins, we performed an over-expression screen 
using a FLAG-tagged cDNA library of ~60 human DUBs (Supplemental Fig. 
1A) in human U2OS cells (Fig. 1A). Specifically, we monitored if DUB over-
expression simultaneously antagonises the ionising radiation (IR)-induced 
formation of 53BP1 foci, a read-out for RNF168-mediated ubiquitylation 
[11], as well as the IR-induced focal accumulation of RAD51, a measure of 
HR efficiency. Given that 53BP1 directly binds to RNF168-induced ubiquitin 
conjugates [9, 11], we reasoned that DUBs modulating both these processes 
are likely to regulate RNF168-mediated HR events. 
Imaging-based analysis revealed that most DUBs did not appreciably alter 
the IR-induced accumulation of 53BP1 or RAD51 (Fig. 1B; black circles – see 
also Supplemental Fig. 1B,C). However, a subset of DUBs predominantly 
impinged on 53BP1 accrual (Fig. 1B; green circles), such as the earlier 
reported enzyme USP44, [21] (Supplemental Fig. 1D), while another set of 
DUBs mainly impacted RAD51 foci formation (Fig. 1B; blue circles), including 
the previously described USP1 [41]. Only a small number of DUBs affected 
both 53BP1 and RAD51 recruitment simultaneously (Fig. 1B; red circles), 
including USP29, an enzyme linked to H2A de-ubiquitylation [21], and the 




fact that we identified various published DUBs demonstrates the validity of 
our screen. Importantly, among the DUBs that suppressed both 53BP1 and 
RAD51 IRIF formation, USP26 and USP37 emerged as novel candidates 
(Fig. 1B and Supplemental Fig. 1D,E). We could not distinguish a common 
pattern in the impact of DUBs on 53BP1 or RAD51 foci formation within USP, 
UCH, MJD, JAMM, OTU or unclassified DUBs (Supplemental Fig. 1B-E), 
suggesting this is a unique property of the identified enzymes. Thus, via our 
screen, we identified USP26 and USP37 as potential novel regulators of 
53BP1 and RAD51.
Figure 1. DUB screen for regulators of 53BP1 and RAD51 IRIF formation. (A) Experimental 
design of the DUB over-expression screens. (B) Bi-dimensional representation of the relative 
decrease in 53BP1 (x-axis) and RAD51 (y-axis) IRIF formation upon over-expression of 
FLAG-tagged DUBs. (C) Impact of the expression of wild-type (WT) or catalytic inactive (CI) 
mCherry-tagged DUBs (red) on 53BP1 (white; left panel) or RAD51 IRIF formation (white; 
right panel) in mAG-geminin-expressing (images not shown) S/G2 cells. Quantified data are 
represented as mean ± S.D. (n=3). *, P<0.05, **, P<0.01, ***, P<0.001 (student’s t test). See 
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USP26 and USP37 reverse RNF168-induced ubiquitylation at DSBs
To validate and extend these findings, we generated mCherry- and GFP-
tagged versions of USP26 and USP37. Over-expression of these DUBs did 
not change the accumulation of γH2AX, MDC1, and RNF8 (Supplemental 
Fig. 2A), yet abrogated ubiquitin conjugation and all events downstream 
of it, including the assembly of ubiquitin-binding factors RNF168, RAP80, 
BRCA1 and 53BP1 after IR in a catalytic-dependent manner (Fig. 1C and 
Supplemental Fig. 2B). Both DUBs were rapidly recruited to laser-induced 
DNA damage tracks (Supplemental Fig. 2C). Given the multitude of DNA 
lesions inflicted by laser micro-irradiation, we additionally used a U2OS cell 
line in which DSBs are specifically induced by targeting the LacR-tagged 
FokI nuclease to a genomic locus containing LacO repeats [43]. In line with 
the results obtained by laser micro-irradiation, both USP26 and USP37 
accumulated at bona fide, FokI-induced DSBs marked by γH2AX (Fig. 2A,B). 
Importantly, USP26 and USP37 were able to remove ubiquitin conjugates at 
these DSBs in a manner dependent on their catalytic activity, as well as their 
C-terminal ubiquitin-binding domains (UIMs) (Fig. 2B,C and Supplemental 
Fig. 2B (FK2 foci), 2D-E). Strikingly, loss of these UIMs did not affect 
recruitment of the DUBs to FokI-induced DSBs (Supplemental Fig. 2E). This 
suggests that both DUBs can directly reverse RNF168-induced ubiquitin 
conjugation. Indeed, when mCherry-LacR-RNF8 or mCherry-LacR-RNF168 
was tethered to a LacO array to induce local chromatin ubiquitylation [18, 44, 
45], robust accumulation of both DUBs was observed (Fig. 2D), indicating 
that these DUBs can recognise RNF8/RNF168-induced ubiquitin moieties. 
Furthermore, we examined if our DUBs affect the ubiquitylation of chromatin 
substrates by RNF168 immobilsed at the LacO array or the subsequent 
recognition of ubiquitylated-H2A-type histones by 53BP1. Both USP26 and 
USP37 reduced FK2 (Supplemental Fig. 3A) and 53BP1 (Supplemental Fig. 
3B) accumulation at the array, implying that they directly remove RNF168-
induced ubiquitylation. RNF168 targets H2A-type histones for ubiquitylation 
[9, 10]. Interestingly, ectopic expression of USP37 moderately decreased 
RNF168-induced H2A ubiquitylation [9, 46], while expression of USP26 
nearly eliminated such ubiquitylation (Fig. 2E). Thus, our results suggest that 




and reverse ubiquitylation induced by these E3 ligases at DSBs.
Figure 2. USP26 and USP37 accumulate at DSBs and regulate chromatin ubiquitylation. 
(A) Recruitment of the indicated GFP fusion proteins to FokI-mCherry-LacR-induced DSBs 
marked by γH2AX (white) in cells containing a LacO array. (B) As in A, but stained for ubiquitin-
FK2 (white). (C) Recruitment of GFP-tagged DUBs lacking their C-termini (ΔC; green) and 
their impact on ubiquitin-FK2 at FokI-induced DSBs (white). (D) Recruitment of GFP-tagged 
DUBs upon tethering of the indicated mCherry-LacR fusion proteins in cells containing a LacO 
array. (E) IP of GFP-H2A under denaturing conditions in the absence or presence of mCherry-
RNF168 and the indicated mCherry-tagged DUBs. Quantified data are represented as mean 
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Loss of USP26 or USP37 impairs DSB repair
To address if the identified DUBs play a role in HR under physiological 
conditions, USP26 and USP37 were depleted using independent siRNAs. 
Immunoblotting (Fig. 3A) and RT-qPCR (Supplemental Fig. 4A) analysis 
confirmed that the protein and mRNA levels of both DUBs were dramatically 
reduced. Loss of these DUBs led to a significant increase in IR-induced 
ubiquitin conjugates (Fig. 3B) and accumulation of the ubiquitin-binding 
protein 53BP1 (Supplemental Fig. 4B), suggesting that USP26 and USP37 
control the levels of DSB-induced ubiquitylation. Surprisingly, however, 
depletion of either DUB also resulted in a clear reduction of IR-induced 
PALB2 and RAD51 (Fig. 3C) accumulation, indicating that excessive DSB-
induced ubiquitylation disrupts HR. In further agreement with a physiological 
role of these DUBs in regulating HR, loss of USP26 or USP37 resulted in 
defective accumulation of the CtIP nuclease and moderately decreased 
DNA-end resection, assayed by RPA foci formation (Supplemental Fig. 4C). 
Flow cytometric analysis of DR-GFP cells confirmed that USP26 or USP37 
depletion leads to a significant defect in HR (Fig. 4A). Notably, over-
expression of mCherry-tagged RNF8 or RNF168 also strongly inhibited HR 
(Fig. 4B). Thus, the over-expression of RNF8/168 phenocopied the depletion 
of USP26/37 as both conditions trigger excessive chromatin ubiquitylation. 
The effects on HR were not due to alterations in the cell cycle as cell cycle 
profiles were unchanged under these conditions (Supplemental Fig. 5A,B). 
Depletion of USP26 or USP37 also rendered cells highly sensitive to a 
poly(ADP-ribose) polymerase (PARP) inhibitor, which is a hallmark of HR-
deficient cells such as those lacking BRCA2 (Fig. 4C) [47]. 
Having shown that USP26 and USP37 regulate HR, we next sought to 
address if these enzymes affect the other major DSB repair pathway, non-
homologous end-joining (NHEJ). Using the flow cytometry-based EJ5-GFP 
reporter assay to monitor NHEJ efficiency [48], we found that USP26 or 
USP37 depletion substantially impaired this repair pathway (Fig. 4D). In line 
with a general defect in DSB repair, the combined knockdown of USP26 and 
USP37 led to a delay in the clearance of IR-induced γH2AX foci (Supplemental 




4E). Collectively, this work reveals USP26 and USP37 as novel factors that 



























































































































































































































Figure 3. USP26 or USP37 depletion abrogates the formation of PALB2-RAD51 complex 
at DSBs. (A) Western blot analysis of GFP-USP26, GFP- or endogenous-USP37 expression 
in cells treated with the indicated siRNAs. (B) Effect of DUB depletion on ubiquitin-FK2 IRIF 
formation in time. Note that 0 hr indicates non-irradiated cells. (C) Effect of DUB depletion 
on PALB2 (white; left panel) or RAD51 (white; right panel) IRIF formation in mAG-geminin-
expressing (green) S/G2 cells. Quantified data are represented as mean ± S.E.M (n=3). *, 
P<0.05, **, P<0.01, ***, P<0.001 (student’s t test).
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Figure 4. USP26 or USP37 depletion disrupts HR and NHEJ and sensitises cells to DNA 
damaging agents.  (A) Impact of the indicated siRNAs on HR efficiency measured using the 
DR-GFP reporter. (B) Impact of the expression of the indicated mCherry-fusion proteins on 
HR efficiency using the DR-GFP reporter. (C) Clonogenic survival of VH10-SV40 cells that 
were transfected with the indicated siRNAs and exposed to PARP inhibitor (Olaparib). (D) 
Impact of the indicated siRNAs on NHEJ efficiency measured using the EJ5-GFP reporter. 
(E) Clonogenic survival of IR-exposed U2OS cells transfected with the indicated siRNAs. 





Loss of USP26 or USP37 impairs HR by antagonising RAP80-dependent 
sequestration of BRCA1
To gain insight into the mechanism that disrupts HR under conditions of 
excessive ubiquitylation, we turned our attention to the BRCA1-Abraxas-
RAP80-MERIT40 complex, which through RAP80 drives the ubiquitin-
dependent recruitment of BRCA1 to RNF8/RNF168-modified chromatin [7, 
13-16, 35-37]. It was recently unveiled that RAP80-mediated recruitment of 
BRCA1 inhibits HR [38, 39], by sequestering BRCA1 from HR sites, thus 
hampering the formation of a BRCA1-PALB2-BRCA2-RAD51 complex, 
which is essential for HR [38, 40]. We reasoned that USP26 and USP37 may 
antagonise the RAP80-dependent sequestration of BRCA1 by removing 
RNF8/RNF168-mediated ubiquitylation and thereby promote HR. To address 
this, we established a quantitative, computer-assisted approach to measure 
BRCA1 foci size. In agreement with an earlier report [38], we found that 
BRCA1 foci were not reduced in number, but rather were considerably smaller 
in size following depletion of RAP80 (Fig. 5A). In contrast, depletion of either 
DUB had the opposite effect, leading to an increase in larger BRCA1 foci 
without affecting the total number of foci (Fig. 5B,C and Supplemental Fig. 
5D). Remarkably, depletion of RAP80 in DUB knock-down cells completely 
rescued the shift towards larger foci and led to a reappearance of small 
BRCA1 foci (Fig. 5B,C). To test the functional relevance of these findings, 
we depleted RAP80 and examined if this would restore HR proficiency in 
USP26 or USP37-depleted cells. Indeed, we found that defective IR-induced 
accrual of both PALB2 and RAD51 in USP26- or USP37-depleted cells could 
be fully rescued by additional depletion of RAP80 (Fig. 6A,B). Similarly, HR 
efficiency was completely restored upon co-depletion of either DUB and 
RAP80, as measured in the DR-GFP reporter assay (Fig. 6C). Cell-cycle 
profiles in these cells remained unchanged ruling out effects of cell cycle 
misregulation (Supplemental Fig. 5E). Together these results suggest that 
USP26 and USP37 promote the BRCA1-dependent loading of PALB2 and 
RAD51 by counteracting the repressive impact of RAP80-dependent BRCA1 
sequestration during HR (Fig. 7). 
67
3
USP26 and USP37 regulate HR by counteracting RAP80
Figure 5. RAP80 depletion restores the formation of small BRCA1 IRIF, indicative of 
HR centers in USP26 and USP37 knock-down cells. (A) Effect of RAP80 depletion on 
RAP80 (green) and BRCA1 (white) IRIF formation (left and middle-right panel), endogenous 
RAP80 expression on Western blot (middle-left panel) and BRCA1 IRIF size (right panel). (B) 
Effect of DUB and RAP80 depletion on RAP80 (green) and BRCA1 (white) IRIF formation. 
(C) Histograms of BRCA1 foci size in cells treated with the indicated siRNAs. Green indicates 
small foci of typical HR size, while red indicates larger foci of the size observed for signalling 
factors. Quantified data are represented as mean ± S.D. (n=2). *, P<0.05, **, P<0.01, ***, 
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Figure 6. HR defects caused by the loss of USP26 and USP37 are reversed upon 
concomitant RAP80 removal. (A) Effect of DUB and RAP80 depletion on PALB2 (white) foci 
formation in mAG-geminin expressing (green) S/G2 cells. (B) As in A, but stained for RAD51 
(white). (C) Effect of the indicated siRNAs on HR efficiency measured using the DR-GFP 
reporter. Quantified data are represented as mean ± S.E.M. (n=2). *, P<0.05, **, P<0.01, ***, 
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DISCUSSION
DSBs elicit a signalling cascade that is driven by the ubiquitin E3 ligases RNF8 
and RNF168. These ligases promote progressive chromatin ubiquitylation, 
eventually leading to the ubiquitin-dependent assembly of BRCA1, RAD18 
and 53BP1 onto damaged chromosomes [7-9, 13-16]. However, while a clear 
picture of the factors that orchestrate the RNF8/RNF168 signalling pathway 
has emerged, we are only starting to understand how it is linked to DSBs 
repair [12, 30, 38, 40, 49-53]. 
In this study, we identify USP26 and USP37 as novel DUBs that reverse 
RNF168-mediated ubiquitylation (Fig. 1-2, Supplemental Fig. 1-2), a process 
known to repress HR by sequestering the BRCA1-Abraxas-RAP80-MERIT40 
complex through its ubiquitin-binding subunit RAP80 [38, 40]. By removing 
RNF168-induced ubiquitin conjugates distal from DSBs, USP26 and USP37 
prevent the RAP80-dependent assembly of this BRCA1-containing complex, 
allowing BRCA1 to function in the BRCA1-PALB2-BRCA2-RAD51 complex 
during HR (Fig. 7). These findings advance our conceptual understanding 
of the RNF168-dependent response to DSBs, by revealing pathways that 
differentially regulate the spatial assembly and function of HR complexes at 
DSBs. 
We propose the following model for RNF168-dependent regulation of HR 
(Fig. 7): RNF168-induced ubiquitin conjugates spread away from DSBs into 
more distal chromatin regions [20]. The BRCA1-Abraxas-RAP80-MERIT40 
complex through RAP80 interactions associates with the RNF168-induced 
ubiquitin conjugates in these regions, thereby sequestering BRCA1 from the 
ssDNA compartment and inhibiting HR [38, 40]. In line with this model, we 
demonstrate that supra-physiological levels of RNF168 triggered extensive 
ubiquitylation of H2A (Fig. 2E), concomitant with a substantial reduction 
in HR efficiency (Fig. 4B). We extend these findings by showing that this 
phenomenon is actively antagonised by USP26 and USP37. Loss of USP26/
USP37 function markedly impairs the assembly of PALB2, RAD51 and 




by the additional loss of RAP80 (Fig. 6A-C). Together, these data suggest 
that USP26/37 limit the magnitude of the BRCA1-Abraxas-RAP80-MERIT40 
complex assembly in DSB-neighbouring chromatin, by actively removing 
RNF168-mediated H2A ubiquitylation (Fig. 2E and Supplemental Fig. 3). 
Indeed, depletion of either DUB resulted in an increase in the size of BRCA1 
foci, indicative of more extensive spreading of the BRCA1-Abraxas-RAP80-
MERIT40 complex from the DSB site, which could be rescued by additional 
loss of RAP80 (Fig. 5A,B and Supplemental Fig. 5D). This scenario explains 
how these DUBs limit the repressive impact of RAP80 on HR. An alternative, 
yet not mutually exclusive scenario, would be in line with recent findings 
showing that DSB-induced H2A/H2AX ubiquitylation needs to be reversed in 
the core of IRIF for DNA end-resection to occur [39]. Given that USP26 and 
USP37 are able to reverse RNF8/168-mediated ubiquitylation and promote 
HR, these enzymes would be ideal candidates to facilitate such events.
 
Figure 7. Molecular model for the role of USP26 and USP37 in HR. BRCA1 is sequestered 
from HR sites through RAP80, which is functionally antagonised by USP26- and USP37-
dependent de-ubiquitylation of RNF168-modified chromatin (see discussion for details). Loss 
of USP26 or USP37 leads to more extensive RNF168-dependent sequestration of BRCA1, 
thereby preventing BRCA1 to form a complex with PALB2-BRCA2-RAD51 in HR. Additionally, 
the more extensive spreading of RAP80 upon USP26 or USP37 depletion reduces DNA end-
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Several other DUBs that affect H2A ubiquitination have been identified as 
important players in the DDR. For instance, the activity of tumour suppressor 
BAP1, which de-ubiquitylates H2A at K119, appeared to be critical for efficient 
HR [42, 54]. However, whether the BAP1-dependent removal of this histone 
modification is important during HR remains unclear. Similar to USP26 and 
USP37, two other DUBs, USP3 and USP44, were shown to reverse RNF168-
induced chromatin ubiquitylation, thereby controlling the accumulation of 
BRCA1 and 53BP1 at sites of DNA damage [21, 25, 55]. Future work has 
to reveal whether these DUBs, similarly to USP26 and USP37, operate 
to control DSB repair, in particular HR. Unravelling the interplay between 
different DUBs during HR may uncover how ubiquitin-dependent control of 
this important DNA damage repair process is orchestrated. 
Notably, both USP26 and USP29 are retrogenes of USP37, which likely 
explains why these DUBs display certain functional similarities. Although 
USP26 is often considered as testis-specific, we were able to detect 
USP26 expression in different cell types (U2OS and HEK293, Fig. 3A 
and Supplemental Fig. 4A), showing that this classification is incorrect. In 
agreement, it has been shown by extensive proteomic analysis that USP26 
is expressed in various human cell-lines and organs [56, 57]. Moreover, 
knockdown of USP26, similar to that of USP37, confers defects in the 
signalling and repair of DSBs in human cells, illustrating non-redundant roles 
for both DUBs in the DSB response. 
A striking conclusion from our study is that non-physiological expression of 
USP26 and USP37 impairs HR. Therefore, it seems likely that the expression 
of USP26 and USP37 needs to be tightly controlled. Failure to do so might 
not only correlate with enhanced genomic instability, but also with increased 
malignant transformation rates. Indeed, a plethora of cancer cell lines 
appear to have either lost (USP26=1457/USP37=446; COSMIC) or amplified 
(USP26=309/USP37=359; COSMIC) the expression of these DUBs. In 
conclusion, we report distinct ubiquitin-dependent pathways that orchestrate 
the assembly and function of HR complexes at DSBs and identify the factors 






U2OS, HEK293 and VH10-SV40-immortalised cells were grown in DMEM 
(Gibco) containing 10% FCS (Bodinco BV). U2OS cells containing an 
inducible shRNA against endogenous RNF8 and stably expressing FLAG-
RNF8, U2OS 2–6-3 cells containing 200 copies of a LacO-containing 
cassette (~4 Mbp) and U2OS 2-6-3 cells stably expressing an inducible 
version of FokI-mCherry-LacR fused to the estrogen receptor (ER) and 
harbouring a destabilisation domain (DD) were previously described [7, 
15, 43, 58]. The ViraPower system (Life Science) was used to produce 
lentivirus using mAG- or mCherry-geminin expression vectors [59]. 
U2OS cells stably expressing mAG- or mCherry-geminin were made by 
standard lentiviral transduction, followed by FACS sorting, in order to select 
homogeneously fluorescent cells. 
Plasmids 
A collection of cDNAs encoding FLAG-tagged DUBs, originally generated 
in Wade Harper’s laboratory [60], was obtained from Addgene. An IRES-
Puro cassette was amplified by PCR and inserted as an EcoRV-EcoRV 
fragment into the HpaI site of EGFP-C1 (Addgene).  The USP26 and 
USP37 cDNAs were inserted in EGFP-C1-IRES-Puro. Overlap PCR was 
used to introduce the inactivation mutations C304S into GFP-USP26 
and C350S into GFP-USP37. Wild-type and catalytic inactive versions of 
USP26 and USP37 were also inserted into mCherry-C1. A BsrGI-BstZ17I 
fragment encompassing amino acids 1-641 of USP26 was inserted into the 
BsrGI-SmaI site of EGFP-C1 to generate GFP-USP26 lacking the putative 
C-terminal UIM. Likewise, a BsrGI-SacI fragment encompassing amino 
acids 1-643 of USP37 was inserted into the BsrGI-SacI site of EGFP-C1 
to generate GFP-USP37 lacking the C-terminal UIM domains. Additional 
plasmids used are listed in the Supplemental Table.
Transfections and RNAi interference
siRNA and plasmid transfections were performed using Lipofectamine 
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RNAiMAX (Invitrogen), Lipofectamine 2000 (Invitrogen) and JetPEI 
(Polyplus Transfection) according to the manufacturer’s instructions. Cells 
were transfected twice with siRNAs (40 nM) within 24 h and examined 
further 48 h after the second transfection, unless stated otherwise. siRNA 
sequences are listed in the Supplemental Table.
Generation of DSBs
IR was delivered by a YXlon X-ray generator (YXlon International, 200 KV, 
10 mA, dose rate 2 Gy/min).
Cell survival assay
VH10-SV40 or U2OS cells were transfected with siRNAs, trypsinised, 
seeded at low density and exposed to IR. 7 days later cells were washed 
with 0.9% NaCl and stained with methylene blue. Colonies of more than 10 
cells were scored. 
FokI assays
U2OS 2-6-3 cells expressing inducible FokI-mCherry-LacR [43] were 
treated with 300 nM 4-OHT and 1 μM Shield-I for 5 hrs. Subsequently, 
cells were fixed with formaldehyde and immunostained with the indicated 
antibodies.
UV-A laser micro-irradiation
U2OS cells were grown on 18 mm coverslips and sensitised with 10 μM 
5′-bromo-2-deoxyuridine (BrdU) for 24 hours as described [18, 44]. For 
micro-irradiation, the cells were placed in a Chamlide TC-A live-cell imaging 
chamber that was mounted on the stage of a Leica DM IRBE wide-field 
microscope stand (Leica, Wetzlar, Germany) integrated with a pulsed 
nitrogen laser (Micropoint Ablation Laser System; Photonic Instruments, 
Inc., Belfast, Ireland). The pulsed nitrogen laser (16 Hz, 364 nm) was 
directly coupled to the epifluorescence path of the microscope and focused 
through a Leica 40x HCX PLAN APO 1.25-0.75 oil-immersion objective. 
The growth medium was replaced by CO2-independent Leibovitz’s L15 




were kept at 37°C. The laser output power was set to 78 to generate strictly 
localised sub-nuclear DNA damage. Following micro-irradiation, cells 
were incubated for the indicated time-points at 37°C in Leibovitz’s L15 and 
subsequently fixed with 4% formaldehyde before immunostaining. Typically, 
an average of 50 cells was micro-irradiated (2 iterations per pixel) within 
10–15 minutes using Andor IQ software.  
Multiphoton laser micro-irradiation
U2OS cells were grown on 18 mm coverslips. Subsequently, they were 
placed in a Chamlide CMB magnetic chamber and the growth medium was 
replaced by CO2-independent Leibovitz’s L15 medium supplemented with 
10% FCS and penicillin-streptomycin.  Laser micro-irradiation was carried 
out on a Leica SP5 confocal microscope equipped with an environmental 
chamber set to 37°C. DSB-containing tracks (1.5 µm width) were generated 
with a Mira mode-locked titanium-sapphire (Ti:Sapphire) laser (l = 800 nm, 
pulse length = 200 fs, repetition rate = 76 MHz, output power = 80 mW) 
using a UV-transmitting 63× 1.4 NA oil immersion objective (HCX PL APO; 
Leica). Confocal images were recorded before and after laser irradiation at 
5 or 10 seconds time intervals over a period of 5 - 10 minutes. 
Microscopy analysis
Images of fixed cells were acquired on a Zeiss AxioImager D2 widefield 
fluorescence microscope equipped with 40x, 63x and 100x PLAN APO (1.4 
NA) oil-immersion objectives (Zeiss) and an HXP 120 metal-halide lamp 
used for excitation. Fluorescent probes were detected using previously 
described filters [61]. Images were recorded using ZEN 2012 software and 
analysed using ImageJ. The average reflects the quantification of 50-150 
cells from 3 independent experiments.
IRIF analysis
PALB2, RAD51, BRCA1 and RAP80 (except in Supplemental Fig. 2B) 
IRIF were analyzed in U2OS cells 6hr after 10Gy, RPA and CtIP IRIF were 
assayed 4hr after 10Gy, whereas conjugated ubiquitin (FK2), γΗ2ΑΧ, 
MDC1, FLAG-RNF8, RNF168, BRCA1 and RAP80 (at Supplemental Fig. 
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2B) and 53BP1 IRIF were examined 1hr after 2Gy, unless stated otherwise. 
IRIF were evaluated in ImageJ, using a custom-built macro that enabled 
automatic and objective analysis of the foci. Full details of this macro will be 
published elsewhere. In brief, cell nuclei were detected by thresholding the 
(median-filtered) DAPI signal, after which touching nuclei were separated 
by a watershed operation. The foci signal was background-subtracted using 
a Difference of Gaussians filter. For every nucleus, foci were identified as 
regions of adjacent pixels satisfying the following criteria: (i) the grey value 
exceeds the nuclear background signal by a set number of times (typically 
2-4x) the median background standard deviation of all nuclei in the image, 
and is higher than a user-defined absolute minimum value; (ii) the area 
is larger than a defined area (typically 2 pixels). These parameters were 
optimised for every experiment by manually comparing the detected foci 
with the original signal.
Immunofluorescent labelling
Immunofluoresecent labelling was carried out as described previously [18, 
19]. Briefly, cells were grown on glass coverslips and treated as indicated in 
the figure legends. Subsequently, cells were washed with PBS, then fixed 
with 2% formaldehyde for 20 minutes and permeabilised with 0.25% Triton 
X-100 in PBS for 5 minutes. Cells were rinsed with phosphate-buffered 
saline (PBS) and then treated with 100 mM glycine in PBS for 10 minutes 
to block unreacted aldehyde groups. Finally, cells were equilibrated in PBS 
containing 0.5% BSA and 0.05% Tween 20, and incubated with primary 
antibodies. Detection was done using goat anti-mouse or goat anti-rabbit 
IgG coupled to Alexa 488, 555 or 647 (Invitrogen Molecular Probes). 
Samples were incubated with 0.1 μg/ml DAPI and mounted in Polymount. 
Primary antibodies and secondary antibodies are listed in the Supplemental 
Table.
Western blotting
Cell extracts were generated by boiling cell pellets in Laemmli buffer, 
separated by SDS-PAGE and transferred to PVDF membranes (Millipore). 




followed by protein detection using the Odyssey infrared imaging scanning 
system (LI-COR Biosciences). 
HR and NHEJ assay
HEK293 and U2OS cells containing a stably integrated copy of either 
the DR-GFP of EJ5-GFP reporter were used to measure the repair of 
I-SceI-induced DSBs by HR or NHEJ, respectively [48, 62]. Briefly, 48 h 
after siRNA transfection, cells were transfected with the I-SceI expression 
vector pCBASce and an mCherry expression vector. [62] 48 or 72 h later 
the fraction of GFP-positive cells among the mCherry-positive cells was 
determined by FACS on a LSRII flow cytometer (BD Bioscience) using 
FACSDiva software version 5.0.3. Quantifications were performed using 
Flowing Software (www.flowingsoftware.com).
Cell cycle profiling
For cell cycle analysis cells were fixed in 70% ethanol, followed by DNA 
staining with 50 µg/ml propidium iodide in the presence of RNase A 
(0.1 mg/ml). Cell sorting was performed on a LSRII flow cytometer (BD 
Bioscience) using FACSDiva software (version 5.0.3; BD). Quantifications 
were performed using Flowing Software.
RT-qPCR-based gene expression analysis 
RNA isolation, reverse transcription (RT)-based cDNA synthesis and 
quantitative (q)PCR were carried out as previously described [61]. The 
primers used are listed in the Supplemental Table. 
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Supplementary Figure 1. A DUB over-expression screen reveals novel DSB response 
regulators. (A) List of FLAG-tagged DUBs expressed in U2OS cells. Enzymes are colour-
coded to signify the different DUB families. In yellow Ubiquitin C-terminal Hydrolases (UCH), 
in green Machado-Josephin Domain-DUBs (MJD), in blue JAMM metalloproteases (JAMM), 
in red OTUbain domain-DUBs (OTU), in purple unclassified DUBs and in grey Ubiquitin 
Specific Proteases (USP). (B) Quantification of 53BP1 IRIF formation upon over-expression 
of the indicated DUBs. Red bars signify hits, i.e. population of cells with >5 53BP1 IRIFs is 
lower than 15% of total transfected cells.  (C) Quantification of RAD51 IRIF formation upon 
over-expression of the indicated DUBs. Red bars signify hits, i.e. population of cells with >10 
RAD51 IRIFs is lower than 15% of total transfected cells. (D) Examples of the impact of the 
over-expression of the indicated (non-) hits/DUBs (green) on 53BP1 IRIF formation (white). 
(E) Examples of the impact of the over-expression of the indicated (non-) hits/DUBs (green) 
on RAD51 IRIF formation (white).
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Supplemental Figure 2. USP26 and USP37 accumulate at DSBs and regulate chromatin 
ubiquitylation. (A) Quantification of the impact of the expression of GFP- or mCherry-tagged 
DUBs (green or red) on γH2AX, MDC1, FLAG-RNF8 IRIF formation. (B) As in A, but RNF168, 
FK2, RAP80 and BRCA1 IRIF formation was quantified. (C) Recruitment of mCherry-tagged 
DUBs (red) to laser-induced DNA damage, marked by γH2AX (green). (D) Schematic 
representation of the catalytic cysteine residues and UIMs of USP26 and USP37. In yellow: 
alignment between UIMs 1 - 3 of USP37 and UIM2 of USP26 in different species. Note that 
USP26 lost two UIMs during evolution. In red: conserved residues important for interaction 
with ubiquitin. UIM consensus sequence: ΦxxAΦxΦS. In light blue: Φ=hydrophobic residues 
(A, F, G, I, L, P, V). (E) Quantification of the localisation of GFP-DUBs lacking their C-termini 
(ΔC) at FokI-induced DSBs in cells containing a LacO array. The ΔC mutants lack functional 
UIMs. All IRIF data obtained 1hr after treatment with 2Gy. Quantified data are represented as 









































































































































































































USP37 UIM-1                         xxA x S 
Hsap_/1979        DKSELENSGFDRMSEEELLAAVLEISKRDASPSLSHEDDDKPTSSPDTGF 
Ptro_/1979        DKSELENSGFDRMSEEELLAAVLEISKRDASPSLSHEDDDKPTSSPDTGF 
Cjac_/1981        DKSEMENSGFDRMSEEELLAAVLEISKREASPSPSHEDDDKPTSSPDTGF 
Ogar_/1986        DKSELENSGFDKMSEEELLTAVLEISKRETLPSLSHEDDDKPTSSPDTGF 
Ocun_/1981        DKSEMENAGFDRMNEEELIAAVLEISKRETSPSPSHEDDDKPTSSPDTGF 
Amel_/1981        DKSELENSGFDGMSEEELLAAVLEMSKRESSPTLSHEDDDKPTSSPDTGF 
Mpfu_/1980        DKSELENSGFDGMSEEELLAAVLEMSKREASPTLSHEDDDKPTSSPDTGF 
Cfam_/1981        DKSELENSGFDGMSEEELLAAVLEMSKREASPTLSHEDDDKPTSSPDTGF 
Fcat_/1980        DKSELENSGFDGMSEEELLAAVLEISKREASPSLSHEDDDKPTSSPDTGF 
Sscr_/1982        DKSELENSGFDAMSEEELLAAVLEISKREASPSPSHEDDDKPTSSPDTGF 
Vpac_/1979        DKSELENSGFDGMSEEELLAAVLEISKREASPSLSHEDDDKPTSSPDTGF 
Btau_/1981        DKSELENSGFDGMSEEELLAAVLEISKREASPSLSHEDDDKPTSSPDTGF 
Ecab_/1981        GKSELENSGFDGMSEEELLAAVLEISKRESSPSLSHEDDDKPTSSPDTGF 
Lafr_/1982        DKSELENSGFDGMSEEELVAAVLEISKRETSPSLSHEDDDKPTSSPDTGF 
Itri_/1976        DKSELENSGFDRMSEEELLAAVLEISKREASPTLSHEDDDKPTSSPDTGF 
Rnor_/1979        GKSELENSGFDRMSEEEVLAAVLEISRREASPVLSPEDDDKPTSSPDTGF 
Mmus_/1979        GKAELENSGFDRMSEEEVLAAVLEISRREASPVLSPEDDDKPTSSPDTGF 
 
USP37 UIM-2 and 3                   xxA x S              xxA x S 
Hsap_/1979      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFVDAL 
Ptro_/1979      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFVDAL 
Cjac_/1981      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFVDTL 
Ogar_/1986      QGEVDWLQQYDMDREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDAL 
Ocun_/1981      QGEVDWLQQYDMEREREEQELQQALVQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDAL 
Amel_/1981      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Mpfu_/1980      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Cfam_/1981      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Fcat_/1980      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Sscr_/1982      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Vpac_/1979      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Btau_/1981      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFVDSL 
Ecab_/1981      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Lafr_/1982      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDIKRATELSLQEFNSSFLDSL 
Itri_/1976      QGEVDWLQQYDMEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDAL 
Rnor_/1979      QGEVDWLQQYDIEREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
Mmus_/1979      QGEVDWLQQYDVDREREEQELQQALAQSLQEQEAWEQKEDDDLKRATELSLQEFNNSFLDSL 
 
 
USP26 pUIM-2        xxA x S              
Itri_/1922      HKQALEQALPQSLPKLNAQE-----HTQNFR-PTELNVQKPDVNSLCSVD 797 
Cpor_/1882      HKDTPQHTLPEGIPKPDAQK-----HQVNVRGQTELNLQKAKP------- 764 
Dord_/1874      KKEAIQQAFTQRCSKLNAQG-----HMRLLNSPNSKKSEKVTK------- 766 
Hsap_/1913      CEQAPQQALPQSFPKPGTQG-----HTKNLLRPTKLNLQKSNRNSLLALG 792 
Ggor_/1914      CEQAPQQALPQSFPKPGTQG-----HTKNLLRPTKLDLQKSNRNSLLALG 794 
Pabe_/1915      CEQAPQQALPRSFPKPGAQG-----HTKNLLRPTKLNLQKSNRNFLLALG 794 
Mmul_/1915      CEQAPQQALPRSFPKPGVQG-----HTKNLIKPTKLNLQKPNRNSLPALG 794 
Mpfu_/1943      YEQALQQALLQALLKPHVQW-----YTQNLRRHTDLSLQGANVNSLGESS 820 
Amel_/1913      YEQALQQALLQALLKPHTRW-----HRENLRKHADLSFQGANVNSLGASG 788 
Cfam_/1924      YEQALQQALLQILLKPDAQW-----YMQNLRRPTNLGPQQARVNSQGASC 800 
Fcat_/1920      YEQALRQALLGALLKTRTRW-----YAKNLRKPAKLRLQETKANSLGAPG 796 
Ecab_/1917      YEQALRQALLESLPEPDAQW-----HTEKLRRPTEVTLQEANVSSLGALG 793 
Mluc_/1917      YEEALWQALLQSLPKTDAQC-----HTDNLTRPTELSLQEANENSHGASS 795 
Sscr_/1904      YEQALWLALLQSLPKPGAR------YTKNPRRPTEVHFQGADVNSLGALG 782 
Vpac_/1914      YEQALWTALLQSLPKPLAQR-----YTENLRKTTELSFQGTNVNSPRALG 791 
Ttru_/1904      FEQDLGILLIRSLSGPDAQW-----HTDKCR-PTQLNFQGTKVSSRGVLG 782 
Btau_/1896      YEQALWLALLQSIPKTKTQKKK---CTEKLKRPKESGVRGTKVKSPGASG 772 
Lafr_/1911      CGHFSEQAWSPSPQKPAQG------HTDNLRRHTELSLQEAKVKLLGALG 787 
Ocun_/1907      YKQASQQVPPQSLPKSKAQK-----QAENLTRSTEFSFQAVSANHVSALG 784 
Ogar_/1930      TKLNLQEDIGTSPEPQQASLLVPQSHTEGCSPPAELNLQEDVVMYQGALD 807 
Sara_/1904      YEKSLQEAILQTVPNVSGQG----HMEDFGRHTEEISLQEASTSSQGASC 779 
Rnor_/1827      ------EALPQSCPKPSSQE-----QTENLGKPAVSHTQNGSLSSQGSSD 713 

















































































































































Supplemental Figure 3. USP26 or USP37 can remove RNF168-induced ubiquitylation. 
(A) Effect of GFP-DUB over-expression on conjugated ubiquitin (FK2) (white) upon tethering 
of mCherry-LacR-RNF168 in cells containing a LacO array. (B) As in (A) only stained for 
53BP1 (white). Quantified data are represented as mean ± S.D. (n=3). *, P<0.05, **, P<0.01, 




Supplemental Figure 4. USP26 or USP37 depletion impairs the DSB response. (A) 
Relative USP26 mRNA expression in U2OS cells treated with the indicated siRNAs. The 
USP26 transcript was not detectable (ND) by reverse transcriptase (RT)-qPCR in cells treated 
with siRNAs against USP26 (left panel). Representative agarose gel showing USP26 PCR 
product amplified from total RNA without (-RT) or with (+RT) reverse transcriptase reaction 
(middle panel). Relative USP37 mRNA expression in U2OS cells treated with the indicated 
siRNAs (right panel). (B) Effect of DUB depletion on 53BP1 IRIF formation in time after 2 
Gy of IR. (C) Effect of DUB depletion on CtIP and RPA IRIF formation 4hr after 10Gy of IR. 
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USP26 and USP37 regulate HR by counteracting RAP80
Supplemental Figure 5. USP26 or USP37 depletion does not alter cell-cycle progression. 
(A) Cell cycle profiles of cells treated with the indicated siRNAs. (B) Cell cycle profiles of cells 
over-expressing the indicated GFP fusion proteins. (C) Effect of combined DUB depletion 
on DSB repair, assayed by clearance of γH2AX foci after 2 Gy of IR. (D) Effect of DUB and 
RAP80 depletion on RAP80 IRIF formation. (E) Cell cycle profiles of cells treated with the 
combinations of the indicated siRNAs. Quantified data are represented as mean ± S.D. (n=3), 
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Target protein Host Obtained from Cat. nr. IF WB
53BP1 rabbit Novus Biologicals NB100-304 1:2000
BRCA1 mouse SantaCruz sc-6954 1:100
BRCA1 rabbit gift Dr. Daniel Durocher 1:1000
BRCC36 rabbit Abcam ab62075 1:1000
FLAG mouse Sigma F1804 1:1000
GFP rabbit Abcam ab290 1:1000
GFP mouse Roche #11814460001 1:2000
γH2AX mouse Millipore JBW301 1:2000
H2AX rabbit Bethyl A330-082A 1:10000
H2B rabbit Millipore 07-371 1:10000
HA mouse SantaCruz sc-7392 1:500
mCherry mouse Abcam ab125096 1:1000
MDC1 rabbit Abcam ab11171 1:1000
PALB2 rabbit Bethyl A301-246A 1:1000
PALB2 rabbit gift Dr.Bing Xia 1:100
RAD51 rabbit SantaCruz sc-8349 1:100
RNF168 rabbit Millipore ABE367 1:200 1:500
Tubulin mouse Sigma T6199 1:5000
Ubiquitin K48 chains rabbit Millipore APU2/05-1307 1:100
Ubiquitin K63 chains rabbit Millipore APU3/05-1308 1:1000
Ubiquitin-FK2 mouse EnzoLifeSciences BML-PW8810-0500 1:100
RPA mouse ThermoScientific Ab-1 9H8 1:1000
CtIP mouse gift Dr. Richard Baer 1:10
RAP80 rabbit Bethyl A300-764 1:1000
RAP80 rabbit Bethyl A300-763A 1:500
Rabbit-700CW donkey Licor 1:20000
Mouse-800CW donkey Licor 1:20000
Target Protein siRNA name Sequence (5'-3')
Luciferase Luc CGUACGCGGAAUACUUCGA
BRCA2 BRCA2 GAAGAAUGCAGGUUUAAUA















Encoded fusion protein Described in
GFP-H2A Luijsterburg et al. Journal of Cell Biology 197: 267-281 (2012)
FokI-LacR-mCherry Tang et al. Nature Structural & Molecular Biology 20: 317-325 (2013)
mCherry-LacR-RNF168 Luijsterburg et al. EMBO Journal 31: 2511-2527(2012)
mCherry-LacR-RNF8 Luijsterburg et al. EMBO Journal 31: 2511-2527(2012)
mCherry-RNF168 Smeenk et al. Journal of Cell Science 126: 889-903 (2013)
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The PALB2 tumour suppressor protein is an essential mediator of DNA 
double-strand break (DSB) repair by homologous recombination (HR). 
PALB2 interacts with and is recruited to DSBs by BRCA1 and subsequently 
promotes the assembly of the core HR proteins BRCA2 and RAD51. In this 
study, we show that the ubiquitin ligase RNF168 is essential for PALB2 accrual 
in a manner that is different from canonical RNF168-dependent signalling. 
Instead, we show that PALB2 associates with RNF168-ubiquitylated 
chromatin in a fashion dependent on its WD40 domain. The latter appears to 
promote a direct interaction between PALB2 and RNF168, which facilitates 
the formation of functional HR complexes. Our findings reveal an RNF168-
dependent mechanism that contributes to efficient execution of error-free 
DSB repair by HR.
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INTRODUCTION
Chromosomal DNA double-strand breaks (DSBs) that arise during replication 
or in early G2 are removed by the Homologous Recombination (HR) 
machinery, which utilises the genetic information from the sister chromatid as 
a template for error-free repair. Following their detection by the MRN complex, 
DSB-ends are resected by specific nucleases to generate 3’ single-stranded 
DNA (ssDNA) overhangs, which are bound by the ssDNA-binding protein 
RPA. In order for homology search to begin, RPA needs to be exchanged 
for the recombinase RAD51. A complex comprising of the PALB2 (Partner 
And Localiser of BRCA2) protein and BReast CAncer susceptibility proteins 
1 and 2 (BRCA1 and BRCA2) is responsible for RAD51 loading on ssDNA. 
More specifically, once recruited to resected DSB ends, PALB2 physically 
bridges the interaction between BRCA1 and BRCA2, thereby facilitating 
the subsequent assembly of the core HR proteins BRCA2 and RAD51 onto 
broken DNA ends [1-3]. Finally, RAD51 probes for homology and, upon its 
detection, catalyses strand invasion and DNA transfer during HR. 
Further delineating the mechanistic basis for PALB2 recruitment to DSBs, it 
was recently demonstrated that recombinant PALB2 directly binds DNA in 
vitro and associates with chromatin in vivo through its evolutionary conserved 
Chromatin Association Motif (ChAM) [4]. Though the association of PALB2 
with resected DNA is primarily mediated by BRCA1, it additionally exploits 
PALB2 oligomerisation and protein-protein interactions with ubiquitin-binding 
proteins, such as MRG15 [2, 3, 5].  
The choice between the major DSB repair pathways HR and Non-Homologous 
End-Joining (NHEJ) is regulated throughout the cell cycle by signalling 
pathways that involve MDC1 and the two E3 ubiquitin ligases RNF8 and 
RNF168 [6, 7]. These enzymes ubiquitylate chromatin in the vicinity of DSBs 
and promote the ubiquitin-dependent recruitment of the RAP80-BRCA1 and 
53BP1-RIF1 complexes [8, 9]. The assembly of both of these complexes 
antagonises HR, largely by limiting DNA end-resection. Therefore it has 
been suggested that RNF8/RNF168-mediated signalling pathways may be 




implicated that RNF8 promotes HR [13-16], suggesting that the intricate 
interplay between RNF8/RNF168-induced ubiquitylation and HR is currently 
not understood in its entirety. 
In this study, we show that PALB2 associates with RNF168-, but not RNF8-, 
ubiquitylated chromatin, indicating that the RNF168-dependent ubiquitylation 
events that promote PALB2 chromatin assembly are not the canonical ones. 
Subsequently, we demonstrate that efficient recruitment and retention of 
PALB2 at DSBs is also dependent on RNF168-induced ubiquitylation, 
promoting BRCA1-dependent PALB2 accrual and the subsequent formation 
of functional HR complexes. Finally, we reveal that PALB2 directly interacts 
with RNF168 via its WD40 domain. These findings define a new RNF168-
mediated mechanism that contributes to PALB2 recruitment and efficient HR.
 
RESULTS AND DISCUSSION
RNF168-mediated ubiquitylation promotes PALB2 recruitment to 
chromatin 
To explore potential links between RNF8/RNF168 and the homologous 
recombination (HR) machinery, we used a chromatin-tethering approach, 
exploiting the strong interaction between the LacR protein and the LacO 
DNA sequence [17, 18]. Human U2OS cells with stably incorporated LacO 
arrays [19] were transfected with LacR-tagged RNF8 or RNF168 (Fig. 1A), 
which triggered the accumulation of 53BP1 and ubiquitin (FK2) conjugates 
(Fig. 1B) at the LacO array, as previously reported [17, 18, 20]. Surprisingly, 
we found that tethering LacR-RNF168 specifically attracted PALB2 and 
RAD51 to the array, while LacR-RNF8 or LacR alone failed to do so. The 
ubiquitin ligase activity of RNF168 was required for these events, since 
tethering of catalytically inactive RNF168C16S (RNF168ΔRING) significantly 
reduced PALB2 and RAD51 accrual (Fig. 1C,D). Importantly, immobilising 
either RNF168 or RNF168ΔRING hardly triggered any accumulation of 
phosphorylated RPA, suggesting that there is little DNA end-resection at the 
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array (Supplemental Fig. 1A). 
Supporting the ubiquitin-dependent nature of PALB2 accrual, we found that 
over-expression of the de-ubiquitylating enzymes USP26 or USP37, which 
we recently showed that reverse RNF168-induced ubiquitylation (Chapter 
3), efficiently suppressed accrual of both PALB2 (Supplemental Fig. 1B) and 
RAD51 (Supplemental Fig. 1C). The RNF8 pathway was recently linked to 
PALB2 recruitment through the assembly of the BRCA1-RAP80-Abraxas 
complex [16]. Conversely, several other studies found RAP80 and Abraxas 
to strongly inhibit HR, likely by sequestering BRCA1 away from resected 
DNA where it loads PALB2 for HR [10, 11, 21]. In line with the latter studies, 
knock-down of RAP80 did not affect PALB2 recruitment after RNF168 
tethering, while BRCA1 recruitment was moderately reduced (Fig. 1E) and 
RAP80 accrual was undetectable (Supplemental Fig. 1D). We conclude that 
forced chromatin binding of RNF168 triggers PALB2 and RAD51 loading onto 
chromatin in a ubiquitin-dependent manner that does not require canonical 




Figure 1. RNF168-dependent chromatin recruitment of PALB2. (A) Schematic of the RNF8/
RNF168 tethering system. (B) 53BP1 (white; upper images) and ubiquitin-FK2 accumulation 
(white; lower images) upon tethering of the indicated mCherry-LacR fusion proteins (red) 
in cells containing a LacO array. (C) As in B, but stained for PALB2 (white). (D) As in C, but 
stained for RAD51 (white). (E) As in C, but stained for PALB2 or RAP80 in control (siLuc) 
or RAP80-depleted cells. 50-100 cells were analysed per experiment. Quantified data are 
represented as mean ± S.D. (n=3). *, P<0.05, **, P<0.01, ***, P<0.001 (student’s t test). See 
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RNF168-mediated ubiquitylation promotes PALB2 recruitment to DSBs
To examine the functional relevance of our findings in the tethering system, 
we depleted cells of RNF8 or RNF168 and assessed the assembly of HR 
factors into ionising radiation-induced foci (IRIF) that contain DSBs. In order to 
specifically monitor recruitment in S and G2 cells, we engineered U2OS cells 
stably expressing the mAG-tagged cell cycle marker geminin and validated 
this cell-line by flow cytometry (Supplemental Fig. 2A). RNF8 or RNF168 
loss largely abolished the accrual of PALB2 in mAG-geminin-positive cells 
(Fig. 2A). Comparable results were obtained in cyclin B1-positive G2 cells 
(Supplemental Fig. 2B). Importantly, BRCA1 depletion completely abolished 
PALB2 recruitment [2, 3], while knock-down of RAP80 had no appreciable 
impact (Fig. 2A and Supplemental Fig. 1E). These results suggest that 
RNF8/RNF168 contribute to the BRCA1-dependent loading of PALB2 at 
DSBs independently of RAP80, in agreement with our tethering results (Fig. 
1E). Depletion of RNF8 or RNF168 also impaired efficient RAD51 assembly 
in cycling cells, following either IR-inflicted DNA damage (Fig. 2B) or laser 
micro-irradiation (Supplemental Fig. 2C) consistent with the role of PALB2 
in loading RAD51. We confirmed these findings in an siRNA-independent 
manner by using RNF168-deficient RIDDLE cells, which displayed markedly 
reduced RAD51 recruitment after IR compared to RNF168-complemented 
RIDDLE cells [7] (Fig. 2B). 
To directly measure HR efficiency, we utilised the flow cytometry-based DR-
GFP reporter gene [22]. As expected, BRCA2 loss impaired the ability to 
repair a DSB induced in the gfp reporter gene demonstrating that the reporter 
accurately reflects HR (Fig. 2C). Depletion of either RNF8 or RNF168, with 
independent siRNAs, also caused a notable reduction in HR efficiency (Fig. 
2C) without any impact on cell cycle distribution (Supplemental Fig. 2D). 
These findings suggest that RNF168-mediated ubiquitylation promotes HR 
by modulating BRCA1-dependent PALB2 recruitment and the subsequent 
formation of a functional HR complex. The fact that RNF8 is dispensable 
for PALB2 recruitment in the tethering system (Fig. 1A,C), but necessary for 
IR-induced PALB2 recruitment, is consistent with the strict requirement for 




RNF168-mediated ubiquitylation confines PALB2 recruitment to DSB 
proximal sites 
Chromatin marked by γH2AX is occupied by signalling factors, such as 
ATM, MDC1 and 53BP1, which spread within megabase-sized DSB-
flanking domains. In contrast, HR factors such as RPA, BRCA2 and RAD51 
accumulate in micro-domains delineated by the presence of single-stranded 
DNA (ssDNA), generated by nucleolytic processing of the broken ends [23, 
24]. Given the interplay between RNF168 and PALB2 during HR (Fig. 2A), 
we sought to determine their spatial organization at DSBs by measuring 
IRIF size. As previously reported [23], we observed a notable difference 
in the distribution of signalling proteins compared to HR factors. RNF168, 
similar to the signalling factors γH2AX, MDC1, BRCA1, RAP80 and 53BP1, 
formed larger foci, indicative of spreading more distally from DSBs, whereas 
PALB2 and the HR factors RPA and RAD51 formed smaller foci, indicative 
of binding to regions more proximally to DSBs (Fig. 2D). Thus, even though 
PALB2 recruitment is facilitated by RNF168, its recruitment is likely confined 
to the ssDNA compartment proximal to DSBs. RNF168 spreads beyond this 
compartment into regions more distal to the break, most likely to promote 
accrual of the BRCA1-Abraxas-RAP80-MERIT40 complex [25-27]. The 
fact that PALB2 foci are much smaller than those of BRCA1 and RAP80 
implies that the BRCA1-Abraxas-RAP80-MERIT40 complex does not 
trigger PALB2 assembly in regions more distal from the break, which is in 
agreement with its antagonistic effect on HR [10, 11]. Thus, while BRCA1 
assembly at regions distal to the break depends on RAP80, its recruitment to 
the ssDNA compartment does not require this protein. Together our results 
suggest that RNF168, in concert with BRCA1 [2, 3], facilitates PALB2 loading 
and subsequent HR complex formation in DSB-associated micro-domains 
demarcated by the presence of ssDNA. 
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Figure 2. RNF168-dependent recruitment of HR factors PALB2 and RAD51 to DSBs. (A) 
Effect of the indicated siRNAs on PALB2 (white) IRIF formation in mAG-geminin-expressing 
(green) S/G2 cells. (B) RAD51 (white) IRIF formation in mAG-geminin-expressing (green) S/
G2 cells transfected with the indicated siRNAs and RNF168-deficient RIDDLE S/G2 cells 
complemented with either an empty vector or wild-type RNF168. (C) Effect of the indicated 
siRNAs on HR efficiency measured using the DR-GFP reporter. Western blot analysis of 
RNF8 and RNF168 expression in cells treated with the indicated siRNAs. (D) IRIF foci size (in 
µm2) of various signalling and HR proteins. Quantified data are represented as mean ± S.D. 
(n=3), except in D where n=2. *, P<0.05, **, P<0.01, ***, P<0.001 (student’s t test). See also 
Supplementary Figure 2.
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PALB2 associates with ubiquitylated chromatin through its WD40 
domain
The RNF168-dependent recruitment of PALB2 at DSBs can be either indirect, 
through association with a ubiquitin-binding partner, or direct, by recognition 
of ubiquitin chains. PALB2 indeed interacts with the ubiquitylated H2B-
binding protein MRG15, which promotes its recruitment to DSBs [28, 29]. 
However, the tethering of RNF168 to chromatin, which triggered massive 
ubiquitylation and robust accrual of PALB2, failed to efficiently recruit HA-
tagged MRG15 (Supplemental Fig. 3A). This was not due to expressing a 
nonfunctional fusion protein, as MRG15-HA was efficiently recruited into IRIF 
(Supplemental Fig. 3B) [5]. Moreover, the recruitment of PALB2 after IR (Fig. 
2A) and upon tethering of RNF168 to chromatin did not require RAP80 (Fig. 
1E). Thus, the RNF168-dependent binding of PALB2 to chromatin does not 
involve these known ubiquitin-binding proteins. 
By means of in silico analysis, it was predicted that the C-terminal WD40 
domain of PALB2 may bind ubiquitin [30], a property that is common amongst 
a wide range of WD40 domains [31]. To test if PALB2 indeed associates 
with ubiquitin through its WD40 domain, we generated YFP-tagged wild-
type PALB2 or PALB2 lacking its WD40 domain (ΔWD40). Both PALB2 
fusion proteins were expressed at comparable levels and localised to the 
nucleus similarly to endogenous PALB2. Similar to endogenous PALB2, 
YFP-PALB2WT was recruited to chromatin following tethering of RNF168 (Fig. 
3A,B). However, YFP-PALB2ΔWD40 failed to associate with RNF168-induced 
ubiquitin conjugates, suggesting that PALB2’s association with ubiquitylated 
chromatin is WD40 dependent (Fig. 3A,B). Subsequently we assessed the 
recruitment of YFP-tagged PALB2 variants to sites of DNA damage. YFP-
PALB2ΔWD40 did not accumulate as readily as YFP-PALB2WT at laser-induced 
DNA damage (Fig. 3C), as well as at bona fide DSBs, induced at the LacO array 
by the LacR-tagged FokI nuclease (Fig. 3D,E). In order to exclude possible 
side effects caused by overexpressing PALB2 (Supplemental Fig. 3C) [32], 
we complemented PALB2-deficient FANCN cells with the aforementioned 
constructs. YFP-PALB2WT localised at sites of IR-induced DNA damage in 
cycling cells more efficiently than its ΔWD40 counterpart (Fig. 3F). Together, 
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these findings support the notion that the WD40 domain of PALB2 facilitates 
its association with RNF168-induced ubiquitin conjugates at DSBs. 
To confirm that PALB2 can recognise ubiquitin in a WD40-dependent 
manner, we tested its ability to associate with ubiquitin in an in vitro binding 
assay. Recombinant GST-ubiquitin efficiently pulled down YFP-PALB2WT and 
endogenous RNF168, a known ubiquitin-binding factor, from cell extracts. In 
contrast, GST alone or GST-ubiquitinI44A failed to do so, showing that these 
interactions require the hydrophobic patch of ubiquitin (I44)[33]. Strikingly, 
YFP-PALB2ΔWD40 did not interact with GST-ubiquitin (Fig. 3G). In order to verify 
if the WD40 domain of PALB2 directly binds ubiquitin or rather it interacts with 
a ubiquitin-binding protein, we performed in vitro interaction experiments. 
Neither purified GST-WD40PALB2 nor any of the other four GST-PALB2 
fragments could interact with recombinant mono-ubiquitin (Supplemental Fig. 
3D). Similar negative results were obtained when assaying if GST-WD40PALB2 
could bind poly-ubiquitin chains of various linkages (Supplemental Fig. 3E). 
Therefore, our results indicate that the WD40 domain of PALB2 supports its 
association with DSB-induced ubiquitin conjugates but it does not directly 
bind such ubiquitylated substrates. Furthermore, our findings support a 
scenario in which PALB2 via its WD40 domain associates with a protein 
binding RNF168-induced ubiquitylation. Since BRCA1 is essential for PALB2 
assembly [2, 3], the WD40-dependent recognition of RNF168-modified 





Figure 3. RNF168-dependent recruitment of PALB2 is regulated by an indirect interaction 
between ubiquitin and its WD40 domain. (A) Schematic of the RNF8/RNF168-tethering 
system. (B) YFP-PALB2 (green) accumulation upon tethering of mCherry-LacR-RNF168 (red) 
in cells containing a LacO array. (C) Recruitment of the indicated YFP fusion proteins (green) 
to mCherry-NBS1-marked DNA damage sites (red) after micro-irradiation. (D) Schematic 
of the system used to induce multiple DSBs upon tethering of the FokI endonuclease. (E) 
Recruitment of the indicated YFP fusion proteins (green) to BRCA1-marked (white) DSBs 
induced by FokI-mCherry-LacR at a LacO array (red). (F) IRIF formation of the indicated 
YFP fusion proteins (green) in complemented PALB2-deficient cells (EUFA1341). Cells in S/
G2 are marked by cyclin A (white) while BRCA1 (red) is used as a DNA damage marker. (G) 
GST-binding assay to assess the binding of YFP-PALB2-WT and YFP-PALB2-ΔWD40 to the 
indicated GST-ubiquitin (GST-Ub) fusion proteins or GST alone. Relative binding to GST was 
determined by normalising the PALB2/GST ratios of each IP sample to that of YFP-PALB2WT/
GST alone, which was set to 1. Quantified data are represented as mean ± S.D. (n=2). See 
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PALB2 interacts with RNF168 via its WD40 domain
Given the fact that residual PALB2 and RAD51 accumulation lingers when 
catalytically inactive RNF168 is immobilised at chromatin (Fig. 1C, D), 
and knowing that RNF168 can itself bind the ubiquitylated substrates it 
catalyses through its MIU domains [6, 7, 20], we sought to examine whether 
PALB2 and RNF168 directly interact. Therefore, we immunoprecipitated 
GFP-tagged RNF8 or RNF168 and noticed that endogenous PALB2 was 
specifically detected upon RNF168-IP (Fig. 4A). Performing the reciprocal 
experiment we obtained similar results, namely endogenous RNF168 was 
co-purified along YFP-PALB2 (Fig. 4B). Aiming to verify that this interaction 
is mediated by the WD40 domain of PALB2, we immunoprecipitated either 
wild-type or ΔWD40 YFP-PALB2 and checked if it associates with RNF168. 
While RNF168 readily bound YFP-PALB2WT, this association was all but lost 
with YFP-PALB2ΔWD40 (Fig. 4C), indicating that the WD40 domain is crucial 
for the RNF168-PALB2 interaction. 
Figure 4. RNF168 and PALB2 interact via the WD40 domain of PALB2. (A) GFP-
immunoprecipitation of indicated GFP-fusion proteins. Blots were probed for PALB2 
(endogenous), GFP and tubulin (loading control). (B) As in A but stained for GFP, RNF168 
(endogenous), RAD51 and histone H3 (loading control). (C) As in B but probed for GFP, 















































 A trimodular recruitment mechanism for PALB2
We propose the following model for RNF168-dependent regulation of HR: 
RNF168 decorates chromatin substrates with ubiquitin following its binding to 
RNF8-modified chromatin proximally to DSBs. Although it may be expected 
that resected DNA is devoid of histones, recent studies have shown that 
resection can actually occur in a nucleosomal context [34, 35]. Subsequently, 
the ubiquitin moieties in the ssDNA compartment attract PALB2 through 
its WD40 domain, which, in turn, facilitates BRCA2 and RAD51 assembly 
and promotes efficient HR. This model integrates three WD40-dependent 
features of PALB2: its accumulation at RNF168-modified chromatin (Fig. 
3B), its association with ubiquitin in vitro (Fig. 3G) and its accrual at IR- and 
FokI-induced DSBs (Fig. 3C-F). We propose that these events contribute to 
a trimodular mechanism for PALB2 recruitment in which 1) BRCA1 promotes 
PALB2 assembly through a protein-protein interaction involving its N-terminus 
[2, 3], 2) the more centrally located chromatin-association motif (ChAM) in 
PALB2 stabilises and promotes its binding to damaged chromatin (in the 
ssDNA compartment), and 3) the C-terminal WD40 domain of PALB2 further 
facilitates its accrual and retention by associating with RNF168-ubiquitylated 
chromatin. We propose that integrating these independent recruitment 
signals leads to the efficient and specific accrual of PALB2 to HR sites. 
Such a recruitment mechanism is not uncommon in the DDR. For instance, 
the assembly of 53BP1 at damaged chromatin requires the simultaneous 
presence of two distinct marks on histones H4 and H2A [36, 37]. These 
findings advance our conceptual understanding of the RNF168-dependent 
response to DSBs by revealing a new mechanism that contributes to the 
assembly and function of HR complexes at DSBs. 
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MATERIALS AND METHODS
Cell culture
U2OS, HEK293, RIDDLE (RNF168-deficient), EUFA1341 (FANCN/PALB2-
deficient) and VH10-SV40-immortalised cells were grown in DMEM (Gibco) 
containing 10% FCS (Bodinco BV). U2OS 2–6-3 cells containing 200 
copies of a LacO-containing cassette (~4 Mbp) and U2OS 2-6-3 cells stably 
expressing an inducible version of FokI-mCherry-LacR fused to the estrogen 
receptor (ER) and harbouring a destabilisation domain (DD) were previously 
described [6, 9, 38, 39]. The ViraPower system (Life Science) was used 
to produce lentivirus using mAG- or mCherry-geminin expression vectors. 
U2OS and RIDDLE cells stably expressing mAG- or mCherry-geminin were 
generated by lentiviral infection [40]. U2OS cells were FACS sorted to select 
fluorescence-positive cells. 
Plasmids 
The WD40 domain of PALB2 was removed by inserting a fragment spanning 
the first 2874 nucleotides of wild-type PALB2 into YFP-C1. Additional 
plasmids used are listed in the Supplemental Table.
Transfections
siRNA and plasmid transfections were performed using Lipofectamine 
RNAiMAX (Invitrogen), Lipofectamine 2000 (Invitrogen) and JetPEI (Polyplus 
Transfection) according to the manufacturer’s instructions. Cells were 
transfected twice with siRNAs (40 nM) within 24 h and examined further 48 h 
after the second transfection, unless stated otherwise. siRNA sequences are 
listed in the Supplemental Table.
Generation of DSBs
IR was delivered by a YXlon X-ray generator (YXlon International, 200 KV, 





U2OS 2-6-3 cells expressing inducible FokI-mCherry-LacR [39] were treated 
with 300 nM 4-OHT and 1 μM Shield-I for 5 hrs. Subsequently, cells were 
fixed with formaldehyde and immunostained with the indicated antibodies.
Laser-assisted DSB induction
U2OS cells were irradiated with a pulsed nitrogen laser (Micropoint Ablation 
Laser System; Photonic Instruments, Inc., Belfast, Ireland; 16 Hz, 364 nm) 
[17, 18] or a Mira mode-locked titanium-sapphire (Ti:Sapphire) laser (l = 800 
nm, pulse length = 200 fs, repetition rate = 76 MHz, output power = 80 mW) 
as described previously [41].
Microscopy analysis
Images of fixed cells were acquired on a Zeiss AxioImager D2 widefield 
fluorescence microscope equipped with 40x, 63x and 100x PLAN APO (1.4 
NA) oil-immersion objectives (Zeiss) and an HXP 120 metal-halide lamp used 
for excitation. Fluorescent probes were detected using previously described 
filters [42]. Images were recorded using ZEN 2012 software and analysed 
using ImageJ. The average reflects the quantification of 50-150 cells from 3 
independent experiments.
IRIF analysis
PALB2, RAD51 and MRG15-HA IRIF were analysed in U2OS cells 6hr 
after 10Gy, whereas γH2AX, MDC1, conjugated ubiquitin (FK2), RNF168, 
RAP80, BRCA1 and 53BP1 IRIF were examined 1hr after 2Gy, unless stated 
otherwise. IRIF were evaluated in ImageJ, using a custom-built macro that 
enabled automatic and objective analysis of the foci. Full details of this 
macro will be published elsewhere. In brief, cell nuclei were detected by 
thresholding the (median-filtered) DAPI signal, after which touching nuclei 
were separated by a watershed operation. The foci signal was background-
subtracted using a Difference of Gaussians filter. For every nucleus, foci 
were identified as regions of adjacent pixels satisfying the following criteria: 
(i) the grey value exceeds the nuclear background signal by a set number of 
times (typically 2-4x) the median background standard deviation of all nuclei 
in the image, and is higher than a user-defined absolute minimum value; (ii) 
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the area is larger than a defined area (typically 2 pixels). These parameters 
were optimized for every experiment by manually comparing the detected 
foci with the original signal.
Immunofluorescent labeling
Immunofluoresecent labeling was carried out as described previously [17, 
41]. Briefly, cells were grown on glass coverslips and treated as indicated in 
the figure legends. Subsequently, cells were washed with PBS, then fixed 
with 2% formaldehyde for 20 minutes and permeabilized with 0.25% Triton 
X-100 in PBS for 5 minutes. Cells were rinsed with phosphate-buffered 
saline (PBS) and then treated with 100 mM glycine in PBS for 10 minutes 
to block unreacted aldehyde groups. Finally, cells were equilibrated in PBS 
containing 0.5% BSA and 0.05% Tween 20, and incubated with primary 
antibodies. Detection was done using goat anti-mouse or goat anti-rabbit IgG 
coupled to Alexa 488, 555 or 647 (Invitrogen Molecular Probes). Samples 
were incubated with 0.1 μg/ml DAPI and mounted in Polymount. Primary 
antibodies and secondary antibodies are listed in the Supplemental Table.
GST-binding assay
HEK293 cells were transfected with the indicated YFP-tagged PALB2 
constructs after which ubiquitin-binding assays were performed as described 
[33]. Shortly, HEK293 cells were transfected with the indicated YFP-tagged 
PALB2 constructs, lysed for 10 min on ice in lysis buffer (50 mM HEPES, 150 
mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton-X-100, 25 mM 
NaF, 10 μM ZnCl2, pH 7.5) containing protease inhibitors. Cell lysates were 
collected, centrifuged for 15 min (13,000g) to remove the insoluble fraction 
and incubated with GST, GST–ubiquitinWT or GST–ubiquitinI44A (UBPBio, 
Aurora, USA) coupled to Glutathione sepharose 4B (Amersham Biosciences, 
Freiburg, Germany) for 4 h at +4 °C. After incubation, the sepharose matrix 
was washed three times with lysis buffer. Bound proteins were eluted with 
10mM reduced glutathione and analysed by immunoblotting. 
Western blotting




separated by SDS-PAGE and transferred to PVDF membranes (Millipore). 
Membranes were probed with the antibodies listed in the Expanded view 
followed by protein detection using the Odyssey infrared imaging scanning 
system (LI-COR Biosciences). 
HR assay
HEK293 and U2OS cells containing a stably integrated copy of the DR-GFP 
reporter were used to measure the repair of I-SceI-induced DSBs by HR as 
described [22]. Briefly, 48 h after siRNA transfection, cells were transfected 
with the I-SceI expression vector pCBASce and an mCherry expression 
vector. 48 or 72 h later the fraction of GFP-positive cells among the mCherry-
positive cells was determined by FACS on a LSRII flow cytometer (BD 
Bioscience) using FACSDiva software version 5.0.3. Quantifications were 
performed using Flowing Software (www.flowingsoftware.com). 
Cell cycle profiling
For cell cycle analysis cells were fixed in 70% ethanol, followed by DNA 
staining with 50 µg/ml propidium iodide in the presence of RNase A (0.1 mg/
ml). Cell sorting was performed on a LSRII flow cytometer (BD Bioscience) 
using FACSDiva software (version 5.0.3; BD). Quantifications were performed 
using Flowing Software. 
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Supplemental Figure 1. PALB2 accumulates at RNF168-induced ubiquitylated 
substrates. (A) Phosphorylated RPA accumulation (white) upon tethering of the indicated 
mCherry-LacR fusion proteins (red) in cells containing a LacO array. (B) Effect of the 
overexpression of the GFP-tagged deubiquitylating enzymes USP26 and USP37 (green) in 
the accumulation of PALB2 (white) upon tethering of mCherry-LacR-RNF168 (red) in cells 
containing a LacO array. (C) As in B but stained for RAD51 (white). (D) As in C, but stained for 
RAP80 (green) in control (siLuc) or RAP80-depleted cells. (E) Effect of the indicated siRNAs 
in the formation of BRCA1 (white; left) and RAP80 (white; right) IRIF in S/G2 cells. 50-100 
cells were analysed per experiment. Quantified data are represented as mean ± S.D. (n=3). *, 















































































































































































































































Supplemental Figure 2. RNF8/RNF168 depletion impairs HR in mAG-geminin U2OS cells. 
(A) Validation of the mAG-geminin U2OS cell line by FACS; plot of propidium iodine staining, 
indicative of DNA content (x-ayis), and mAG-geminin expression (y-axis). Quantification of 
FACS results (right panel). (B) Effect of the indicated siRNAs on PALB2 (white) IRIF formation 
in cyclin B1-expressing (green) S/G2 cells. (C) Impact of the indicated siRNAs on RAD51 
recruitment (white) to γH2AX-marked DSB tracks (green) generated after UV-A laser micro-
irradiation in mCherry-geminin-expressing (red) S/G2 cells. (D) Cell cycle profiles of cells 
treated with the indicated siRNAs. Quantified data are represented as mean ± S.D. (n=3). *, 
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Supplemental Figure 3. PALB2 accrual at RNF168-ubiquitylated chromatin is not 
mediated by MRG15 or direct ubiquitin binding. (A) MRG15-HA (white) accumulation upon 
tethering of the indicated mCherry-LacR fusion proteins (red) in cells containing a LacO array. 
(B) MRG15-HA (white) IRIF formation in cyclin A-expressing (green) S/G2 cells. (C) Impact of 
the overexpression of YFP-PALB2 (green) in the formation of RAD51 IRIF (white) in cyclin B1-
expressing (red) S/G2 cells. (D) GST-immunoprecipitation based in vitro interaction studies 
of the indicated GST fusion proteins and recombinant mono-ubiquitin. Blots were probed for 
GST and ubiquitin. (E) As in (D) only incubated with recombinant polyubiquitin chains of K48, 
K63 or K27 linkage. Quantified data are represented as mean ± S.D. (n=3). *, P<0.05, **, 
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DNA damage response signalling is crucial for the protection of the genome 
in all organisms and presents avenues to combat chemo- or radio-therapy 
resistance of cancer cells. In an RNAi screen for (de)ubiquitylases and 
sumoylases modulating the apoptotic response of embryonic stem (ES) 
cells to DNA damage, we identified the E3 ubiquitin ligase/ ISGylase, 
Ariadne homologue 1 (ARIH1). ARIH1 depletion sensitised ES and cancer 
cells to genotoxic compounds, irrespective of their p53- or caspase-3 
status. Expression of wild-type, but not ubiquitylase-defective, ARIH1 
constructs reversed the ARIH1-loss-induced sensitisation. ARIH1 protein 
abundance increased after DNA damage through attenuation of proteasomal 
degradation that required ATM signalling. ARIH1 associated with 4EHP and 
in turn, this competitive inhibitor of the translation initiation factor eIF4E, 
underwent increased non-degradative ubiquitylation upon DNA damage. 
Genotoxic stress led to an enrichment of ARIH1 in perinuclear, ribosome-
containing regions and triggered 4EHP association with the mRNA 5’ cap 
as well as mRNA translation arrest, in an ARIH1-dependent manner. Finally, 
restoration of DNA damage-induced translation arrest in ARIH1-depleted 
cells, by means of an eiF2 inhibitor, was sufficient to reinstate resistance to 
genotoxic stress. These findings establish ARIH1 as a potent mediator of 




ARIH1 protects by initiating a 4EHP-mediated translation arrest
INTRODUCTION 
DNA damage leads to acute toxicity, accumulation of mutations and 
subsequent chromosomal instability, potentially resulting in malignant 
transformation [1, 2]. To counteract these deleterious effects of DNA damage 
the cell is equipped with a highly complex signalling response termed the 
DNA damage response (DDR). The DDR activates effector components 
involved in protective pathways, including DNA damage repair, cell cycle 
arrest, transcription regulation, chromatin remodelling and cell death (1). 
The several complexes that collectively constitute the DDR are crucial for 
the protection of the genome in all organisms. Moreover, understanding 
DDR signalling in the context of chemical or ionising radiation-induced 
DNA damage is important to design improved strategies to combat therapy 
resistance. In tandem with phosphorylation-mediated signalling, which 
is largely executed by the PI3Kl like kinases ATM, ATR and DNA-PK, the 
checkpoint kinases Chk1 and Chk2, and members of the MAPK family [3, 4], 
protein modifications by ubiquitin and ubiquitin-like moieties are crucial at all 
levels of the DDR [5]. 
The ubiquitylation machinery can form various, differentially interpreted tags, 
including both degradative (K48-, K11-linked chains) and non-degradative 
(mono-ubiquitylation, K63-linked chains) signals [6]. In parallel, a growing 
family of UBiquitin-Like (UBL) proteins such as SUMO, Nedd8 and ISG15 has 
been identified. Covalent attachment of these UBLs on downstream targets 
mostly provides non-degradative signals. The ubiquitylation, sumoylation, and 
ISGylation systems have been shown to share several common enzymes [7-
9]. Ubiquitin mediated signalling is vital to many cellular processes, including 
the response to DNA damage. Recognition and processing of double strand 
breaks (DSBs) and intrastrand crosslinks, polymerase switching during 
translesion synthesis (TLS), nucleotide excision repair, and p53 stability are 
all regulated by ubiquitylation [5, 10, 11]. More recently, ISGylation was also 
implicated in the DDR, as ATM-mediated deactivation of the ISG system was 




protein turnover after DNA damage [12].
Ubiquitin and ubiquitin-like modifications occur through three enzymatic 
steps, commencing with an E1 activating enzyme, which forms a thioester 
bond to the ubiquitin protein. Subsequently, the charged ubiquitin monomer 
is relayed to an E2 enzyme that conjugates the ubiquitin molecule to its 
target protein with the aid of an E3 ubiquitin ligase [13]. While there are only 
a few E1 and E2 enzymes, a large number of E3 ubiquitin ligases dictates 
substrate specificity and ensures substrate diversity of the ubiquitin system 
(13). There are two E3 ubiquitin ligase families. In RING ubiquitylases, the 
ligase functions as an adaptor between the E2 enzyme and the substrate, 
facilitating transfer of the ubiquitin moiety to the target protein. In HECT 
ubiquitylases, the ubiquitin is first conferred to a conserved residue within 
the HECT domain and then added to the substrate protein [14]. Recently, it 
was established that ubiquitin ligases of the Parkin family, including Parkin 
and the human homologue of Ariadne1 (ARIH1; HHARI) resemble hybrids 
between HECT and RING domain ubiquitin ligases [15].
In response to DNA damage, ongoing transcription and translation have to 
be adjusted to allow execution of stress-specific programs, save energy, 
accomplish DNA repair and avoid the transcription and subsequent translation 
of potentially mutated genetic material [16]. Genotoxic stress has been 
shown to induce a block in protein synthesis [17-19]. Eukaryotic mRNAs 
are mostly recruited to the ribosome through their 5’ 7-methylguanosine cap 
[20]. The rate-limiting step of eukaryotic cap-dependent translation initiation 
is the binding of the eIF4F complex to the mRNA 5’ cap structure. eIF4F is 
composed of the cap-binding protein eIF4E, the RNA helicase eIF4A and the 
scaffold protein eIF4G [21, 22]. Recruitment of additional eIF proteins and 
the 40S ribosomal subunit completes the pre-initiation complex that scans 
the mRNA for the AUG codon and drives mRNA translation initiation (20-
22). If eIF4E is substituted by its structural analog 4EHP at the mRNA 5’ 
cap, the formation of the pre-initiation complex is abolished [20]. Thus, 4EHP 
constitutes a negative regulator of translation initiation.
Here, we describe the identification of the Parkin family E3 ubiquitin ligase, 
ARIH1 in an RNAi screen for modulators of chemosensitivity. We show that 
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ARIH1 levels and cellular localisation are regulated in response to DNA 
damage. In turn, ARIH1 protects stem- and cancer cells against genotoxic 
compounds and γ-irradiation (IR) by promoting and fine-tuning a 4EHP-
mediated mRNA translation arrest.
RESULTS
Identification of CP response modulators by an RNAi screen for 
ubiquitylation-family enzymes 
We performed an siRNA-based screen using the Dharmacon ubiquitylation 
SMARTpool library and custom made SMARTpool libraries targeting all 
known cellular deubiquitylases (DUBs), sumoylases, and desumoylases 
(Table S1). Mouse embryonic stem (ES) cells that display a robust apoptotic 
response to genotoxic compounds including CP (Fig S1A, B), were treated 
with 10mM CP or vehicle and cell viability was monitored after 24h. 50 
identified SMARTpools met our selection criteria [no significant effect under 
control conditions; modulation of viability in presence of CP with Z-score +/- 
1.5 and p-value > 0.05] (Fig 1A; Table S2). As controls, we included siRNA 
SMARTpools targeting either Kif11, expected to already induce cell killing 
under control conditions due to mitotic spindle defects, or p53, expected to 
protect ES cells against CP-induced killing. In all experimental plates, siKif11 
resulted in ~90% reduction in viability under both control and CP-treated 
conditions whereas sip53 protected against CP-induced loss of viability (Fig 
S1C). As a quality measurement, Z’-factors were calculated based on siLamin 
(negative control) and sip53. The average of calculated Z’-factors was 0.45, 
indicating a good signal to noise ratio and reproducibility of the screens (Fig 
S1D). To exclude off-target effects, the 50 identified SMARTpools entered 
a deconvolution screen, where 28/50 hits were confirmed with at least 2/4 
independent sequences reproducing the effect of the SMARTpool (Fig 1B,C, 
Table S3).
The 28 confirmed hits included siRNAs targeting six DUBs, one E1 ubiquitin-




as well as 12 siRNAs targeting E3 ubiquitin ligases (Fig 1D). Moreover, we 
identified seven siRNAs targeting proteins with no described ubiquitylation-
related function that were included in the ThermoFischer “ubiquitylation 
library” based on the presence of predicted domains associated with 
ubiquitylase function, such as RING, SOCS, or SPRY (see discussion). The 
knockdown of the E1 ubiquitin enzyme Ube1x (Uba), which has recently been 
shown to be a crucial E1 enzyme in the DDR following ionising radiation and 
replication stress [23], resulted in a particularly strong reduction of viability 
(Fig 1C).
Enrichment of p53-modyfiers and DNA repair regulators  
A large proportion of the identified hits have been previously shown to control 
the levels or activity of the transcription factor p53, which acts as a master 
regulator of the outcome of the DDR in various cell types, including ES cells 
(Fig 1E) [1, 2, 24]. Three of the identified DUBs, USP7 (HAUSP), USP4, 
and USP5 can directly or indirectly influence p53 protein levels [10, 25-
27]. In addition, the E3 ligases Rfwd3, Pirh2 and TOPORS were previously 
implicated in regulation of p53 stability [10, 28, 29] (Fig 1E; Table S3). Besides 
p53 regulators, we identified several other ubiquitin ligases involved in DDR-
related processes, like post-replication repair (SHPRH [30]), translesion 
synthesis (Pirh2 [31]), DSB repair (BRCA1 [32]), and the RPA-mediated 
repair of single strand breaks (Rfwd3 [33]), further confirming the validity of 
the targets identified in our screen.
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Silencing ARIH1 sensitises to genotoxic stress
One of the strongest obtained hits was the Parkin family ubiquitin ligase 
Ariadne Homologue 1 (ARIH1) [34]. The ARIH1 SMARTpool, as well as all 
four of the individual sequences tested in the deconvolution experiments, 
significantly sensitised ES cells to CP-induced loss of viability (Fig 1A,C; Table 
Figure 1. Identification of modulators of the CP response by an RNAi screen for 
ubiquitylation / sumoylation enzymes. (A) Hits identified in primary screens; protecting 
siRNA SMARTpools in red, sensitising siRNA SMARTpools in blue. (B) Results of 
deconvolution screen for 50 SMARTpools identified in primary screen. (C) Z-scores obtained 
for 28 confirmed hits in deconvolution screen. ARIH1 results indicated in blue. (D) Distribution 
of hits over different gene families as indicated. (E) Metacore-predicted network derived from 





S3). In order to examine if ARIH1 was involved in the response to specific 
types of stress, the effect of ARIH1 knockdown in ES cells was examined 
after treatment with various genotoxic and non-genotoxic compounds. All 
compounds were used at equitoxic doses causing ~50% loss-of-viability after 
24h treatment (Fig 2A). ARIH1 depletion, using the SMARTpool or individual 
siRNAs, did not affect ES cell viability under control conditions (Fig 2B,C). 
Similar to its effect on CP-sensitivity, silencing ARIH1 using the SMARTpool 
or individual siRNAs significantly sensitised ES cells to all tested genotoxic 
drugs, including the topoisomerase inhibitor etoposide, the DNA intercalator 
doxorubicin, and the DNA crosslinking compound mitomycin C (Fig 2B,C). In 
contrast, ARIH1 loss did not sensitise ES cells to non-genotoxic agents such 
as the oxidative stressor diethyl maleate (DEM), the ER stressor thapsigargin 
(THAPS), or the microtubule poison Vincristine (VINC) (Fig 2C). Decreased 
viability, as measured in the ATPlite assay, correlated with an increased 
subG1/G0 fraction in ARIH1-depleted ES cells that could be detected after 
treatment with a lower dose of CP, pointing to increased cell death (Fig 2D).
In order to validate these findings in human cancer cells, we examined the 
effect of silencing ARIH1 in U2OS, p53 wild-type human sarcoma cells. We 
introduced lentiviral shRNAs targeting ARIH1 and, following bulk puromycin 
selection, identified two short hairpins providing ~90% reduction in ARIH1 
protein levels (Fig 2E). Basal cell survival was somewhat reduced when 
compared to a lentiviral control cell line (Fig 2F). Nevertheless, analogous 
to the effect observed in ES cells, both ARIH1-depleted cell lines showed 
a significantly increased loss of viability in response to treatment with 10 
or 25mM CP for 48h (Fig 2F). In further agreement with these findings, 
clonogenic survival in a colony-formation assay of ARIH1-depleted U2OS 
cells was also markedly more impaired by 24 hour pretreatment with a dose 
range of CP as compared to control cells (Fig 2G). 
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Figure 2. Silencing ARIH1 sensitises to genotoxic 
stress. (A) ES cell viability after treatment for 24 hours 
with indicated equitoxic concentrations of CP, mitomycin C 
(MMC), etoposide (ETO), doxorubicin (DOX), diethylmaleathe 
(DEM), thapsigargin (THAPS), or Vincristine (VINC). (B) 
ES cell viability in presence of control or ARIH1 siRNA after 
treatment with equitoxic concentrations of CP, ETO, or MMC. 
(C) ES cell viability in presence of Kif11-siRNA (only for PBS), 
GFP-siRNA, p53-siRNA, or 2 individual siRNA sequences 
targeting ARIH1 after treatment with equitoxic concentrations 
of CP, DOX, DEM, THAPS or VINC (normalised to siGFP). (D) 
Sub-G1/G0 apoptotic fraction of control or siARIH1 ES cells 
treated with 7.5mM CP for 24h. (E) ARIH1 protein levels and 
H2B loading control in U2OS cells bulk puromycin-selected 
for expression of shcontrol or 3 individual shRNAs targeting 
ARIH1. Percentages indicate remaining ARIH1 expression. 
Asterisks indicate shARIH1 #2 and #3 used in all further experiments. (F) U2OS cell viability 
in shcontrol or 2 individual shARIH1 cell lines after treatment with vehicle (PBS) or 10 or 
25mM CP for 48h. (G) Colony formation capacity in shcontrol or shARIH1-2 and -3 U2OS cell 





Genotoxic stress-induced ARIH1 accumulation represents a p53- and 
caspase-3-independent adaptive response
In contrast to reported functions for many of the other identified hits (Fig 
1E, Table S3), ARIH1 did not control basal or genotoxic stress-induced p53 
stability in ES or U2OS cells (Fig 3A,B). In further disagreement with a role 
for p53 in the enhanced sensitivity to genotoxic stress observed in ARIH1-
depleted cells, silencing ARIH1 effectively sensitised the p53-deficient 
non-small-cell lung cancer cell line H1299 [35] to CP (Fig 3C,D). Transient 
knockdown of ARIH1 also sensitised the caspase-3 deficient human breast 
cancer cell line MCF7, indicating that the effect of ARIH1 was not restricted 
to caspase 3-mediated apoptosis (Fig 3E). Although less prominent, the 
same effect was observed using 2 independent MCF7 shARIH1 lines (Fig 
3F,G). DNA damage can trigger a p53-dependent or independent cell cycle 
arrest [36]. In MCF7, ARIH1 loss did not alter the basal cell-cycle distribution 
or the CP-induced increase of S/G2 populations (Fig 3H,I). Likewise, ARIH1 
knockdown did not affect the basal cell-cycle distribution or the CP-induced 
G2/S arrest in ES cells (Fig 3J,K). Together, these data indicate that ARIH1-
depleted cells display normal cell-cycle arrest in response to genotoxic stress, 
while cell survival upon DNA damage is compromised in the absence of 
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Figure 3. Silencing ARIH1 enhances cell death in response to genotoxic stress in a p53 
and caspase-3 independent manner. (A) p53 and tubulin control protein levels in ES cells in 
presence of indicated siRNAs treated with PBS control or 5mM CP for 8h (n=4). (B) p53 and 
tubulin control protein levels in U2OS cells in the presence of the indicated shRNAs treated 
with PBS control or 10mM CP for 16h (n=3). (C) p53 and tubulin control protein levels in p53-
deficient H1299 cells treated with indicated concentrations of CP for 24h. Note absence of 
p53. (D) H1299 cell viability under control or siARIH1 conditions after treatment with vehicle 
control PBS or 25mM CP for 24h. (E) MCF7 cell viability under control or siARIH1 conditions 
after treatment with PBS or 25mM CP for 48h. (F) ARIH1 and tubulin control protein levels in 
MCF7 cells in the presence of the indicated shRNAs (G) Cell viability for shcontrol and two 
shARIH1 MCF7 cell lines treated for 48h with PBS, 10 or 25mM CP. (H) FACS analysis for cell 
cycle content in shcontrol and shARIH1 MCF7 cell lines treated for 24h with PBS or 10μM CP. 
(I) Quantification of cell cycle profiles in wt, shcontrol and shARIH1-2 and -3 MCF7 cell lines 
after treatment with PBS or 10mM CP for 24h. (J) FACS profiles for HM1 cell cycle content 
under control, siGFP, or siARIH1 conditions after treatment with vehicle control or 1μM CP. (K) 




Subsequently, we tested if DNA damage affected the abundance of ARIH1. 
ARIH1 protein levels were boosted following CP treatment in U2OS cells (Fig 
4A). This could not be explained by elevated mRNA levels, indicating that 
genotoxic stress triggered either increased synthesis or enhanced stability 
of the ARIH1 protein (Fig 4B). Treatment with the proteasome inhibitor 
MG132 led to increased basal ARIH1 levels, with CP treatment not causing 
further ARIH1 accumulation under these conditions (Fig 4C). KU-5593, an 
inhibitor of ATM, a central kinase within the DDR signalling network, blocked 
CP-induced ARIH1 accumulation, suggesting that DNA-damage caused 
ATM-mediated attenuation of proteasomal degradation of ARIH1 (Fig 4C). 
We then sought to address whether regulation of ARIH1 abundance might 
occur through suppression of self-ubiquitylation. Although ARIH1 indeed 
appeared to be ubiquitylated, this modification was not regulated by CP 
and was unaffected by ATM inhibition (Fig S2A). Moreover, a ubiquitylation-
deficient ARIH1 mutant (C208A) displayed a markedly similar ubiquitylation 
pattern (Fig S2A) (24). Notably, by MS analysis of GFP-ARIH1 immuno-
precipitations we identified K144 as a ubiquitylated site in ARIH1, yet this 
was not modulated by CP treatment (Fig S2B). We also identified multiple 
ARIH1-interacting components of the ubiquitylation machinery (i.e. ubiquitin 
itself, the E1 enzyme UBA1, and the E2 enzyme UBE2L3 known to interact 
with ARIH1). Such interactions, as well as a potential product (K48 poly-
ubiquitin chains), were moderately increased upon CP treatment (Fig S2B).
CP treatment induces 4EHP ubiquitylation
In response to DNA damage, ongoing cellular activities are suppressed while 
stress programs and DNA repair processes are activated. One aspect of the 
DNA damage response is the acute inhibition of protein synthesis through 
alterations of the cap-dependent translation initiation complex [37]. This can 
be achieved in several ways, including cap-recruitment of 4EHP (eIF4E2), a 
competitive inhibitor of the canonical cap-binding translation initiation factor, 
eIF4E [20]. In contrast to eIF4E, 4EHP cannot bind the structural component 
eIF4G that is required for ribosome accrual and subsequent mRNA 
translation. Although ARIH1 can act as an E3 ubiquitin ligase for 4EHP [38], 
there is also evidence that ARIH1 can ISGylate 4EHP, thus enhancing its 
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affinity for the mRNA cap structure and its ability to replace eIF4E [39]. Co-
immunoprecipitations in U2OS cells showed that the increased abundance 
of ARIH1 in CP-treated cells was accompanied by increased association of 
ARIH1 with 4EHP and this 4EHP-associated ARIH1 was lost in shARIH1 
cells (Fig 4D,E). 
Furthemore, we analysed CP-induced posttranslational modification of 
wild-type 4EHP and a [K121/130/134/222R]-mutant (4KR) that cannot be 
ISGylated [39]. Immunoprecipitation of wild -ype 4EHP showed bands of 
higher molecular weight appearing upon CP treatment (Fig 4F). Identical 
bands were also observed for the 4KR-4EHP mutant arguing against a 
CP-induced 4EHP-ISGylation. Moreover, such species were detected by 
a ubiquitin antibody, whereas Western blotting for co-expressed HA-ISG15 
did not detect these species, despite the fact that free ISG15 was readily 
detected in the FLAG immunoprecipitations. The most prominent modification 
corresponded to mono-ubiquitylated 4EHP (28+7 kDa) although the ubiquitin 
Western blot indicated that 4EHP di-ubiquitylation may also occur.
ARIH1 ubiquitylation function mediates adaptation to genotoxic stress
Results thus far suggested that 4EHP is ubiquitylated, not ISGylated, after 
genotoxic stress. We tested whether the ISGylation or ubiquitylation function 
of ARIH1 was required for its protective role in genotoxic stress. Therefore, 
we silenced endogenous ARIH1 using an siRNA targeting the 3’ UTR in 
U2OS cells expressing either exogenous wild-type ARIH1 or a C208A mutant 
that fails to associate with the E2 enzyme UbcH7, rendering it defective in 
ubiquitylation (whereas interaction with UbcH8 and hence, ISGylase activity 
remains intact) [40]. In agreement with earlier findings, ARIH1-silenced cells 
were more sensitive to CP treatment although the effect of the transient 
siRNA was less prominent than stable shRNA-mediated silencing (see Fig 
2G). More importantly, expression of wild-type- but not ubiquitylation-deficient 
(C208A) ARIH1, restored colony formation capacity under genotoxic stress 
in cells depleted for endogenous ARIH1 (Fig 4G). Put together, these data 
indicate that 4EHP ubiquitylation constitutes the predominant modification 
induced by genotoxic stress, with the ubiquitylase function of ARIH1 being 




Figure 4. ARIH1 accumulates after DNA damage and 
interacts with 4EHP.  (A) ARIH1 protein levels in U2OS 
cells treated for 4h with PBS or 5mM CP. (B) qPCR analysis 
of ARIH1 RNA levels, normalised to GAPDH in U2OS cells 
treated for 4h with PBS or 5mM CP. (C) Western blot for 
ARIH1 and tubulin loading control. For inhibitor treatment, 
cells were pretreated for 30min with DMSO vehicle control, 
10mM proteasome inhibitor MG132, or 5mM ATM inhibitor 
KU-55933 and subsequently exposed to 5mM CP or PBS 
vehicle control for 4h in the presence of indicated inhibitors 
(n=4). (D) Total cell lysates and FLAG pull-down of U2OS 
cells transfected with control FLAG-LacR or FLAG-4EHP 
with vehicle control or 5μM CP for 4h. Blots were probed for FLAG, ARIH1 and Histone 
H3 (loading control). (E) FLAG pull-down of U2OS cells in the presence of the indicated 
shRNAs, subsequently transfected with control (empty) or FLAG-4EHP cDNAs, and treated 
with vehicle control or 5μM CP for 4h. Blots were probed for 4EHP (FLAG) and ARIH1. Open 
and shaded arrowheads as explained in D. (F) Total cell lysates and FLAG pull-down of U2OS 
cells transfected with FLAG-4EHP (wt or 4KR) in combination with HA-ISG15 and treated 
with vehicle control or 5μM CP for 4h. Blots were probed for FLAG, HA, ubiquitin and tubulin 
(loading control) (G) Colony formation capacity after 24h treatment with CP at indicated 
concentrations in control U2OS cells or U2OS cells stably expressing GFP-tagged wild-type 
or C208A mutant ARIH1, in absence or presence of siRNA targeting luciferase (control) or the 
ARIH1 3’UTR. * p<0.05.
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CP-treatment induces 4EHP cap-binding and translation arrest in an 
ARIH1-dependent manner
ARIH1-dependent ISGylation has been reported to regulate 4EHP association 
with the mRNA 5’ cap but ARIH1-mediated ubiquitylation of 4EHP, although 
described, is not known to affect this process. In order to clarify whether 
ARIH1 supported 4EHP translocation to the mRNA cap upon CP treatment, 
we utilised 5’ 7-methylguanosine cap-pulldown assays. Indeed, 4EHP 
binding to the mRNA cap was induced in response to CP in U2OS, MCF7, 
as well as ES cells (Fig 5A-D). Importantly, this response was dependent on 
ARIH1 as the CP-induced 4EHP:cap association was abrogated in U2OS, 
MCF7, and ES cells upon ARIH1 depletion (Fig 5A-D). Subsequently, to test 
if the 4EHP:cap association represents an ARIH1-regulated pathway that is 
involved in protection against CP, 4EHP itself was silenced. In line with such 
a protective function, ES cells and U2OS cells were sensitised to genotoxic 
compounds following 4EHP silencing, while viability of H1299 in presence of 
CP and control conditions was compromised (Fig 5E-H).
These findings hint that the ability of ARIH1 to protect against genotoxic 
stress-induced cell death involves 4EHP-mediated translation inhibition at 
the mRNA 5’ cap. To address whether ARIH1 localised at sites of mRNA 
translation upon genotoxic stress, we performed immunostainings to assess 
subcellular distribution of ARIH1. Whereas in untreated U2OS cells ARIH1 
resided in the nucleus and diffusely throughout the cytoplasm, treatment 
with CP or IR caused ARIH1 accumulation at both the nucleus and speckled 
structures in perinuclear regions, which markedly resemble ribosomes (Fig 
5H). In agreement with a genotoxic stress-induced transittion of ARIH1 
to ribosomes, and a role in 4EHP-mediated translation arrest, eIF4G2, a 
ribosomal marker, co-localised to such ARIH1-containing perinuclear regions 




Figure 5. ARIH1 mediates DNA damage-induced cap binding of 4EHP. (A-C) m7G-cap 
pulldown from control and ARIH1-silenced U2OS (A), MCF7 (B) or HM1 ES cells (C) treated 
with vehicle control or indicated concentrations of CP. Blots were probed for 4EHP and tubulin 
(loading control). Numbers at the bottom of A and B indicate cap-associated 4EHP levels 
relative to total 4EHP. (D) Quantification of m7G-cap-bound 4EHP in ES cells treated with 
indicated siRNAs (n=2). (E) ES cell viability in the presence of the indicated siRNAs after 
treatment with PBS, 10mM CP, 150nm ETO, 10mg/ml MMC for 24h. (F) ES cell viability in the 
presence of the indicated siRNAs after treatment with vector, 10mM CP, 150nm ETO or 10mg/
mL MMC. (G) As in (F) but for U2OS after treatment with PBS, 10 or 25μM CP. (H) As in (F) for 
H1299 cells after treatment with PBS or 25μM CP. (I) FLAG-ARIH1 localisation before or after 
treatment with 5μM CP for 4h or 4h after treatment with 2Gy IR. Arrowheads indicate regions 
of perinuclear accumulation. (J) Higher magnification of perinuclear staining for FLAG-ARIH1 
(green), ribosomal marker eiF4G2 (red) staining after CP treatment or IR. *p<0.05; **p<0.01.
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To directly address whether ARIH1 was important for inducing a DNA damage-
induced translation arrest, Click-iT® metabolic labelling was used to quantify 
newly synthesised proteins. CP treatment caused a significant translation 
arrest in U2OS cells with a 30% reduction of protein synthesis at 2h post-
treatment and maintenance of a 25% reduction at 4 and 8h post-treatment 
(Fig 6A). In line with a critical role for ARIH1 in mediating this arrest, two 
independent shARIH1 lines did not show this CP-induced translation arrest. 
Notably, a 60% reduction in translation caused by cyclohexamide in wild-type 
U2OS remained intact in ARIH1-silenced cells (Fig 6A,B). 
Finally, we investigated if the ARIH1-mediated translation arrest was critical 
for the role of ARIH1 in adaptation to genotoxic stress. For this, we made 
use of salubrinal, an inhibitor of eIF2a dephosphorylation that renders the 
eIF2 initiation factor inactive and inhibits mRNA translation under stressed 
conditions. Co-treatment with salubrinal restored the CP-induced translation 
arrest in ARIH1-depleted cells (Fig 6B). Indeed, such an alternatively triggered 
translation arrest significantly restored viability of CP-treated ARIH1-silenced 
U2OS, ES and MCF7 cells (Fig 6C-E).
Altogether, these findings support a model in which DNA damage induces 
an increase in ARIH1 protein levels and an association of ARIH1 with 4EHP. 
In turn, this causes 4EHP recruitment to the mRNA cap where it is known 
to compete with eIF4E. The resulting mRNA translation arrest represents 
an adaptive response to genotoxic stress: ARIH1 depletion sensitises cells 
to genotoxic stress while reestablishing the translation arrest at the level of 




Figure 6. ARIH1 mediates CP-induced mRNA translation arrest. (A) Methionine 
incorporation in U2OS cells after treatment with 15mM CP for 2h, 4h or 8h or 2mg/ml 
cyclohexamide (CHX) for 1h. Alexa546 signal (reflecting newly synthesised protein) / number 
of nuclei (DAPI), normalised to PBS condition is shown. (B) As in (A) but in the presence 
of the indicated shRNAs and after treatment with 2mg/ml CHX for 1h, 15μM CP for 2h, or 
co-treatment with 15μM CP and 2.5mM salubrinal (SAL) for 2h. Alexa546 signal / number 
of nuclei, normalised to PBS condition is shown. (C-E) Cell survival in cells treated with the 
indicated siRNAs or shRNAs after treatment with indicated concentrations of CP (hr treatment) 
in absence or presence of 2.5mM SAL. C, U2OS 48; D, ES cells 24h; E, MCF7 48h. (F) 
Model for the role of ARIH1 in regulating sensitivity to genotoxic stress. i) Under non-stressed 
conditions, eIF4E binds the mRNA m7G-cap, a pre-initiation complex is formed scanning 
the mRNA until the AUG codon is found. ii) Upon genotoxic stress, ARIH1 associates with 
4EHP, resulting in recruitment of 4EHP to the 5’ cap where it replaces eIF4E, resulting in a 
cytoprotective translation arrest. iii) In the absence of ARIH1, 4EHP is not recruited to the 
mRNA 5’ cap, DNA damage-induced translation arrest does not occur, and cell survival is 
compromised. iv) Restoration of translation arrest in ARIH1-depleted cells by preventing 
formation of a pre-initiation complex through inhibition of eIF2 also restores cell survival.
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DISCUSSION 
Ubiquitylation plays a vital role in the DDR signal transduction cascade. 
Our RNAi screen targeting the cellular ubiquitylation and sumoylation 
machinery helped us identify several genes that modulate the response 
to the chemotherapeutic drug CP. Some of the identified DUBs and E3 
ubiquitin ligases have been previously implicated in p53 regulation or DNA 
repair processes [5, 10]. In addition, through our screen we picked up 
genes associated with cell cycle control or developmental processes. These 
include Fbxw7, a tumour suppressor that marks several proto-oncogenes, 
such as Myc, Jun, cyclin E, and Notch for degradation; and Dtx2, an E3 
ligase also proposed to control the Notch signalling pathway [41-43]. Which 
of these functions explains the role of these ubiquitin ligases in the response 
to genotoxic stress is not known. Moreover, while two of the individual 
siRNAs mimicked the SMARTpool for these genes, the deconvolution screen 
also revealed one individual siRNA for these genes to have the opposite 
effect. This indicates that either of those outcomes is likely an off-target 
effect and further experiments are required to determine the role of these 
genes in the response to genotoxic stress. We also identified another F-box 
protein, Fbx017, where the SMARTpool and 3/4 individual siRNAs caused 
sensitisation, thus bestowing more confidence in a potential role of this gene 
in adaptation to genotoxic stress. However, no mechanism of action has 
been described for Fbx017 yet.
Another group of identified hits has been associated with intracellular 
transport processes, including the DUB USP8, which regulates endosomal 
sorting of membrane receptors and RUFY and SYTL4, which are involved in 
Rab-mediated vesicular transport [44-46].Notably, some of the hits from the 
“ubiquitylation SMARTpool library” do not have established (de)ubiquitylase 
function. These include i) the Zinc finger-containing chromatin remodeling 
factor CHD4 that lacks domains associated with (de)ubiquitylase activity 
[47]; ii) the Rab-interacting proteins RUFY and SYTL4 that have a FYVE- 




46]; and iii) TCE1 and Rspry1, containing a SPRY domain that is found in 
members of the TRIM-family of ubiquitin ligases [48]. In addition, Rspry1 
contains a RING domain and TCE1 also harbors a SOCS box domain, which 
mediates interactions with the Elongin BC complex, an adapter module in E3 
ubiquitin ligase complexes [49]. 
The Parkin family ubiquitin ligase, ARIH1 has not been previously implicated 
in DDR signalling. Our findings reveal that ARIH1 protects pluripotent stem 
cells, as well as various cancer cells, from the toxic effects of genotoxic 
chemical agents that cause DSBs. The cytoprotective role of ARIH1 is also 
observed in cancer cells lacking a functional p53 or caspase-3 response. 
Hence, ARIH1 is not required specifically for dampening p53-induced, 
caspase-3-mediated apoptosis. Instead, we find that ARIH1 mediates an 
mRNA translation arrest in response to DNA damage by binding to 4EHP 
and stimulating its recruitment to the mRNA 5’ cap.
The temporary arrest of mRNA translation is an important event in the 
response to cellular stress and alterations in this regulatory hub have been 
suggested to be important for resistance of cancer cells to therapy [19, 50]. 
A well-described mechanism for translation repression is the enhanced 
interaction of the cap-binding protein eIF4E with its negative regulator eIF4-
BP1. Under normal conditions this interaction is suppressed by mTOR-
mediated phosphorylation of eIF4-BP1 [51]. Alternative eIF4E-dependent 
and independent mechanisms for translation repression have also been 
described [20].  For instance, impaired Met t-RNA recruitment, through eif2a 
Ser51 phosphorylation, represents a canonical response to accumulation 
of improperly folded proteins in the endoplasmic reticulum; the so-called 
unfolded protein response [52]. Yet another way to arrest mRNA translation 
is through enhanced mRNA 5’ cap-binding of eIF4E2, also known as 4EHP 
[53]. Our findings implicate this latter mechanism in the DNA damage-
induced protein synthesis arrest and provide evidence that it is regulated 
through ARIH1.
4EHP is an eIF4E homologue that has low affinity for binding the cap structures 
of most mRNAs [54]. The protein has been implicated in the regulation of 
translation of a specific subset of mRNAs in Drosophila involved in embryonic 
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patterning [55, 56]. ARIH1 can ISGylate 4EHP, thus leading to increased 
mRNA 5’ cap affinity, but it is not known under which conditions ARIH1-
mediated ISGylation of 4EHP is induced [39]. Here, we demonstrate that in 
response to DSB-inducing genotoxic stress, ARIH1 protein accumulates and 
interacts with 4EHP, leading to increased recruitment of 4EHP to the mRNA 
5’ cap. Our findings using a non-ISGylatable 4EHP mutant and 4EHP:ISG15 
co-immunoprecipitations, indicate that ubiquitylation, not ISGylation is the 
predominant DNA damage-induced 4EHP modification. Moreover, we show 
that ubiquitylation capacity is required for the ARIH1-mediated adaptive 
response to genotoxic stress.
The accumulation of ARIH1 depends on activity of ATM, a key kinase in 
the DDR, and most likely involves inhibition of proteasomal degradation. 
Despite a putative ATM target motif (S-Q) in the ARIH1 protein at Serine 
514, phosphorylation of this site has not been detected by us or by other 
groups in the presence or absence of genotoxic stress (unpublished data; 
[3, 57, 58]; http://www.phosphosite.org). Although this may be an outcome 
of technical limitations of MS used in these studies (for example a very short 
tryptic fragment), it points to an indirect mechanism by which ATM signalling 
leads to increased ARIH1 expression after genotoxic stress. One possible 
mechanism would involve attenuation of ARIH1 self-ubiquitylation following 
genotoxic stress. However, our results do not suggest auto-ubiquitylation, or 
its regulation by genotoxic stress or ATM, as the relevant mechanism. It is 
worth mentioning that our MS analysis indicates that ARIH1 is primarily part 
of a complex of ubiquitylation-related enzymes. The detailed composition of 
this complex and its regulation in response to genotoxic stress will be the 
topic of further study.
Translation arrest is effectuated by 4EHP due to its capacity to act as a 
competitive inhibitor for eIF4E. Unlike eIF4E, 4EHP cannot interact with 
the scaffolding protein eIF4G, which is required for formation of the pre-
initiation complex. In line with this, 4EHP cannot complement eIF4E in 
gene knockout experiments in yeast [59]. Our following findings indicate 
that ARIH1-mediated recruitment of 4EHP to the mRNA 5’ cap underlies 




4EHP to the mRNA 5’ cap is ARIH1-dependent, ii) DNA damage-induced 
translation arrest is ARIH1-dependent, and iii) RNAi targeting ARIH1 or 
4EHP sensitises ES or cancer cells to DNA damage. In H1299 cells, 4EHP 
depletion also compromises viability under control conditions, which may be 
related to endogenous genotoxic stress. Our data do not support the notion 
that a genotoxic stress-induced mRNA translation arrest is lost in cancer 
cells, as was described for other eIF4E dependent routes, such as 4EBP-1 
phosphorylation [19]. U2OS cells do attenuate protein synthesis following 
genotoxic stress and depletion of ARIH1 leads to sensitisation of all cancer 
cell lines tested thus far. Intriguingly, while inhibition of eIF4E cap binding 
can sensitise cancer cells to different chemotherapeutics [19, 50], we 
show that inhibition of the competitive process involving ARIH1 and 4EHP 
has the same effect. Clearly, ongoing mRNA 5’ cap-mediated translation, 
as well as the ability to temporarily halt translation in response to DNA 
damage is required for (cancer) cells to escape genotoxic stress-induced 
death. Our immunofluorescence experiments indicate that upon genotoxic 
stress, ARIH1 is increasingly concentrated in nuclei and perinuclear regions 
where ribosomes cluster, placing ARIH1 at the correct location to control this 
process.
As mentioned above, an alternative route to attenuate protein synthesis 
is through eiF2a Ser51 phosphorylation, a modification typically triggered 
by accumulation of misfolded proteins in the ER [52]. This response can 
be enhanced by salubrinal, an inhibitor of the phosphatase complex that 
dephosphorylates eIF2a [60]. Interestingly, treatment with salubrinal restores 
the CP-induced translation arrest and the subsequent cellular survival 
in ARIH1-depleted cells. This shows that alternative means for restricting 
protein synthesis can compensate for the inability to do so through enhanced 
4EHP:cap binding. Moreover, it provides further evidence in favour of a model 
showing that the ability of ARIH1 to couple DSB-induced genotoxic stress to 
attenuation of mRNA translation underlies its cytoprotective role.
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MATERIAL AND METHODS 
Cell culture, plasmids and other reagents
HM1 mouse ES cells derived from OLA/129 genetic background (provided 
by Dr. Klaus Willecke, University of Bonn GE) were maintained under feeder 
free conditions in GMEM medium containing 5x105U mouse recombinant 
leukemia inhibitory factor (LIF; PAA). All other cell lines were purchased from 
ATCC. MCF7 human breast cancer cells and H1299 human non-small cell 
lung cancer cells were maintained in RPMI medium. U2OS human sarcoma 
cells were kept in DMEM. All media contained 10% FBS and 25U/ml penicillin, 
and 25µg/ml streptomycin. All cell lines, including stable shRNA expressing 
derivatives, were confirmed to be mycoplasma-free using the Mycosensor kit 
from Stratagene.
Wild-type (#17342) and non-ISGylatable [K121/130/134/222R]-mutant (4KR) 
(#17353) FLAG-tagged versions of 4EHP, as well as HA-tagged ISG15 
(#12444) were provided by Dr. Dong-Er Zhang, Scripps Research Institute, 
La Jolla CA - through Addgene [39]. By means of site-directed mutagenesis, 
a point mutation (C208A) was introduced into wild-type ARIH1 cDNA, yielding 
an ubiquitylation-deficient ARIH1 mutant [40]. Wild-type and C208A ARIH1 
cDNAs were cloned into entry vector pENTR4-GFP-C1 (#w392-1) provided 
by Dr. E. Campeau, University of Massachusetts Medical School, Worcester, 
MA - through Addgene [61]. Subsequently, they were recombined into 
pLenti6.3 V5-DEST (Invitrogen) using Gateway® recombination. Destination 
vectors containing such GFP-tagged ARIH1 versions were used for either 
direct overexpression in mammalian cells or lentiviral production.
Genotoxicants included the DNA cross-linkers cisplatin (CP; Cis-PtCl2(NH3)2) 
(provided by the Pharmacy unit of University Hospital, Leiden NL) and 
mitomycin C (Sigma), as well as the inhibitors of topoisomerase II-mediated 
DNA unwinding, doxorubicin (Sigma) and etoposide (Sigma). Oxidative 
stressor diethyl maleate (DEM), microtubule-poison Vincristine, and ER-
stressor Thapsigargin were also obtained from Sigma. The pan-caspase 
inhibitor z-Val-Ala-DL-Asp-fluoromethylketone (z-VAD-fmk) was purchased 




Calbiochem.  ATM inhibitor KU-5593 and proteasome inhibitor MG132 were 
acquired from Tocris Biosciences. Antibodies against p53 and phospho-
p53(Ser15) were purchased from Novacostra and Cell signalling, respectively. 
Antibodies against tubulin and FLAG were obtained from Sigma. Antibodies 
against mouse or human 4EHP and eIF4G2 were from Cell Signalling. ARIH1 
antibody was from Novus Biologicals. Monoclonal antibody against ubiquitin 
was purchased from Enzo-Biosciences (FK2 clone).
RNAi experiments
siRNAs were purchased from ThermoFisher Scientific. For primary screens, 
the Dharmacon siGENOME SMARTpool siRNA Library- Mouse Ubiquitin 
Conjugation Subsets 1 (G-015610), 2 (G-015620) and 3 (G-015630) were 
used. For Deubiquitylation and SUMOylation-screens customised siGENOME 
SMARTpool siRNA libraries were used (Table S1). For deconvolution 
confirmation screens, customised libraries containing 4 individual siRNAs 
targeting each selected mRNA were used. GFP, Lamin A/C, and RISC free 
control siRNAs were used according to MIARE guidelines. Kif11 siRNA was 
used as transfection efficiency control.
The siRNA screens were performed on a Biomek FX (Beckman Coulter) 
liquid handling system. 50nM siRNA was transfected in 96 well plates using 
Dharmafect1 transfection reagent (ThermoFisher Scientific). The medium 
was refreshed every 24h and cells were exposed to indicated compounds or 
vehicle controls 64h post-transfection for 24h. Primary screens were done in 
duplicate and deconvolution screens were done in quadruplicate. As readout, 
a cell viability assay using ATPlite 1Step kit (Perkin Elmer) was performed 
according to the manufacturer’s instructions followed by luminescence 
measurement using a plate reader.
For stable gene silencing, cells were transduced using lentiviral TRC 
shRNA vectors at MOI 1 (LentiExpressTM; Sigma-Aldrich; Dr. Rob 
Hoeben and Mr Martijn Rabelink, University Hospital, Leiden NL) 
according to the manufacturer’s procedures and bulk selected in medium 
containing 2.5μg/ml puromycin. Control vector expressed shRNA targeting 
TurboGFP. shRNAs targeting ARIH1 were CCAGATGAATACAAGGTCATC 
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(shARIH1#1), CTACCTTGAACGAGATATTTC (shARIH1#2), 
CTGTTAAATGTAAGTGGTTAC (shARIH1#3). For ARIH1 gene silencing in 
combination with ectopic expression of GFP-ARIH1 constructs, an siRNA 
targeting the 3’UTR (GCACACAGCUGUAGGCAUUUU) of ARIH1 was used 
(ThermoFisher Scientific).
RNAi screen data analysis
As a quality control Z’-factors were determined for each plate, using Lamin 
A/C as a negative control and p53 as a positive control. To rank the results, 
Z-scores were calculated using as a reference i) the mean of all test samples 
in the primary screen and ii) the mean of the negative control samples in 
the secondary deconvolution screen (in order to prevent bias due to pre-
enrichment of hits) [62]. Hit determination was done using Z-scores with a 
cut off value of 1.5 below or above the reference and p-value lower than 
0.05. Enrichment of canonical pathways and formation of p53/ ubiquitylation 
signalling network was performed using MetaCore™ data-mining software.
Apoptosis and cell cycle analysis
ES cells were exposed to vehicle or CP for 8h for cell cycle analysis or 24h for 
apoptosis analysis. MCF7 cells were exposed for 24h for cell cycle analysis. 
Floating and attached cells were pooled and fixed in 80% ethanol overnight. 
Cells were stained using PBS EDTA containing 7.5mM propidium iodine and 
40mg/ml RNAseA and measured by flow cytometry (FACSCanto II; Becton 
Dickinson). The amount of cells in the different cell cycle fractions or in sub 
G0/G1 for apoptotic cells was calculated using BD FACSDiva software. 
Alternatively, apoptosis was determined using live imaging of Annexin V 
labelling, as described previously [63].
Clonogenic survival assay
U2OS cells (250 cells/plate) expressing different shRNAs were seeded in 
triplicate in 9cm plates. The following day, cells were treated for 24h with a 
dose range of CP or IR. After a recovery period of 10 days, surviving cells 






Extracts were prepared in Tris/Sucrose/EDTA buffer containing protein 
inhibitor cocktail and separated by SDS-PAGE on polyacrylamide gels, 
transferred to PVDF membranes, and membranes were blocked using 5% 
BSA. Following incubation with primary and secondary antibodies signal was 
detected using a Typhoon™ 9400 from GE Healthcare.
Immunofluorescence
U2OS cells were seeded on glass coverslips and allowed to grow for two days. 
Subsequently, they were treated with CP and fixed using 2% formaldehyde for 
20min at the indicated time-points. After washing extensively and rehydrating 
in PBS, post-fixation extraction took place by incubating with 0.25% Triton-X 
for 5min. Cells were extensively washed with PBS to remove any detergent 
and then blocked in 5% BSA. Finally, coverslips were immunostained 
with mouse anti FLAG and rabbit anti eiF4G2 antibodies and appropriate 
secondary fluorescent antibodies.
Cap binding assay 
HM1 ES cells, U2OS, and MCF7 breast cancer cells were seeded in 6-well 
plates at a density of 0.5 million cells/ well. Cells were treated with different 
concentrations of CP for 4h (U2OS, MCF7) or 8h (ES) and proteins were 
harvested in lysis buffer containing 1mM phenylmethylsulfonyl fluoride 
(Cell Signalling). Cap binding proteins were precipitated using 7-methyl-
GTP-Sepharose 4B beads (Amersham) as described previously [64]. 
Precipitated proteins were separated on 12% SDS-PAGE gels and analysed 
by immunoblotting for 4EHP (EIF4E2). 
Metabolic labelling for detection of translational changes after CP 
treatment
Click-iT® metabolic labelling reagents for proteins was purchased from 
Invitrogen and used according to manufacturer’s instructions. In short, 
U2OS cells were seeded to 80% confluence in 96 well mclear plates and 
subsequently treated with 15mM CP for 2-8h or with 2mg/ml cyclohexamide 
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(CHX) for 1h, or for 2h with a combination of 15mM CP and 2.5mM salubrinal. 
During the last hour of treatment DMEM was replaced with methionine-free 
medium. Subsequently, cells were incubated with azide-labeled methionine 
analogue for 1h and fixed for 15min in 4% formaldehyde and stained 
according to manufacturer’s protocol. DAPI was used as counterstain and 
images were acquired using a BD-pathway imaging system. Image analysis 
was performed using BD Attovision software.
FLAG-Co-Immunoprecipitation
U2OS cells, expressing different shRNAs, were transiently transfected 
with FLAG-tagged wild-type 4EHP or [K121/130/134/222R]-mutant (4KR) 
4EHP cDNAs or FLAG-LacR control plasmid in absence or presence 
of pCAGGS-5HA-mISG15 cDNA in OptiMEM (Invitrogen), using JetPEI 
(Polyplus Transfection). The following day, medium was refreshed and 48h 
post transfection cells were lysed in FLAG-lysis buffer (50mM Tris-HCl pH 
7.4, 150mM NaCl, 1mM EDTA, 0.5% NP-40, 0.5% Triton-X, 1mM PMSF, 
supplemented with complete protease inhibitor cocktail (Roche)). After 
30 min incubation on ice, lysates were diluted 5 times with FLAG-dilution 
buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1mM PMSF, 
supplemented with complete protease inhibitor cocktail) and incubated 
with prewashed M2-FLAG magnetic beads (Sigma) for 3h. Subsequently, 
beads were washed 3 times for 5min with FLAG-dilution buffer and lysed 
in Laemmli-SDS-sample buffer. FLAG-ARIH1 co-immunoprecipitation from 
lysates from SILAC-labeled cells followed by Mass Spectrometry (MS) was 
performed as described above, with the exception of eluting FLAG-bound 
proteins by competition with the 3xFLAG peptide instead of boiling in sample 
buffer. Following elution, samples were trypsinised over-night, desalted, 
freeze-dried and finally used for MS analysis.
qPCR
RNA was extracted using RNeasy Plus Mini Kit from Qiagen. cDNA was made 
from 50ng total RNA with RevertAid H minus First strand cDNA synthesis kit 
(Fermentas) and real-time qPCR was subsequently performed in triplicate 




system (Applied Biosystems). The following qPCR primer sets were used: 
GAPDH forward (fw) AGCCACATCGCTCAGACACC; GAPDH reverse (rev) 
ACCCGTTGACTCCGACCTT; ARIH1 fw TCATGCCTCTACCCAAGCCTT; 
ARIH1 rev ACCAAACCCACAGCAACACA.  Data were collected and 
analysed using SDS2.3 software (Applied Biosystems). Relative mRNA 
levels after correction for GAPDH control mRNA were expressed using 2^(-
∆∆Ct) method.
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Figure S1. Caspase-dependent apoptosis in ES cells treated with CP and quality of 
ubiquitination/sumoylation screen. (A) Induction of SubG1/G0 apoptotic fraction in HM1 
ES cells treated with 7.5μM CP for 24h and prevention by co-treatment with 100μM pan-
Caspase inhibitor ZVADfmk. (B) Real time imaging of fluorescently labeled Annexin V binding 
(Puigvert et al., 2010) shows accumulation of apoptotic ES cells during treatment with 7.5μM 
CP and prevention by 100μM ZVADfmk. Ratio [AnexinV signal: total cell area] is shown. (C) 
ATPlite readout for indicated set of control siRNAs in each Smartpool library plate. Bars show 
average and standard deviation of two control and two 10μM CP-treated plates. (D) Average 




Figure S2. ARIH1 is part of a ubiquitination complex and CP and ATM inhibitor do not 
affect ubiquitination of WT or C208A ARIH1. (A) Western blot using antibodies against 
GFP or ubiquitin on total lysates and GFP-immunoprecipitations from GFP-ARIH1(WT)- and 
GFP-ARIH(C208A)-expressing U2OS cells treated with vehicle control or treated for 4 hours 
with 5μM CP with or without pre-treatment for 1hr with 5μM ATM inhibitor KU-55933. Grey 
arrowheads indicate ARIH1. (B) MS analysis of native FLAG-immunoprecipitations from 
SILAC-labelled FLAG-ARIH1 U2OS cells. SILAC ratios of peptides detected after 4 hours 
treatment with 5μM CP and control conditions are shown.
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Table S1. Custom siRNA libraries for Deubiquitinases and (De)-Sumoylases. Indicated 




Deubiquitinases custom library 
Gene Symbol Gene Id Accession Number 
MJD 110616  NM_029705 
E030022H21RIK 217218  NM_001098837 
DUB-1A 381944  NM_201409 
DUB2 13532  NM_010089 
BAP1 104416  NM_027088 
C130067A03RIK 320713  NM_177239 
TNFAIP3 21929  NM_009397 
1810057B09RIK 223527  NM_175009 
HIST2H2BE 319190  NM_178214 
DXIMX46E 54644  NM_138604 
C6.1A 210766  NM_145956 
CYLD 74256  NM_173369 
FBXO7 69754  NM_153195 
FBXO8 50753  NM_015791 
E130307M08RIK 68047  NM_026530 
1300006C06RIK 74158  NM_028792 
1110007C05RIK 66124  NM_025368 
OTUB1 107260  NM_134150 
4930586I02RIK 68149  NM_026580 
4933428L19RIK 71198  XM_991213 
D8ERTD69E 73945  NM_001081164 
2600013N14RIK 72201  NM_152812 
USP1 230484  NM_146144 
USP2 53376  NM_198091 
USP3 235441  NM_144937 
USP4 22258  NM_011678 
USP5 22225  NM_013700 
USP7 252870  NM_001003918 
USP8 84092  NM_019729 
USP9X 22284  NM_009481 
USP9Y 107868  NM_148943 
USP10 22224  NM_009462 
USP11 236733  NM_145628 
USP12 22217  NM_011669 
USP13 72607  NM_001013024 
USP14 59025  NM_001038589 
USP15 14479  NM_027604 
USP16 74112  NM_024258 
Usp17 436004  NM_001033494 
USP18 24110  NM_011909 
USP19 71472  NM_027804 
USP20 74270  NM_028846 
USP21 30941  NM_013919 
USP22 216825  NM_001004143 
Usp24 329908  XM_915524 
USP25 30940  NM_013918 
USP26 83563  NM_031388 
USP28 235323  NM_175482 
USP29 57775  NM_021323 
USP30 100756  NM_001033202 
6330567E21RIK 76179  XM_992065 




Table S1 (continued). Custom siRNA libraries for Deubiquitinases and (De)-Sumoylases. 
Indicated are gene symbols, Entrez IDs and Accession numbers.
USP33 170822  NM_001076676 
LOC244144 244144  XM_886523 
Usp36 72344  XM_916680 
4932415L06RIK 319651  NM_176972 
USP38 74841  NM_027554 
USP39 28035  NM_138592 
USP40 227334  NM_001033291 
Usp42 76800  NM_029749 
USP43 216835  NM_173754 
E430004F17 327799  NM_183199 
4930550B20RIK 77593  NM_152825 
2410018I08RIK 69727  NM_177561 
USP47 74996  NM_133758 
USP48 170707  NM_130879 
C330046L10RIK 224836  NM_198421 
4930511O11RIK 75083  NM_029163 
LOC635253 635253  NM_001137547 
USP52 103135  NM_133992 
AA939927 99526  NM_133857 
USP54 78787  NM_030180 
UBR1 22222  NM_009461 
UCHL1 22223  NM_011670 
UCHL3 50933  NM_016723 
UCHL5 56207  NM_019562 
UFD1L 22230  NM_011672 
UBE4B 63958  NM_022022 
COPS5 26754  NM_013715 
PLP2 18824  NM_019755 
 
 
SUMOylation custom library 
Gene Symbol Gene Id Accession Number 
UBLE1B 50995  NM_016682 
Ube2i 22196  NM_011665 
MDM2 17246  NM_010786 
D11BWG0280E 52915  NM_028601 
BC065120 328365  NM_183208 
PIAS1 56469  NM_019663 
MIZ1 17344  NM_008602 
PIAS3 229615  NM_018812 
PIAS4 59004  NM_021501 
RANBP2 19386  NM_011240 
CBX4 12418  NM_007625 
2510027N19RIK 67711  NM_026330 
TOPORS 106021  NM_134097 
RNF110 22658  NM_009545 
SENP1 223870  NM_144851 
SENP2 75826  NM_029457 
SENP3 80886  NM_030702 
SENP5 320213  NM_177103 
SENP6 215351  NM_146003 
2810413I22RIK 66315  NM_001003973 
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Table  S2. Hits from primary screens. Indicated are gene symbols, Z-scores and p-values.
Table S2.  
gene symbol Z-score p-value 
RBX1 -3.49229 0.000239 
FBXO6A -2.96913 0.001493 
SYTL4 -2.69639 0.003505 
RCHY1 -2.68571 0.003619 
RNF166 -2.67699 0.003714 
Rfwd3 -2.51751 0.005909 
UBE1X -2.28613 0.011123 
TCE1 -2.25446 0.012084 
ARIH1 -2.16801 0.015079 
FBXW7 -2.11149 0.017365 
TOPORS -2.11004 0.017428 
BARD1 -2.05953 0.019722 
C730024G19RIK -2.05522 0.019929 
LOC380928 -2.0437 0.020492 
LOC381621 -2.02454 0.021458 
USP8 -2.02454 0.021458 
UBE2D3 -2.02396 0.021487 
CHD4 -1.93042 0.026778 
BRCA1 -1.85984 0.031454 
PHF15 -1.85 0.032157 
TRIM21 -1.80426 0.035595 
SHPRH -1.75546 0.03959 
MKRN2 -1.73969 0.040957 
USP4 -1.73969 0.040957 
A530081L18RIK -1.70491 0.044106 
DXIMX46E -1.70491 0.044106 
FBXW5 -1.68291 0.046196 
USP5 -1.45575 0.07273 
USP7 -1.37068 0.085238 
Usp42 1.637496 0.050763 
FBXO17 1.650206 0.04945 
ASB3 1.656369 0.048824 
1110002E23RIK 1.708269 0.043793 
LOC668173 1.728961 0.041908 
6330567E21RIK 1.728961 0.041908 
Trim61 1.750478 0.040018 
FBXO34L 1.804707 0.03556 
MGRN1 1.934613 0.026519 
4933428L19RIK 1.934613 0.026519 
DTX2 1.986825 0.023471 
AL033326 2.010687 0.022179 
USP54 2.078665 0.018824 
ZNRF2 2.153452 0.015642 
LNX2 2.196345 0.014034 
CUL4A 2.21634 0.013334 
RNF110 2.29063 0.010992 
USP22 2.29063 0.010992 
CUL1 2.479363 0.006581 
CDC34 2.994131 0.001376 






Table S3. Hits from secondary deconvolution screens. Indicated are gene symbols, Entrez 
IDs, Accession numbers, ubiquitination function and validation status. Asterisks indicate hits 
known to affect p53. Sensitising siRNAs in blue; protecting siRNAs in red.
 
Table S3.  
gene symbol gene ID 
Accession 
number Function  validation 
USP4 * 22258 NM_011678   DUB 2 out of 4  
USP7 * 252870  NM_001003918  DUB 3 out of 4 
USP8 84092 NM_019729 DUB 4 out of 4 
DXIMX46E 54644 NM_138604 DUB 2 out of 4 
E430004F17 327799 NM_183199 DUB 2 out of 4 
USP5 * 22225  NM_013700 DUB 3 out of 4 
RUFY1 216724 NM_172557 no known UB-function 2 out of 4 
RCHY1 * 68098 NM_026557 E3 2 out of 4 
Rfwd3 * 234736 NM_146218 E3 4 out of 4 
4930470D19RIK 67610 NM_026274 no known UB-function 4 out of 4 
ARIH1 23806 NM_019927 E3 4 out of 4 
UBE1X 22201 NM_009457 E1 4 out of 4 
SYTL4 94121 NM_013757 no known UB-function 3 out of 4 
CHD4 107932 NM_145979 no known UB-function 3 out of 4 
FBXW7 50754 NM_080428 E3 2 out of 4 
LOC381621   XM_355579 no known UB-function 2 out of 4 
UBE2D3 66105 NM_025356 E2 4 out of 4 
DTX2 74198 NM_023742 E3 2 out of 4 
ZNRF2 387524 NM_199143 E3 2 out of 4 
RBX1 9978 NM_019712 E3 4 out of 4 
TCE1 79043  NM_027141 no known UB-function 2 out of 4 
TOPORS * 106021  NM_134097 E3 2 out of 4 
C730024G19RIK 232566  XM_132975 no known UB-function 3 out of 4 
BRCA1 NM_009764 NM_009764 E3 3 out of 4 
TRIM21 20821  NM_009277 E3 4 out of 4 
SHPRH 268281  NM_172937 E3 2 out of 4 
AL033326* 24105  NM_019705 E3 3 out of 4 
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Genome stability is gravely endangered by exogenously or endogenously 
induced DNA Double Strand Breaks (DSBs). In order to counteract 
their detrimental effects, mammalian cells have evolved sophisticated 
mechanisms that allow for their efficient and timely removal. Those 
mechanisms are collectively known as the DSB response and are centered 
around the concerted mode of action of the kinases ATM/ATR and the E3 
ubiqutiin ligases RNF8/RNF168. Although, these proteins constitute the 
master regulators of the DSB response, ongoing research has hinted that 
there are more ubiquitin-family enzymes promoting efficient DSB repair. We 
recently identified the E3 ubiquitin ligase ARIH1 in a cisPt lethality screen as 
a cytoprotective protein facilitating a significant, transient arrest of translation 
upon DSB induction. Intriguingly, ARIH1 also appears to be recruited to 
sites of DNA damage, while its depletion hinders DSB repair by homologous 
recombination. Interaction studies additionally indicate that ARIH1 directly 
interacts with the KU-heterodimeric complex which initiaties DSB repair by 
non-homologous end-joining. Cumulatively, our results favour a direct role of 
ARIH1 in regulating DSB repair.
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INTRODUCTION
DNA Double Strand Breaks (DSBs) present cellular DNA repair mechanisms 
with a formidable challenge, as genetic information is simultaneously assaulted 
on both strands [1]. In order to counteract DSBs and their deleterious effects, 
mammalian cells trigger an elaborate response orchestrated by the ATM/
ATR kinases [2] and the RNF8/RNF168 E3 ubiquitin ligases [3]. The DSB 
response is a multifaceted process entailing chromatin remodelling, cell-cycle 
checkpoint activation and DNA repair [4], primarily by either of the main DSB 
repair pathways, Non-Homologous End-Joining (NHEJ) [5] or Homologous 
Recombination (HR) [6]. 
Recent work has made it increasingly clear that protein post-translational 
modifications by ubiquitin or ubiquitin-like proteins exert key roles in 
orchestrating spatiotemporally the efficient execution of DSB repair [7-13]. 
Protein ubiquitylation constitutes an elaborate molecular switch that controls 
many aspects of DSB proteins, including their stability [8], recruitment and/or 
residence time at sites of damage [14, 15] and segregation from chromatin 
[16, 17]. Besides the mainstream known E3 ubiquitin ligases RNF8 and 
RNF168, which are known to regulate the DSB response at multiple levels 
[8, 15, 18-22], several alternative E3 ligases have been associated with 
DSB repair [10, 12, 23-25], indicating that ubiquitylation plays a much more 
extensive role than initially believed and that, most likely, more ubiquitin-
related enzymes will be eventually implicated in DSB repair. 
After performing a siRNA-screen for enzymes of the ubiquitin and SUMO 
family upon cisplatin-induced DNA damage, we identified the E3 ubiquitin 
ligase ARIadne Homolog 1 (ARIH1) (Chapter 5) as a primary, sensitising hit. 
We then illustrated that ARIH1 regulates a transient translation arrest that 
facilitates cell survival. Whilst investigating its role in inducing this translation 
arrest, we noticed that upon DNA damage induction by either cisplatin or 
Ionising Radiation (IR), ARIH1 increasingly translocated both to ribosomes 




The DNA damage mediated nuclear localisation of ARIH1 prompted us to 
examine whether ARIH1 holds a nuclear function, and more specifically if 
it plays a direct role in regulating DSB repair. To our surprise, we witnessed 
that ARIH1 accumulated at laser-induced damage. Furthermore, ARIH1 
depletion impaired not only general DSB repair but also specifically HR, 
evident by decreased end-resection and RAD51-recombinase loading on 
ssDNA. Intriguingly, when trying to identify potential partners of ARIH1 by 
Mass Spectrometry (MS) or co-immunoprecipiation coupled to western 
blotting, we stumbled upon the KU-complex, the known initiator of NHEJ. In 
conclusion, our initial results support the notion that ARIH1 directly impinges 
on DSB repair by HR and NHEJ, by affecting RAD51 loading and probably 
by interacting with the KU70-KU80 heterodimer, respectively.
RESULTS
ARIH1 protects cells against IR-induced damage
We recently demonstrated that the E3 ubiquitin ligase ARIH1 promotes 
cellular survival after treatment with cisplatin (Chapter 5), an agent known 
to induce intra/interstrand crosslinks as well as mono-adducts. Loss of 
ARIH1 renders cells incapable of launching a temporary halt of translation, 
thereby sensitising them to cisplatin. Knowing that ARIH1 is important for this 
translational arrest, we wondered if ARIH1 depletion would be detrimental to 
human cells exposed to forms of DNA damage other than the ones tested 
in our original study. We therefore exposed ARIH1-depleted cells (for knock-
down efficiency please look at Fig. 2E of Chapter 5) to either IR or UVC light. 
Interestingly, cells lacking this E3 ligase were more sensitive to IR (Fig. 1A), 
but not to UV (Fig. 1B), indicating that ARIH1 may specifically confer a defect 
to DNA double-strand break inducing agents rather than to DNA intrastrand 
crosslinks per se. In agreement with this rationale, in our original study we 
had observed that ARIH1 depletion was detrimental to mouse ES cells upon 
treatment with agents, such as cisplatin, mitomycin C and doxorubicin, that 
induce DSBs either directly or upon replication (Chapter 5). 
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Given its role in establishing a translational arrest after cisplatin, we wondered 
whether ARIH1 exerts its cytoprotective role in a direct or indirect manner. 
Our previous results had hinted that, in parallel to facilitating a transient pause 
of protein synthesis, ARIH1 translocated to the nucleus upon DNA damage 
(Chapter 5). In order to validate the potential significance of this increased 
nuclear localisation, we examined the behaviour of ARIH1 upon laser micro-
irradiation. To our surprise, GFP-tagged ARIH1 rapidly accumulated at laser-
induced DNA damage (Fig. 1C). Similarly, an ARIH1-mutant (C208A) that is 
unable to interact with its major E2 partner (UBE2D3), and is therefore less 
proficient in ubiquitylating downstream substrates, could also assemble at 
sites of damage, albeit less readily than its wild-type counterpart (Fig. 1C)
We then sought to expand our findings by assaying if ARIH1 can form 
IR-Induced Foci (IRIF), as several factors involved in DSB signalling or 
DSB repair by HR do. We could not detect any ARIH1 IRIF, either at early 
time-points (1hr; Fig. 1D, left panel), indicative of DSB-signalling related 
complexes, or at later time-points (6hr; Fig. 1D, right panel), indicative of 
HR-related complexes. Along the same lines, wild-type or ubiquitylation-
deficient GFP-tagged ARIH1 did not assemble at FokI-induced DSBs (Fig. 
1E), implying that detection of ARIH1 at isolated DSBs may require specific 
extraction protocols, like several NHEJ factors do [26]. As expected from the 
lack of any phenotype upon UV exposure, ARIH1 did not accumulate at sites 
of UV-induced damage (Fig. 1F). Finally, we tried to exclude the possibility 
that ARIH1 exert its role in DSB repair by solely regulating the expression 
of specific repair proteins. Though much more comprehensive testing is 
needed to rule out a predominantly indirect role, all probed repair-proteins 
appeared to be expressed at similar levels upon ARIH1 depletion and control 
conditions (Supplemental Fig. 1). Taken together, these results suggest that 




ARIH1 depletion delays DNA repair by Homologous Recombination
Having shown that ARIH1 is necessary for the response to DNA damage 
inflicted by either cisplatin or IR, we investigated whether this E3 ligase 
directly affects DSB repair by assessing the rate of removal of γH2AX and 
53BP1 foci. Stable, shRNA-mediated depletion of ARIH1 (Chapter 5 Fig. 2E) 
resulted in impaired repair kinetics at early time-points, assessed by γH2AX 
Figure 1. ARIH1 is involved in the DSB response. (A) Clonogenic survival of U2OS cells 
transfected with the indicated siRNAs and subsequently exposed to IR. (B) As in A only 
exposed to UVC irradiation. (C) Recruitment of GFP-tagged ARIH1 (wild-type or C208A 
mutant) (green) to FK2- (red) and MDC1- (white) marked DNA damage sites after laser 
micro-irradiation. (D) Lack of recruitment of the indicated GFP fusion proteins (green) at early 
IRIF, marked by 53BP1 (white; left), or late IRIF, marked by RAD51 (white; right). (E) Lack of 
recruitment of the indicated GFP fusion proteins (green) to FokI-mCherry-LacR-induced DSBs 
marked by γH2AX (white) in cells containing a LacO array. (F) Lack of accumulation of the 
indicated GFP-fusion proteins (green) to sites of UV-induced damage, marked by p89 (white).
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(Fig.2A) and 53BP1 (Fig. 2B) IRIF removal, but relatively undisturbed repair 
kinetics at later time-points, indicating that ARIH1 is important for efficient 
DSB repair. Subsequently, we inquired upon which specific DSB repair 
pathway ARIH1 primarily regulates. In order to confirm a potential role in HR, 
we assayed if RPA and RAD51 IRIF formation is altered upon ARIH1 loss. 
We restricted our analysis to replicating cells by either utilising a U2OS cell-
line stably expressing geminin, a known S/G2 marker, or immuno-staining 
for cyclin A, a protein expressed during late S/G2 phase. siRNA-mediated 
ARIH1 depletion (Supplemental Fig. 1) had a severe impact on DNA end-
resection, as RPA IRIF formation was more than halved in ARIH1-less cells 
when compared to their control counterparts (Fig. 2C). In further agreement 
with ARIH1 holding a regulatory role in HR, loss of ARIH1 additionally 
abrogated RAD51 IRIF formation (Fig. 2D) in S/G2 cells. To consolidate our 
findings, we employed a well-described and widely-employed GFP-reporter 
assay that allows monitoring the efficiency of DSB repair by HR [27]. In line 
with our IRIF observations, ARIH1 loss led to a substantial decrease in the 
efficiency of HR execution (Fig. 2E), an effect not caused by gross alteration 
in cell-cycle progression (Fig. 2F), as both control and ARIH1-depleted cells 




Figure 2. ARIH1 depletion hinders efficient DSB repair. (A) Effect of ARIH1 depletion on 
DSB repair, assayed by clearance of γH2AX foci multiple time-points after 2 Gy of IR. (B) As 
in A but for 53BP1 IRIF. (C) Effect of ARIH1 depletion on RPA (white) IRIF formation in cyclin 
A-expressing S/G2 cells (green) 4hr after 10 Gy of IR. (D) As in D but for RAD51 (white) IRIF in 
mAG-geminin-expressing S/G2 cells (green) 6hr after 10 Gy of IR. (E) Impact of the indicated 
siRNAs on HR efficiency measured using the DR-GFP reporter. (F) Cell cycle profiles of cells 
treated with the indicated siRNAs. Quantified data are represented as mean ± S.D. (n=3). *, 
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ARIH1 interaction studies reveal an unexpected partnership with NHEJ 
factors
Having demonstrated that ARIH1 depletion attenuates HR execution, we tried 
to identify novel ARIH1 interacting proteins, hoping to retrieve repair-related 
proteins as potential partners. To this end, we generated cell lines stably 
expressing either FLAG- or GFP-tagged ARIH1, labelled them using SILAC, 
performed native immuno-precipitations and analysed samples by Mass 
Spectrometry. As expected, we were able to detect known ARIH1 interactors 
such as the E2 enzyme UBE2L (UBCH7) and the E1 enzyme (UBA1), 
verifying that we indeed isolated physiologically relevant ARIH1 complexes 
(Fig. 3A), primarily linked to ARIH1-related ubiquitylation. However, to our 
surprise, amongst the proteins we identified in our initial FLAG-ARIH1 IPs 
were Ku70 (XRCC6), Ku80 (XRCC5) and DNA-PKcs, all known regulators 
of NHEJ (Fig. 3A). Very similar results were obtained with FLAG-ARIH1-IP 
employing SILAC-label-swapped cells (Fig. 3B). To exclude the possibility of 
identifying false positive interactions due to non-specific binding to the M2-
FLAG beads, we repeated our IP, this time utilising GFP-ARIH1 and including 
quantitative analysis of the basal complex, where samples from cells stably 
over-expressing GFP-ARIH1 are compared to samples from cells stably over-
expressing GFP-NLS (control). Once more, Ku70 was specifically enriched 
upon ARIH1 purification (Fig. 3C), although this interaction appeared to be 
independent of IR-induced DNA damage (Fig. 3D). Finally, we tried to verify 
the observed ARIH1-Ku70 interaction by western blotting. In agreement with 
our MS data, endogenous Ku70 clearly co-immuno-precipitated with GFP-
ARIH1 (Fig. 3E), albeit IR did not appear to affect this interaction. On the 
contrary, DNA-PKcs or HR-associated proteins RAD51 and RPA did not 
associate with ARIH1 (Fig. 3E). Put together, our interaction studies establish 






We previously demonstrated that the E3 ubiquitin ligase ARIH1 is responsible 
for inducing a transient translation arrest upon the induction of DNA damage 
by cisplatin, and concluded that the ARIH1-dependent temporary halting 
of protein synthesis benefits cellular survival (Chapter 5). However, our 
observation that ARIH1 increasingly translocates to the nucleus upon DNA 
Figure 3. Exogenous ARIH1 interacts with the KU-complex. (A) Proteins identified by MS 
after FLAG-ARIH1-Immunoprecipitation. Sequence coverage represents the percentage of 
the indicated protein that was retrieved in individual peptides, while the SILAC ratio indicates 
the amount of Heavy:Light labelled protein copurified. Cells labelled with Heavy SILAC were 
left untreated, while cells labelled with Light SILAC were treated with 5μΜ cisplatin for 4hr. (B) 
As in A, but SILAC labels were swapped, namely untreated cells were pre-labelled in Light 
SILAC, while cisplatin-treated cells were pre-labelled in Heavy SILAC. (C) Proteins identified 
by MS after GFP-ARIH1- or GFP-NLS-Immunoprecipitation. GFP-ARIH1-IP took place in 
cells labelled with Heavy SILAC, while GFP-NLS was performed in cells labelled with Light 
SILAC. (D) Proteins identified by MS after GFP-ARIH1-Immunoprecipitation. Untreated cells 
were pre-labelled in Light SILAC, while IR-treated cells (10Gy/1hr) were pre-labelled in Heavy 
SILAC. (E) GFP-Immunoprecipitation of the indicated GFP-fusion proteins. Blots were probed 
for DNA-PKcs, KU70, GFP, RAD51, RPA, Histone H3 (loading control).
A
Protein Sequence Coverage (%) cisplatin/untreated SILAC ratio (H/L)
ARIH1 47,6 2,1 0,47
UBE2L3 10,4 1,56 0,64
UBA1 4,3 1,07 0,93
KU70 (XRCC6) 42 1,75 0,57
KU80 (XRCC5) 21,6 1,7 0,59
DNA-PK cs 9,8 1,15 0,87
B




KU70 (XRCC6) 33,8 0,99
KU80 (XRCC5) 16 1,01




Protein Sequence Coverage (%)
ARIH1 17,1 7,01
KU70 (XRCC6) 15,9 2,24
KU80 (XRCC5) 6,4 1,35




Protein Sequence Coverage (%)
ARIH1 22,4 1,01
UBE2L3 18 1,03
KU70 (XRCC6) 12,3 0,96
KU80 (XRCC5) 3,6 0,92
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damage, by either cisplatin or IR, prompted us to investigate if ARIH1 has 
a secondary role in physically promoting DNA metabolism. The additional 
finding that ARIH1 depletion specifically sensitises to DSB-inducing agents, 
but not UV or non-genotoxic stressors, raised the possibility that ARIH1 is 
indeed directly involved in repair of DSB repair either generated directly or by 
DNA damage interference during replication (Chapter 5 and Fig. 1A, B). The 
swift accumulation of ARIH1 at laser-induced damage further promoted this 
rationale (Fig. 1C). Though the lack of recruitment at IRIF or FokI-induced 
DSB may seem perplexing, it is worth mentioning that specific conditions may 
be necessary in order to visualise ARIH1 accrual at sites of damage, as is the 
case for the KU70-KU80 heterodimer [26]. Follow-up immunofluorescence 
experiments under these conditions and ARIH1-ChIP experiments will be 
necessary to validate that the laser-induced-damage accumulation of ARIH1 
is indeed physiologically relevant.
In agreement with this scenario, silencing ARIH1 inhibits DSB repair of a 
sub-fraction of DSBs, indicated by the approximately 2 fold reduced loss 
of γH2AX (Fig. 2A) and 53BP1 foci (Fig. 2B) during the first 4 hours after 
IR. More precisely, ARIH1 depletion seems to induce severe problems in 
HR execution, evident by a drop in resection rates (Fig. 2C) and loading of 
the RAD51 recombinase (Fig. 2D). These results are further solidified by 
the substantially diminished HR efficiency in the DR-GFP reporter assay 
(Fig. 2E). As ARIH1 knock-down does not compromise normal cell-cycle 
progression, (Fig. 2F) and barring unaccounted for, gross, siRNA off-target 
side-effects, our data support the hypothesis that ARIH1 plays a role in error-
free repair of DSBs by HR.  
Whatever the eventual mechanism will be, it has to account for the finding 
that the level of impairment of HR by ARIH1 depletion is comparable to that of 
BRCA2 a key player in HR (Fig.2E). However, the way that ARIH1 contributes 
to DSB repair is currently rather sketchy. Our initial search for ARIH1-
interacting partners that are involved in DSB repair yielded unexpected results. 
Instead of identifying factors orchestrating HR in a complex with ARIH1, we 
stumbled upon a potential interaction between ARIH1 and the KU70-KU80 




by western blotting (Fig. 3E) and, therefore this novel interaction is in all 
probability true. Though we cannot exclude the possibility that we missed 
potential interactions between ARIH1 and one or more HR-related proteins, 
it seems reasonable to currently shift our attention towards the investigation 
of the KU-connection. 
Numerous hypotheses can explain our thus far acquired data and certainly 
further experiments are going to be needed in order for a clear molecular 
mechanism to emerge, but one possible scenario is that ARIH1 promotes 
the timely removal of the KU complex, which has been shown to be subject 
to ubiquitylation-dependent removal from sites of damage [8, 28]. That would 
fit with the significantly decreased HR efficiency we observed upon ARIH1 
depletion (Fig. 2E). According to this model, loss of ARIH1 would abnormally 
prolong KU70-KU80 residency at DSBs, therefore reinforcing the latter’s 
antagonising effect on DNA end-resection [5]. 
Since ARIH1 appears to directly interact with KU70-KU80, it might ubiquitylate 
either of these proteins, thereby facilitating VCP- (or VCP-like)-dependent 
removal [16] of KU70-KU80 once its role is completed. Alternatively, ARIH1 
might directly target KU70 (or KU80) for proteasomal degradation, in a 
fashion similar to RNF8 [8], which would also lift KU-imposed restraints on 
HR. Though it is not clear if ARIH1 can catalyse the formation of polyubiquitin 
chains and if so of what linkage, the major ARIH1-interacting E2 enzyme, 
UBE2L3, has been shown to promote the formation of degradative-
poylubiquitin chains on certain substrates [29], but not of K63-chains [30]. 
Examining if and how ARIH1 affects the ubiquitylation status of KU70 (or 
KU80) by denaturing IPs followed by western blotting or MS would confirm 
whether ARIH1 can indeed ubiquitylate them. Along the same lines, it would 
be worthwhile to estimate KU70 protein stability in ARIH1-depleted cells by 
cycloheximide chase experiments. Furthermore, it would be interesting to 
assess the effect of ARIH1 depletion both on the accumulation of KU70 at 
laser-induced damage and in the EJ5-reporter cell line (to measure NHEJ 
efficiency), but also to investigate if loss of ARIH1 exacerbates IR sensitivity 
or DSB repair efficiency in KU70-/- cells. Finally, if ARIH1 does not primarily 
target either of the KU proteins, it is conceivable that it may control the steady-
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state levels of another protein at the vicinity of the DSB, which is recruited at 
the same time frame as KU70. An exciting candidate fitting these criteria is 
53BP1. Rather intriguingly, supporting this hypothesis, it was demonstrated 




Wild-type or lentivirally transduced U2OS were grown in DMEM (Gibco) 
containing 10% FCS (Bodinco BV). All lentivirally transduced cell-lines were 
kept under blasticidin selection. The ViraPower system (Life Science) was 
used to produce lentivirus for GFP-ARIH1 wild-type or C208A expression 
vectors.
Transfections and RNAi interference
siRNA and plasmid transfections were performed using Lipofectamine 
RNAiMAX (Invitrogen) and JetPEI (Polyplus Transfection) according to the 
manufacturer’s instructions. Cells were transfected twice with siRNAs (40 
nM) within 24 h and examined further 48 h after the second transfection, 
unless stated otherwise.
Generation of DSBs and UV-induced damage
IR was delivered by a YXlon X-ray generator (YXlon International, 200 KV, 
10 mA, dose rate 2 Gy/min). UV-damage was generated by exposure to UVC 
light for 60sec at a rate of ~0.5J/m2/sec
Cell survival assay
U2OS cells were transfected with siRNAs, trypsinised, seeded at low density 
and exposed to IR or UV. 7 days later cells were washed with 0.9% NaCl and 





U2OS 2-6-3 cells expressing inducible FokI-mCherry-LacR [31] were treated 
with 300 nM 4-OHT and 1 μM Shield-I for 5 hrs. Subsequently, cells were 
fixed with formaldehyde and immunostained with the indicated antibodies.
UV-A laser micro-irradiation
U2OS cells were grown on 18 mm coverslips and sensitised with 10 μM 
5′-bromo-2-deoxyuridine (BrdU) for 24 hours as described [16, 32]. For 
micro-irradiation, the cells were placed in a Chamlide TC-A live-cell imaging 
chamber that was mounted on the stage of a Leica DM IRBE wide-field 
microscope stand (Leica, Wetzlar, Germany) integrated with a pulsed nitrogen 
laser (Micropoint Ablation Laser System; Photonic Instruments, Inc., Belfast, 
Ireland). The growth medium was replaced by CO2-independent Leibovitz’s 
L15 medium supplemented with 10% FCS and penicillin-streptomycin and 
cells were kept at 37°C. The laser output power was set to 78 to generate 
strictly localised sub-nuclear DNA damage. Following micro-irradiation, cells 
were incubated for the indicated time-points at 37°C in Leibovitz’s L15 and 
subsequently fixed with formaldehyde before immunostaining.
Microscopy analysis
Images of fixed cells were acquired on a Zeiss AxioImager D2 widefield 
fluorescence microscope equipped with 40x, 63x and 100x PLAN APO (1.4 
NA) oil-immersion objectives (Zeiss) and an HXP 120 metal-halide lamp used 
for excitation. Fluorescent probes were detected using previously described 
filters [33]. Images were recorded using ZEN 2012 software and analysed 
using ImageJ. The average reflects the quantification of 50-150 cells from 3 
independent experiments.
IRIF analysis
RAD51 and RPA IRIF were analyzed in U2OS cells 6hr after 10Gy. IRIF were 
evaluated in ImageJ, using a custom-built macro that enabled automatic and 
objective analysis of the foci.
Immunofluorescent labelling
Immunofluorescent labelling was carried out as described previously [32, 
34]. Briefly, cells were grown on glass coverslips and treated as indicated in 
the figure legends. Subsequently, cells were washed with PBS, then fixed 
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with 2% formaldehyde for 20 minutes and permeabilised with 0.25% Triton 
X-100 in PBS for 5 minutes. Cells were rinsed with phosphate-buffered 
saline (PBS) and then blocked with PBS containing 5% BSA. Finally, cells 
were equilibrated in PBS containing 0.5% BSA and 0.05% Tween 20, and 
incubated with primary antibodies. Detection was done using goat anti-
mouse or goat anti-rabbit IgG coupled to Alexa 488, 555 or 647 (Invitrogen 
Molecular Probes). Samples were incubated with 0.1 μg/ml DAPI and 
mounted in Polymount.
Western blotting
Cell extracts were generated by boiling cell pellets in Laemmli buffer, 
separated by SDS-PAGE and transferred to PVDF membranes (Millipore). 
Membranes were probed with the indicated antibodies. Fluorescent signals 
were then detected using the Odyssey infrared imaging scanning system 
(LI-COR Biosciences).
HR assay
HEK293 cells containing a stably integrated copy of the DR-GFP reporter 
were used to measure the repair of I-SceI-induced DSBs by HR as described 
[27]. Briefly, 48 h after siRNA transfection, cells were transfected with the 
I-SceI expression vector pCBASce and an mCherry expression vector. 48 or 
72 h later the fraction of GFP-positive cells among the mCherry-positive cells 
was determined by FACS on a LSRII flow cytometer (BD Bioscience) using 
FACSDiva software version 5.0.3. Quantifications were performed using 
Flowing Software (www.flowingsoftware.com).
Cell cycle profiling
For cell cycle analysis cells were fixed in 70% ethanol, followed by DNA 
staining with 50 µg/ml propidium iodide in the presence of RNase A (0.1 mg/
ml). Cell sorting was performed on a LSRII flow cytometer (BD Bioscience) 






Cells were lysed in lysis buffer (for FLAG-IP: 50mM Tris-HCl pH 7.4, 150mM 
NaCl, 1mM MgCl2, 0.5% NP-40, 0.5% Triton-X, 1mM PMSF, supplemented 
with complete protease inhibitor cocktail (Roche)/ For GFP-IP: 50mM HEPES-
KOH pH 7.5, 150mM NaCl, 0.5% Triton-X, 1mM MgCl2, supplemented with 
complete protease inhibitor cocktail (Roche)). After 30 min incubation on ice, 
lysates were cleared by centrifugation and then diluted 5 times with dilution 
buffer (For FLAG-IP: 50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1mM 
PMSF, supplemented with complete protease inhibitor cocktail/ For GFP-IP 
instead of 50mM Tris-HCl pH 7.4, 50mM HEPES-KOH pH 7.5 was used) and 
incubated with prewashed M2-FLAG magnetic beads (Sigma) for 3h or GFP-
Trap® beads for 1hr. Subsequently, beads were washed 3 times for 5min 
with dilution buffer and FLAG-bound proteins were eluted by competition with 
the 3xFLAG peptide, whereas GFP-bound beads were directly trypsinised 
to obtain bound proteins. Following elution, samples were trypsinised over-
night, desalted, freeze-dried and finally analysed by MS.
 
Supplemental Figure 1. ARIH1 loss does not affect the steady-state levels of key DSB 
repair proteins. Effect of ARIH1 depletion on the steady-state levels of various repair proteins. 
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Though as scientists we strive to decipher the cellular conundrum, quite often 
our studies give rise to more questions instead of providing straightforward 
answers. This thesis is not different in that sense. Notwithstanding our 
identification of novel regulators of DSB-induced ubiquitylation (Chapter 3), 
novel interactions between important players in the DSB response (Chapter 
4), an alternative mechanism of DNA-damage-induced translation arrest 
(Chapter 5) and a potential new modulator of DSB repair (Chapter 6), several 
points await to be addressed. 
In the case of the newly-identified DUBs, structural studies may provide a 
detailed mode of action, while MS analysis may reveal additional proteins 
targeted for deubiquitylation by USP26 and USP37. On the subject of 
comprehending better the ubiquitylation-dependent part of the DSB response, 
recognition of RNF168-substrates has long eluded us. We therefore ought 
to take advantage of current MS approaches to pinpoint novel targets of 
DSB-induced ubiquitylation. With regards to the PALB2 dependency on 
RNF168-mediated ubiquitylation, in vitro interaction experiments examining 
the potential interaction between PALB2 and RNF168, in concert with 
immunoprecipitations (IPs) followed by MS, may elucidate the sequence 
of events that promote RNF168-modulated loading of PALB2/RAD51 on 
ssDNA. Finally, our discovery that ARIH1 holds a dual role in the DDR, 
temporarily halting protein synthesis, but also directly promoting DSB repair, 
dictates further work to understand how these rather different functions are 
accomplished and regulated. Monitoring the cellular compartmentalisation 
of ARIH1 upon genotoxic stress by live-cell imaging and identifying ARIH1-
ubiquitylated proteins by MS would be steps towards the right direction. All 
the aforementioned scientific suggestions are placed into perspective and 
are elaborated in the following sections.
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Deciphering the role of USP26/USP37 and developing 
inhibitors for clinical applications
The current mainstream approaches for cancer therapy are founded upon the 
premise of inducing excessive, irreparable DNA damage in tumour cells. An 
obvious caveat in this approach is the intrinsic lack of specificity as healthy 
cells will be targeted and killed as well. In order to circumvent this perilous 
side-effect, unique aspects of cancer cells acquired during transformation 
have to be exploited. Most typically, tumours lose one or more of the main 
DNA-repair pathways, therefore being disproportionately dependent on the 
remaining one(s). Inactivation of these residual repair pathways, in concert 
with chemotherapeutica, confers lethality predominantly to transformed 
rather than normal cells. This embodies the concept of synthetic lethality 
which has become the focal point of the development of novel anti-cancer 
drugs [1].
Given the demonstrated importance of PTMs in the regulation of the DDR, 
increasing emphasis is currently being placed in the development of small-
molecule inhibitors of either the phosphorylation or ubiquitylation machinery 
[2]. As we showed in Chapter 3, USP26 and USP37 are important players in 
the DDR, because they regulate both major aspects of the DSB response, 
namely the RNF8/RNF168-signalling cascade and DSB repair. The 
significance of these two DUBs is further underscored by their deregulated 
expression patterns in cancer cells, where USP26 and USP37 are often 
either lost or amplified (for precise numbers please look at the Discussion of 
Chapter 3).
Since their depletion renders cells sensitive to IR and PARP-inhibition, by 
impairment of NHEJ and HR respectively, developing specific inhibitors 
against USP26 and/or USP37 function can be considered as an attractive 
strategy. However, before undertaking laborious screens to that end, further 
experiments identifying their substrates, other than histone H2A, will be 
crucial. USP26 or USP37 chromatin IP followed by MS, or alternatively KGG-
antibody-IP followed by MS in DUB-depleted cells, would help in the search 




then MS, indicate that USP37 may interact with key proteins orchestrating 
DNA-end resection, whereas results for USP26 were inconclusive. 
On the other hand, it will also be necessary to obtain more insight in the 
mode of action of our DUBs, especially USP26. This can be achieved by 
a combination of structural studies and in vitro deubiquitylation assays. 
For USP37 it was recently shown that its 3 Ubiquitin-Interacting Motifs 
(UIMs) enable binding to stereochemically-diverse polyubiquitin chains, 
but convey limited specificity for chain linkage [3]. This is in line with our 
findings that over-expressed USP37 can deubiquitylate various HR-related 
proteins. These findings indicate that USP37 may be a promiscuous DUB 
whose activity is mainly regulated by direct interactions with its partners. 
The likelihood that USP26 behaves similarly is unlikely, yet still possible, 
as USP26 has evolutionarily retained a single UIM. Additionally, our results 
show that USP26 is more enzymatically active, at least towards H2A-type 
histones and RNF168-induced ubiquitylation. In agreement with a potential 
high-processivity, USP26 protein levels are significantly lower than USP37 
[4, 5]. How does then USP26 remove ubiquitin from its substrates? Does 
it display chain-linkage specificity? The latter question could be answered 
by in vitro debiquitylation assays. If an array of targets for our DUBs exists, 
as we suspect, and this is identified, whilst their function becomes better 
understood, the task of developing small-molecule inhibitors would be 
worthwhile.      
Finding new RNF8/RNF168 substrates   
In recent years we have witnessed an unprecedented progress in the study 
of proteins PTMs, largely due to ever-improving MS facilities and innovative 
IP techniques, allowing the extensive analysis of modifications such as 
phosphorylation or ubiquitylation at the peptide level [6]. Current research 
indicates that the study of other protein PTMs, such as SUMOylation [7, 
8], acetylation [9, 10] and poly-(ADP-ribose)ylation [11, 12], is following 
swiftly. Interestingly, though global profiles of protein phosphorylation or 
ubiquitylation, under basal conditions [13] or genotoxic stress [14-16], have 
been published, a report has yet to emerge, describing the ubiquitylome 
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upon depletion of key ubiquitin E3 ligases. 
The case of DDR-orchestrating E3 ligases RNF8 and RNF168 is especially 
intriguing. Limited targets have been identified for RNF8 [17-20], and even 
less for RNF168 [21, 22], making it hard to resolve conflicting reports on 
their role in regulating DSB repair [17, 23-25]. Coupling either Crispr/Cas9- 
or inducible shRNA-depletion with KGG-antibody-IP and MS-analysis 
would provide a detailed picture of RNF8/RNF168-ubiquitylated substrates. 
Elucidating their common, but most importantly their divergent, targets would 
give crucial insight on several unresolved questions that have lingered in the 
DSB field. How do RNF8 and RNF168 modulate DSB-repair pathway choice? 
Do they have a singular or divergent role in promoting or antagonising error-
free repair by HR? How do they integrate DSB signalling and repair with 
other simultaneous processes such as chromatin remodelling, checkpoint 
activation, replication and transcription restart?
Mechanistically explaining the RNF168-dependency of 
PALB2 recruitment at DSBs
Our unexpected discovery that RNF168-induced ubiquitylation promotes 
PALB2 recruitment at DSBs demonstrates that key DDR enzymes fulfill 
multiple roles with often varying macroscopic effects. On one hand, 
RNF168 ubiquitylates H2A-type histones [22], thereby promoting BRCA1 
sequestration in the form of the RAP80-mediated BRCA1A complex [26, 27] 
and 53BP1 recruitment at the vicinity of DSBs [28, 29], which in turn inhibits 
extensive processing of DNA-ends [30]. In that sense RNF168 exerts an anti-
recombinogenic role. On the other hand, RNF168 recruits PALB2 at sites of 
damage, thereby enabling RAD51 loading on resected DNA (Chapter 4). In 
that sense RNF168 bolsters HR. The emerging question lies in the chromatin 
parameters regulating the balance of these contradictory roles and possibly 
the nature of the inflicted DSB.
As mentioned in the previous section, establishing detailed RNF168-
ubiquitylation profiles would be a key step towards answering this puzzle. The 
results we obtained from the LacR/LacO targeting system indicate that the 




is not the canonical one, i.e. H2A/H2AX ubiquitylation [22]. In line with this 
hypothesis, we have also observed that RNF168-induced ubiquitylation does 
not promote the association of PALB2 with histone H2A. Hence, RNF168 
probably mediates PALB2-accumulation at DSBs in another manner. 
Based on our thus far results, we favour a scenario of a direct interaction 
between RNF168 and PALB2, via the latter’s WD40 domain. In vitro 
interaction experiments between recombinant RNF168 and PALB2 would 
help confirming our IP data. The way that the ubiquitylation activity of 
RNF168 facilitates PALB2 assembly is less clear. A simplistic explanation 
would be that the known increase of RNF168 at DSBs, upon RNF168-
ubiquitylation of histones H2A/H2AX [28, 29], is sufficient to promote further 
PALB2 buildup. Simply put: more RNF168 begs more PALB2. Unfortunately, 
it is not easy to test this proposition, because utilising the ΔMIU-RNF168 
mutant, which cannot mediate auto-amplification, would also abrogate 
RNF168 recruitment [29]. The alternative option of complementing RIDDLE 
cells with a catalytically inactive version of RNF168 would not give a definite 
answer either, as such cells would miss all RNF168-ubiquitylation-dependent 
PALB2 accrual. Another, not mutually exclusive, hypothesis is that RNF168 
decorates PALB2 with K63-ubiquitin chains which somehow assist with either 
its recruitment or retention at the ssDNA compartment. This can be verified 
by a denaturing PALB2-IP in RNF168 over-expressing cells followed by MS 
analysis. Finally, it is also possible that RNF168 ubiquitylates another protein 
which bridges the interaction between the E3 ligase and PALB2. Common 
interactors identified in independent IPs for PALB2 and RNF168 would be 
prime candidates to fulfill this bridging role. 
No matter which scenario proves to be correct, an inescapable issue that 
arises, if RNF168 and PALB2 indeed interact, is that those two proteins 
do not completely overlap in their positions with respect to the DSB. While 
PALB2 remains strictly associated within the ssDNA compartment, RNF168 
is known to spread away from the DSB [31], with its associated ubiquitin-
chains also being repositioned away from the DSB at latter stages [32]. This 
difference is also evident by the distinct size of IR-induced foci that these 
proteins form [33]. Therefore, a mechanism inhibiting the PALB2-RNF168 
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interaction distally from the DSB is rather likely to exist. The potential PALB2 
K63-ubiquitylation or a constraint in the number of interactions mediated 
by the WD40 domain of PALB2, due to spatial limitations, are just two of 
possible mechanisms restricting the PALB2-RNF168 interaction at the 
ssDNA compartment.
Exploiting ARIH1-dependent translation inhibition
Cancer cells universally display deregulated growth patterns, favouring 
accelerated expansion and survival under challenging conditions. One of 
the main ways they obtain this growth advantage is by lifting constraints in 
protein synthesis. Expectedly, transformed cells boast increased translation 
rates, evident by the increase in their ribosomal content [34]. On the contrary, 
untransformed cells are subject to numerous ways of inhibiting translation, 
especially at the rate-limiting step of translation initiation [35]. This notable 
difference has driven intensive research into the development of translation 
initiation inhibitors as potential drugs, augmenting the action of mainstream 
cancer treatments [34, 36, 37]. 
Our finding that the E3 ubiquitin ligase ARIH1 facilitates 4EHP-dependent 
translation stalling upon DSB induction may provide in the future a new 
weapon in the increasing arsenal of translation inhibitors. Importantly, we 
demonstrate that the ARIH1-induced response is unique, in that it is retained 
in cancer cells, unlike the more prevalent 4E-BP1-dependent path which is 
often silenced [38]. Subsequent efforts should initially focus on identifying 
the part of the proteome that is affected by the ARIH1-induced translational 
arrest. Establishing ARIH1- and 4EHP-dependent proteome-profiles can be 
accomplished by isolating and analysing by MS newly-synthesised proteins. 
A complementary approach could also be undertaken, in which mRNAs 
bound to polysomes are purified and sequenced. The emergence of a more 
detailed picture of the affected proteins would provide important insight on 
the mechanism of the observed ARIH1-dependent sensitisation. Eventually, 
the development or discovery of substances that can potentiate ARIH1-
dependent translation inhibition, by enhancing its stability or facilitating 4EHP 




With regards to the apparent, direct involvement of ARIH1 in DSB repair, 
though a lot of work remains to elucidate its precise role, an obvious riddle 
arises: how can a protein directly regulating a cytoplasmic function, such 
as translation, be simultaneously involved in the nuclear process of DNA 
repair? A straightforward answer has yet to emerge, but several observations 
indicate unique behavioural aspects for ARIH1. Firstly, upon DSB induction 
ARIH1 increasingly translocates to ribosomes and the nucleus, placing it at 
the correct micro-environment. Secondly, ARIH1 is part of a special family 
of E3 ubiquitin ligases, the RING-In-Between-RING (RBR) enzymes, which 
have retained characteristics from both traditional E3 families, namely the 
RINGs and HECTs [39]. As such, ARIH1 may contain unique structural 
aspects that enable it to target distinct substrates, but also exhibit unusual 
auto-inhibitory effects [40]. Finally, as with most E3 ubiquitin ligases, their role 
is largely dictated by their binding partners and their associated E2s. ARIH1 
is known to directly interact with 4EHP [41, 42] which resides in the cytosol, 
while its primary E2 partner, UBCH7 (UBE2L3) [43], also resides both in the 
cytoplasm and in the nucleus, where it has been shown to regulate the half-
life of 53BP1 [44].      
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The genome contains, in the form of DNA building blocks, the necessary 
information for orchestrating all cellular functions and ensuring species 
continuity. However, though being chemically stable, DNA is under constant 
assault by various endogenous or exogenous sources. To counteract the 
perils arising due to DNA damage and to ensure genome integrity, life has 
evolutionarily acquired an arsenal of protective mechanisms, amongst which 
prominent is DNA repair. Depending on the nature of the inflicted DNA 
damage, specialised DNA repair pathways are activated in order to restore 
the original genetic information. 
During this work I focused on the elucidation of DNA repair- or other 
cytoprotective-mechanisms ensuing upon the induction of primarily DNA 
Double Strand Breaks (DSBs) or secondarily helix-distorting lesions. 
DSBs are mainly repaired by two pathways: error-prone Non-Homologous 
End-Joining (NHEJ) and error-free Homologous Recombination (HR). On 
the other hand, helix-distorting lesions, such as those arising due to UV-
irradation or cisplatin-induced mono-adducts, are rectified by Nucleotide 
Excision Repair (NER).   More specifically, I put emphasis on the role of 
protein-ubiquitylation, a widespread protein Post-Translational Modification 
(PTM), in the spatiotemporal regulation of an efficient DSB response. 
In Chapter 2, I summarise recent developments, integrate novel findings and 
present our speculative views on the possible ways that ubiquitylation and 
other PTMs coordinate diverse processes, such as chromatin remodelling 
and repair-protein retention at the sites of damage, in order to regulate NER. 
In Chapter 3, I present our findings establishing a role for the De-Ubiquitylating 
(DUB) enzymes USP26 and USP37 in the regulation of the DSB response. 
Upon performing over-expression screens, we identified the aforementioned 
DUBs as factors regulating both the DSB signalling cascade and DSB repair. 
More specifically, we show that USP26 and USP37 readily accumulate at sites 
of damage where they keep RNF8- and RNF168-dependent ubiquitylation in 
check. Thereby, these DUBs limit the repressive effect of RAP80 on both 





In Chapter 4, I describe a novel, unexpected mechanism of PALB2-dependent 
control of homologous recombination. I demonstrate that RNF168 facilitates 
error-free repair, due to PALB2 accumulation at RNF168-modified chromatin. 
PALB2 accrual at RNF168-ubiquitylated chromatin requires the former’s 
WD40 domain and is probably mediated by direct protein-protein interaction 
between PALB2 and RNF168.
In Chapter 5, I put forward our results from a functional genomics screen 
for potential regulation of the cisplatin response by enzymes of the ubiquitin 
family. I show that ARIH1, one of the top hits, promotes cellular survival upon 
cisplatin-induced damage in a manner independent of p53-status. I further 
on manifest that ARIH1 orchestrates a transient translation arrest upon DNA 
damage, which is both required and retained in untransformed and cancer 
cells.
In Chapter 6, I describe our initial results indicating that ARIH1, in addition 
to inducing a temporary arrest of translation, translocates to the nucleus and 
accumulates at DSBs. Moreover, I show that ARIH1 appears to exert a direct 
role in the regulation of DSB repair by promoting efficient HR.
Finally, in Chapter 7, I provide an overview of our discoveries in a broader 
context, incorporating recent, relevant developments in the DDR field. 
Additionally, I try to put our findings in perspective, speculating about the 
entailed molecular mechanisms, with the ultimate goal of using this knowledge 





Het genoom bevat, in de vorm van DNA-bouwstenen, de informatie 
noodzakelijk voor het orkestreren van alle cellulaire functies en het 
waarborgen van de continuïteit van een soort. Ook al is DNA chemisch 
redelijk stabiel, de integriteit van het DNA wordt constant bedreigd door 
verschillende endogene of exogene bronnen van DNA-schade. Om de 
integriteit van het genoom te waarborgen en DNA-schade te neutraliseren 
is er een arsenaal aan beschermende mechanismen geëvolueerd, met een 
prominente rol voor DNA-herstelmechanismen. Afhankelijk van de aard van 
de toegebrachte DNA-schade, zijn gespecialiseerde herstelmechanismen 
ontstaan die de oorspronkelijke genetische informatie herstellen.
Tijdens mijn werkzaamheden als promovendus heb ik mij gericht op het 
ontrafelen van de DNA reparatieroutes en cellulaire beschermingsmechanismen 
die volgen na de inductie van DNA dubbelstrengs breuken (DSBs) en/of 
DNA-helix verstorende lesies. DSBs worden voornamelijk gerepareerd door 
twee reparatieroutes: foutgevoelige Non-Homologe End-Joining (NHEJ) 
en accurate Homologe Recombinatie (HR). Helix-verstorende lesies, 
zoals die ontstaan door UV-bestraling of cisplatina behandeling, worden 
gerepareerd door Nucleotide Excision Repair (NER). In het bijzonder heb 
ik de nadruk gelegd op de rol van eiwit-ubiquitinering, een wijdverspreide 
post-translationele modificatie (PTM) van eiwitten, in de spatiotemporele 
regulering van een efficiënte DSB respons.
In hoofdstuk 2 vat ik de recente wetenschappelijke ontwikkelingen, onze 
nieuwe bevindingen en onze speculatieve opvattingen samen betreffende de 
mogelijke manieren waarop ubiquitinering en andere PTMs diverse aspecten 
van NER kunnen reguleren, waaronder het herstructureren van chromatine 
of het behouden van reparatie-eiwitten op de plaats van DNA-schade.
In hoofdstuk 3 presenteer ik onze bevindingen omtrent de De-ubiquitinering 
(DUB) enzymen USP26 en USP37 en hun rol in de DSB-respons. Door 
het uitvoeren van overexpressie screens, hebben we de eerder genoemde 
DUBs geïdentificeerd als factoren in zowel de signaleringscascade als de 




op plaatsen van DNA-schade, waar ze RNF8- en RNF168-afhankelijke 
ubiquitinering onder controle houden. Bovendien bevorderen deze DUBs 
homologe recombinatie, door het repressieve effect van RAP80 te beperken 
op zowel DNA eind-resectie als BRCA1-accumulatie op DNA breuken.
In hoofdstuk 4 beschrijf ik een nieuw, onverwacht mechanisme van PALB2-
afhankelijke regulering van homologe recombinatie. Ik toon aan dat RNF168 
foutloze DNA-reparatie faciliteert via PALB2 accumulatie op RNF168 
gemodificeerd chromatine. De rekrutering van PALB2 naar RNF168-
geubiquitineerd chromatine vereist het WD40 domein van PALB2 en wordt 
waarschijnlijk gemedieerd door een directe eiwit-eiwit interactie tussen 
PALB2 en RNF168.
In hoofdstuk 5, presenteer ik onze resultaten van een functional genomics 
screen gericht op de regulering van de respons op cisplatina door enzymen 
van de familie van ubiquitines. Ik laat zien dat ARIH1, een van de tophits, de 
cellulaire overleving bevordert na cisplatina-geïnduceerde schade, op een 
manier die onafhankelijk is van de p53-status. Ik toon verder aan dat ARIH1 
een tijdelijke translatie-stop implementeert na DNA-schade, welke behouden 
en essentieel is in getransformeerde- en kankercellen.
In hoofdstuk 6 beschrijf ik onze initiële resultaten die aangeven dat ARIH1, 
naast het induceren van een tijdelijke translatie-stop, ook accumuleert op 
DSBs in de celkern. Bovendien laat ik zien dat ARIH1 een directe rol lijkt te 
hebben in de regulatie van DSB reparatie door het bevorderen van efficiënte 
HR.
Tenslotte wordt in hoofdstuk 7 een overzicht gegeven van onze ontdekkingen 
in een bredere context, in het licht van recente, relevante ontwikkelingen op 
het gebied van DNA-schade. Daarnaast probeer ik onze bevindingen in een 
klinisch perspectief te plaatsen en speculeer ik over het uiteindelijke doel 







BER: Base Excision Repair




DDR: DNA Damage Response
DEM: Diethylmaleate
DOX: Doxorubicin
DSBs: Double Strand Breaks
DUBs: De-Ubiquitylating Enzymes
ETO: Etoposide















ROS: Reactive Oxygen Species
SAL: Salubrinal
SDSA: Synthesis Dependent Strand Annealing
SSA: Single Strand Annealing
SSBs: Single Strand Breaks
ssDNA: single-stranded DNA




UBD: Ubiquitin Binding Domain
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